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Su miliary
Isolation and molecular characterization of Mycobacterium avium
paratuberculosis in Ireland - Pierre Emmanuel Douarre

subsp.

MAP is a proven animal pathogen causing Johne's disease, one of the most
widespread and economically important diseases of ruminants. Since 1992 and the
opening of the European market, the prevalence of MAP in Ireland has increased
considerably. Improvements in diagnostic strategies for Ireland and elsewhere are
urgently required. MAP infects a wide host range and has emerged as a potential threat
to human health and has been associated with Crohn's disease. The control of
paratuberculosis infection requires a better understanding of the genetic diversity of the
pathogen. The objective of this study was to isolate and characterize this enteric
pathogen in Ireland using sophisticated molecular typing methods.
In total, 290 cattle collected from seven selected Irish herds over 2 years were
screened for MAP by a conventional culture method and two PCR assays. MAP was
isolated and cultured from 23 faecal samples (7.9%) on solid medium. From a
molecular perspective, 105 faecal samples (36%) were PCR positive for MAP specific
DNA. The cultivation of MAP was characterized by poor recovery but high specificity
whereas the PCR produced faster results with improved sensitivity. In total a bank of 38
MAP strains (15 pre-existing and 23 novel isolates) was characterized using 11 multi
locus short sequence repeat (MLSSR) loci and 8 variable number of tandem repeat
(VNTR) loci. Three subtypes were detected by the VNTR method with a discrimination
index (DI) of 0.540. In contrast, the MLSSR method differentiated the 38 MAP isolates
into 18 types with Dl of 0.921. Among these, 6 types have not been recorded
previously.
This thesis also describes the development of a new diagnostic PCR assay and the
evaluation of a novel method to differentiate MAP strains using High Resolution
Melting PCR. Based on analysis of a strategically chosen genomic region, 37 genes
were screened by in silica analysis to evaluate their potential as a diagnostic target. Five
genes were predicted to be unique to MAP and were then tested by PCR. Among them
the MAP2179 gene was identified as a specific and sensitive novel target for MAP
diagnosis. As previously mentioned, this study also described the application of an
optimized High Resolution Melting technique capable of clearly differentiating MAP
"C" type from MAP "S" type. This broad genotyping technique is simple, inexpensive
and provides results in less than 20 minutes after amplification using a fluorescent dye.
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Introduction
In the last two decades, the profile of Mycobacterium avium subsp. paratuberculosis
has increased considerably in Ireland. Improvements in diagnostic strategies and the
accumulation of molecular epidemiology data are urgently required in Ireland to control
this pathogen. This project set out in collaboration with veterinarians to isolate and
characterize MAP in Ireland.
This first objective of this study was to isolate MAP from bovine samples collected
from animals suspected of paratuberculosis infection. Another priority was to optimise
and evaluate several diagnostic strategies for MAP in selected Irish herds by comparing
culture and molecular assays.
Consequently, the thesis is divided into 5 chapters, the literature review and 4
experimental chapters describing various aspects of MAP diagnosis, epidemiology,
molecular typing and assay development.
Published information on the general characteristics of MAP, Johne's disease, MAP
diagnosis, MAP genome, genotyping and MAP in Ireland are discussed in the Chapter 1
(literature review).
The isolation and detection of MAP from cattle in Ireland using both traditional culture
and molecular based methods is described in Chapter 2.
The molecular characterization of Irish MAP isolates using multi-locus short sequence
repeat (MLSSR) and variable number tandem repeat (VNTR) typing methods is
explained in Chapter 3
The development and the evaluation of two novel methods for MAP diagnosis and
strain differentiation are described in Chapters 4 and 5.

XV

Chapter 1

Chapter 1

Literature review

1 The pathogen
1.1 Taxonomy / Classification

Mycobacterium avium subsp. paratuberculosis (MAP) is classified as a member of
the order Actinomicetales, family Mycobacteriaceae, genus mycobacterium and species
Mycobacterium avium.
Based on numerical taxonomy analysis and DNA-DNA hybridization studies [1,2].
Mycobacterium avium was initially divided into three subspecies M. avium subsp.
avium, M. avium subsp. paratuberculosis, and M. avium subsp. silvaticum (originally
called "wood pigeon" mycobacteria). More recently, a molecular study [3] differentiated
M. avium subsp. avium into two distinct subspecies: Mycobacterium avium subsp
hominissius isolated from humans and pigs and M. avium subsp. avium isolated from
birds. These four Mycobacterium avium species are grouped together as the
Mycobacterium avium complex (MAC) (Figure 1.1). Genetic studies revealed that
MAP is a clone of closely related organisms derived from Mycobacterium avium subsp.
hominissuis. Phylogenetic analysis also showed that M. avium subsp. avium and M.
avium subsp. silvaticum strains clustered together on one branch, while a distinct branch
defined MAP organisms [4]. Although commonly grouped in the Mycobacterium
avium-intracellulare complex (MAI complex), M. intracellulare is a genetically distinct
species [5].
The Mycobacterium avium complex (MAC) comprises slowly growing mycobacteria
which are ubiquitous in the environment and cause a variety of disease in animals and
humans ranging from tuberculosis-like disease in humans and birds, opportunistic
infections in immunocompromised patients and Johne's disease in ruminants [6,7,8].
Members of the MAC are the second most frequently isolated mycobacteria from
humans in developed countries after the Mycobacterium tuberculosis complex.
2
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Figure 1.1: Phylogenetic tree based on 16S rRNA sequences ofslow growing mycobacteria.
Mycobacterium avium-intracellulare complex is a group of closely related organisms including
the four Mycobacterium avium species (MAC) and Mycobacterium intracellulare [9], [10].

Despite their taxonomic relationship, these subspecies represent phenotypically diverse
organisms and many characteristics distinguish MAP from other members of the MAC.
These unique characteristics such as typical culturing, infection, virulence and MAP
specific genes are described further on in the literature review.

1.2 General characteristics
MAP is an intracellular pathogen, which is gram-positive, aerobic, non-spore
forming, non-motile, acid-fast bacillus. The bacilli (0.5 to 1.5 pm) generally occur in
clumps linked together by a network of intercellular filaments.
MAP has a complex lipid-rich cell wall, containing 60% of lipid, mostly composed
of long chain mycolic acid [11]. The thick waxy cell wall confers the organism, its acid
fast properties and hydrophobicity [12] It also gives a general survival advantage and
increased resistance to high temperatures [13], low pH, salt, chemicals [14] and

antibiotics [ 15] but the consequence of this defence is slow growth because of limiting
the uptake of nutrients through the cell wall [16].
The type strain of the species is MAP strain "ATCC 19698" isolated from the faeces of
a cow with paratuberculosis [ 17].

1.3 Mycobactin dependency

One of the major phenotypic differences between MAP and most other mycobacteria
is its inability to produce the iron chelator mycobactin for in vitro growth [18,19].
Mycobactin is a lypophilic siderophore responsible for the transport and binding of iron
into the cells and is essential for bacterial metabolism. As MAP is incapable of
producing its own mycobactin it must be provided exogenously in bacteriological
media. Practically all MAP strains require a supplement of mycobactin [20]. Although
the mycobactin dependence is a strong evidence for MAP it cannot be considered as a
definitive identification test because Mycobactin dependence is not solely restricted to
MAP. It has been noted in M avium subsp. silvaticum and some strains of
Mycobacterium avium isolates [2].
Moreover, absolute mycobactin dependence is often exhibited only on initial
isolation. Upon subculture, the organism is often capable of some growth in un
supplemented medium [21].

1.4 Culture

MAP is one of the slowest growing of the cultivable mycobacteria with a generation
time under optimal growth conditions of over 20 h [22]. Primary culture from veterinary
or clinical samples can take 6 months or longer. However, once established, a MAP

isolate will produce colonies within 8-12 weeks upon subculture at the optimum growth
temperature of 37°C under aerobic conditions.
In vitro cultivation is commonly carried out on solid media such as Herrolds egg yolk,
or Lowenstein-Jensen (Middlebrook) supplemented with mycobactin. The colonies are
small (1-2 mm), usually white, non pigmented and either smooth or rough depending on
the medium, on which it is cultivated. However pigmented (yellow) strains have been
reported in sheep [23].

A better understanding of its natural host range as well as its mode of transmission is
essential to control and eradicate MAP.

1.5 Host Range (Wildlife reservoir)
MAP has a wide host range. Wild and domestic ruminants are the types of animal most
commonly infected. Some of the more common ruminants are cattle, sheep, goats, deer,
elk and bison [24,25].
There are also infrequent reports of MAP infections in non-ruminant wildlife species
such as rabbits, fox, weasel, racoons, stoat and crow [26,27]. Several studies
demonstrated the potential for transmission and infection of MAP in non ruminants
species and provides possible evidence of interspecies transmission [28,29].
Two reports of naturally confirmed MAP infection in primates (macaques and mandrill)
have been described [30,31 ].

1.6 MAP Survival (Natural reservoir)
Compared to other members of the MAC which are widespread in the environment,
MAP only occurs in environments contaminated by faeces of infected animals. MAP is
5

described as an obligate parasitic pathogen of animals [32], so in theory it can only
survive inside the host. Because of its mycobactin dependence, it can only grow and
multiply inside animal cells where it steals iron from macrophages. However, this
organism can survive for long periods outside the host, enabling it to persist and spread
in the environment. For example MAP has been shown to persist for up to 55 weeks in
the environment [33], up to 48 weeks in dam water [34], and for 841 days in lake water
microcosms [35]. In each of these studies, Whittington et al. proposed dormancy as a
possible explanation for their findings.
Other mechanisms for MAP survival were also investigated. Two studies provide
evidence of significant interaction between MAP and protozoa at ambient laboratory
temperature (20-25°C). Whan et al. [36] demonstrated that protozoan engulfment gives
MAP protection from chemical disinfectants (chlorine) in addition to enhanced survival.
The second study showed that MAP has the potential for long-term persistence within
environmental amoebae [37]. Another study suggested earthworms and insects may also
represent possible vectors of transmission of MAP [38]
MAP clearly has the potential to take advantage of intracellular existence (within
protozoa and insects) and dormancy as survival strategies while it waits to be ingested
by a susceptible host.
In addition to surviving in the environment under severe conditions, MAP is also
resistant to many disinfectants. However, it is killed within 10 minutes in aqueous
solutions of formalin (5%), sodium hypochloride (1:50) and phenol (1:40) [39]. The
most efficient disinfectants are phenolic products in the presence of a high detergent
concentration.
Since MAP is highly resistant to heat, pasteurization is not sufficient to kill all
microorganisms in milk and its derivatives [13].
6

2 Virulence and potential disease
2.1 Johne*s disease
2.1.1 History
The slowly progressing enteric disease of ruminants later
known as Johne's disease (or paratuberculosis) was originally
described in 1894 by Johne and Frothingham in Germany
[40]. On histological examination, Johne and Frothingham
identified organisms in granulomatous lesions in the intestines
of affected cattle that stained acid-fast. They concluded that
Heinrich Albert Johne

the disease observed in the cow was caused by some type of
mycobacterial organism and, in recognition of the pathologic similarity to intestinal
tuberculosis proposed the name "pseudotuberculous enteritis" for the disease.
However, it was not until 1910 that Twort successfully cultivated the organism in the
laboratory and classified it as a mycobacterium [41]. The organism was fully
characterized several years later and named Mycobacterium paratuberculosis.

2.1.2 Prevalence
Johne’s disease is prevalent in domestic livestock worldwide. "In all likelihood,
Johne's disease is to be found in every country. Being free of the disease is probably
more a function of how hard one has looked than a true lack of incidence" [42]. With
the global trade of animals, paratuberculosis has progressively spread around the world.
First recognized in Europe (Germany, 1894), it has now been reported on every
continent.
In the African continent, paratuberculosis has been reported in both sheep and cattle
from isolated herds in South Africa and is believed to be highly prevalent in this country
7

[43]. JD has been reported in sheep in Zambia, in camels in Tunisia and in cattle in
Egypt [44].
Asia, China, Japan, India, Korea, Kazakhstan, Nepal and the Philippines are
countries with infrequent reports of Johne's disease. In Japan, a national annual study
reported 574 cases of paratuberculosis in 1997 (compared to 298 cases in 1996) [45].
In Australia, JD infection in dairy herds was reported to range between 9% and 22%
[46]. The disease occurs in temperate south-eastern Australia mainly in dairy cattle but
also in beef cattle, goats and deer. Approximately, 1300 cattle herds were classified as
infected in 2003 (Animal Health Australia, 2004).
Johne's disease is endemic in Europe. In a recent review, MAP prevalence was
estimated based on available data from 34 publications (1990-2007) including
prevalence studies from 19 European countries [47]. The true prevalence among cattle
appeared to be approximately 20% and was at least 3-5% in several countries
(Germany, Slovenia, and Italy). The prevalence among herds appeared to be >50%.
Although some countries like Sweden present a very low prevalence of paratuberculosis
with only 53 infected herds identified since 1993 [48], no countries had published
sufficient information to claim freedom from MAP or just a near-zero prevalence of
MAP infections.
A study carried out by the National Animal Health Monitoring System Dairy in 2007
indicates that 68.1 percent of U.S. dairy operations are infected with MAP (NAHMS
Dairy, 2007). The same study also suggests that at least 25% of U.S. dairy operations
may have a relatively high percentage of paratuberculosis infected cows in their herds.
The prevalence appears to be lower in beef cattle. In US, it is estimated that 8% of beef
herds contain at least one animal infected with MAP (Center for food security and
public health, 2007)
8

"The incidence of Johne's disease appears to be increasing due to the veterinarian's
interest and attention. With greater investigation comes increased appreciation of the
extent ofproblem” [42].

2.1.3 Economic impact

Johne's disease causes considerable economic losses to the animal industry
worldwide and has a significant impact on the global economy. In the United States, the
economic loss associated with paratuberculosis was estimated to $1.5 billion to the
agriculture industry every year [49].

It is considered to be one of the most serious diseases affecting dairy cattle [50]. The
effect of paratuberculosis on dairy operations in the USA was estimated at around $200
to $250 million a year [51]. In dairy herds, losses are associated with reduced milk yield
and weight gain, lower reproductive efficiency, premature culling and reduced values of

culled cattle [52]. A study reported that milk produetion losses were down
approximately 15% in paratuberculosis-infected cows in the US [53]. Additional
economic costs include diagnostic testing (veterinary costs), control measures, and
accelerated cull and replacement rates.
A study carried out by the National Animal Health Monitoring System (1996) in US
found that dairy herds with a low Johne’s disease clinical cull rate lost an average of
S40 per cow and dairy herds with a high Johne’s disease clinical cull rate lost an
average of S227 per cow. However, because of all the complex factors involved,
accurately assessing losses in productivity and profit at both herd and national level is
difficult, and it is likely that the impact of this disease is underestimated nationwide
[54]. In a more recent study, a simulation model based on 4 components of direct
production losses was developed to estimate the annual losses in Canadian dairy herds
due to MAP infection. For an average dairy herd with 12.7% of cows seropositive for
MAP, the mean loss was $2992 annually, or $49 per cow per year [55]. In a similar
Scottish study, the annual losses were estimated at £27 per cow [56].
A simple tool for estimating the cost of Johne’s disease for commercial dairies has just
been developed (2010) by the National Johne’s Education Initiative, with financial
support from IDEXX Laboratories, Inc. A brochure and an excel spreadsheet to make
the cost calculations for individual herds is downloadable on the Johne’s Information
center website (http://www.iohnes. or^/handouts/liles/CostofJD IDEXX%20booklet.pdf).

2.1.4 Control programmes

The most important reasons to control and eradicate paratuberculosis are economic
losses experienced by the animal industry, as well as the zoonotic potential of MAP.
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The development of control programmes depends on the animal species, the resources
available, the goals of the animal enterprise, and the methods of animal husbandry. The
prevalence of the infection at both herd and animal level is a key issue to determine the
importance of the infection and to decide which appropriate measures to apply
(surveillance in case of possible infection, eradication in case of low prevalence and
control in terms of high prevalence) [47].
However all control strategies rely on two approaches that must be employed at the
same time: (1) Calves must be protected from MAP exposure and raised in a clean
environment and fed with milk and water free of MAP contamination, (2) Infected adult
animals must be identified and managed to ensure no young animals are in contact with
their milk or manure.

2.1.6 Pathogenesis

Johne’s disease in cattle can be categorised into three distinct stages of disease or
infection; early infection, subclinical infection and clinical infection.

Early Infection

Animals are usually infected with MAP early in life as calves but often do not
develop clinical signs until 2 to 5 years [57]. Cattle are primarily infected by the
ingestion of faecal material, milk, or colostrum containing MAP organisms [58] but can
also be infected through in utero transmission [59]. Following ingestion by the host,
MAP organisms are carried through the gut in the ingesta. Before establishing a close
contact with the mucosa, MAP must survive the non-specific defences of the host
including bile, acidity, digestive enzymes and competition by other gut flora.
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Once in contact with the mucosa, MAP enters the lymphatic system through
endocytosis by M-cells present in the Peyer’s patches of the distal ileum. After gaining
aecess to the subepithelial layer of the intestinal mucosa MAP is phagocytosed by
subepithelial macrophage or dendritic cells [60]. It takes only 20 hours from M-cell
ingestion to the mycobacteria being phagocytosed by macrophages [61].
Once inside, MAP is not exposed to the humoral response and proliferates. Most of the
organisms escape the macrophage killing and misdirecting the normal immune
response. Various mechanisms are used by the intracellular pathogen to evade the host's
normal first line of defence: escape of the phagosome and multiplication in the
cytoplasm, prevention of the phagolysozome fusion and resistance to the effects of
lysozome and phagosome enzymes [62,63]. One study also demonstrated that within
bovine monocytes MAP elicited only modest production of reactive oxygen
intermediates (ROl) and reactive nitrogen intermediates (RNI) [64]
However, a small proportion of MAP is simultaneously killed in the phagosome and
initiates a cell mediated immune response. Successfully killed MAP results in the
presentation of antigens on the macrophage cell surface by the MHC II pathway. This in
turn stimulates CD4+ immune response and proinflammatory cytokines production such
as IFN-y and TNF-a which are involved in recruitment and activation of immature
macrophage and lymphocytes.
Due to its intracellular nature and prevention of phagolysosome fusion, the immune
system must elicit a strong CD8+ cytotoxic response to clear persistent MAP infection
in macrophage. However, CD8+ T cells require antigen presentation via the MHC class
I pathway which necessitates the presence of antigens in the cytosolic region as opposed
to the phagosome.

12

Most of MAP cells escape the destruction within the phagosome and replicate in the
cytosol. A recent study demonstrated that during infection, MAP was capable of
secreting a functional low molecular tyrosine phosphatase into the macrophage
cytoplasm which is suspected of mediating interaction with host cell substrates and
interference with pathways necessary for killing the engulfed bacteria [65].
The activation of both CD4+ and CD8+ T lymphocytes as well as proinflammatory
cytokines is vital for preventing the spread of MAP. However, failure of the host to
elicit a strong enough CD8+ response to effectively clear infection results in increased
tissue damage to intestinal epithelial cells (due to prolonged exposure to high levels of
proinflammatory cytokines) along with an increase in bacterial loads, both of which are
characteristic of sub clinical infection.

Subclinical Infection
The subclinical stage of .Tohne's disease is characterized by the lack of clinical
symptoms, infrequent, low-level shedding of bacteria, and often an undetectable to low
level of MAP-specific antibodies and increasing IFN-y responses. It is during the sub
clinical phase that MAP infection is most difficult to diagnose.
Granuloma formation is an important characteristic of the subclinical phase of MAP
infection and serves to sequester persistently infected macrophage to prevent the
pathogens spreading to adjacent cells [66].
TNF-a produced by macrophages and CD4+ T cells is critical for granuloma formation
[67] and is a key cytokine produced during sub-clinical infections with MAP. Despite
the potential for tissue damage, the maintenance of locally high concentrations of TNFa within MAP granulomas may help control the growth of the pathogen by activating
newly recruited macrophages. An increase in the number of successfully killed bacilli
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within the phagosome is usually followed by the secretion of significant amounts of IL10 (normally secreted by the host to limit damage caused by pro-inflammatory
cytokines such as TNF-a). The secretion of these cytokines suppresses critical CD4+ Tcell responses and thus decreases secretion of IFN-y, so newly recruited macrophages
become more susceptible to infection. Once again, the host’s normal response to
bacterial invasion is used against it to promote the successful spread of mycobacteria.
Within the granuloma, due to increasing levels of toxic intermediates (ROI or RNI), or
alternatively due to cytotoxic T cells, lysis of infected macrophages occur along with
the sporadic release of MAP, which accounts for the intermittent shedding of MAP in
faeces during subclinical infection. Cattle shed minimal amounts of MAP in their feces
during the subclinical phase of infection, and yet, over time, this shedding can lead to
significant contamination of the environment and an insidious spread of infection
throughout the herd.
The shedding of MAP from granulomas in such a manner also leads to the spread of
the disease along the intestinal tract, whereby each new site of infection reverts to initial
CD4+ immune response and the disease progresses. After an incubation period of
several years, extensive granulomatous inflammation occurs in the terminal small
intestine, leading to malabsorption and protein-losing enteropathy.
Paratuberculosis has a long incubation period, which generally lasts for many months
or years, during which the disease progresses in the absence of clinical signs. The
majority of affected animals become clinically ill from between two and six years of age
although the range is from 4 months to 15 years. The long and variable incubation
period dictates that even in a herd with a high prevalence of infection, clinical cases
occur only sporadically and a number of animals may be culled for other reasons and
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never recognised as paratuberculosis cases. It has been suggested that for every clinical
case of paratuberculosis in a herd there are a further 25 infected animals [68],

Clinical Infection
During the clinical stage of Johne’s disease, significant damage to the hosts’
intestinal tract arises from the numerous granulomas present which also cause poor
nutrient uptake from feed. A gradual weight loss may also be observed (Figure 1.2).

Figure 1.2: Photo of cow with Johne’s disease illustrating the weight loss

The animal may suffer from intermittent or persistent diarrhoea and sheds high levels of
MAP (which can exceed lO'® organisms/g of faeces) into the environment [58]. In late
sub-clinical and clinical stages of paratuberculosis, infected animals also shed
considerable numbers of MAP bacilli in milk and colostrum [69], Thus milk and faecal
PCR offers a rapid method for identification of infected animals [70]. As the disease
progresses from subclinical to clinical stages, the cell-mediated immune response
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wanes, and a strong humoral response predominates. At this stage of disease the
infection is characterized by abundant serum antibodies and decreasing IFN-y response.
However, normal control strategies against MAP would result in culling the animal
from the herd before reaching this stage of infection [68].
The terminal clinical stage of disease is characterized by chronic diarrhoea, rapid weight
loss, diffuse oedema, decreased milk production, and infertility.

2.2 MAP and Crohn's disease
A critical question which surrounds paratuberculosis is whether Mycobacterium
avium subsp. paratuberculosis (MAP) is strictly an animal pathogen or whether MAP is
also a zoonotic agent associated with Crohn's disease (CD) in human.
The hypothesis postulating that MAP may be the cause of CD dates nearly one
century ago when Dalzeil who first reported the disease in 1913 proposed MAP as the
causative agent. Nowadays, the advances in molecular techniques have enabled
researchers to demonstrate that there is an association between MAP and CD.
However, the role of MAP as a cause or aetiological agent of CD is still controversial.
Crohn’s disease is a chronic, systemic inflammatory disease of the gastrointestinal
tract. The disease is both episodic both over time (relapsing and remitting) and space
(anatomical distribution). Historically, the first reason to consider MAP as a possible
cause of CD was the argument of analogy. Because MAP has been shown to cause an
inflammatory bowel disease in a variety of hosts [71] it is possible but unproven that it
may cause chronic bowel disease in humans. Even though this first argument remains
compelling it mostly serves as the basis for further investigations, such as looking for
evidence of MAP infection in humans. Furthermore, all other animal pathogens within
the genus mycobacterium do also infect humans.
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2.2.1 Epidemiological data
Diagnostic tests for MAP infection in humans mostly consists of looking for the
organism at the cellular or DNA level or looking for a specific immune res|>onse.
Epidemiological studies to detect the presence of MAP in humans have largely used
three types of tests: the culture which is considered as the gold standard for MAP
diagnosis, microscopy and molecular analysis including PCR. Of these tests, the more
convincing methods (isolation of MAP by culture) has been the least rewarding. The
number of MAP isolates (as defined as identification of pure colonies on solid media)
has been surprisingly low, suggesting that human disease caused by MAP is very
uncommon [72].
There are several potential reasons for the low number of culture positive results.
Most studies looking for MAP in CD patients use mucosal biopsies. However, the
disease extends well beneath the mucosa, throughout the bowel wall and other sites
such as the mesenteric fat and fistulas [73]. So far, only a few samples of deeper tissues
including mesenteric lymph nodes or lymphatics have been studied for evidence of
MAP. Further studies are therefore encouraged to consider carefully the tissue being
investigated and attempt to analyse the full thickness of the intestinal sample.
For microscopy, a number of different approaches have been applied including
examination of tissues stained by Ziehl-Neelsen, and in situ hybridization for either
rRNA or 1S900. Direct examination of stained tissues is not recommended because the
presence of the acid fast bacilli depends on the stage of the disease and it can't be
differentiated from other mycobacteria. Two studies have reported that in situ
hybridization using IS900 as a probe produced non-specific signals [74,75]. Ziehl
Neelsen and in situ hybridization for ribosomal DNA were not able to resolve beyond
the subspecies level.
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In comparison to the small number of reports on MAP infection by culture and
microscopy, there is abundant literature on the detection of MAP DNA by PCR.
However, the important issue of this technique is standardisation, validation and
reproducibility [76]. These PCR studies can be divided into those that detect MAP in
CD and those that do not. An inspection of these findings suggests that the large
majority of these studies have detected an association between MAP and CD. Also,
there are only a few studies that have found a negative association. However, the nature
of the association still remains unknown.
Bull et al. found MAP DNA in about one-third of control tissues, compared with
90% of Crohn's disease tissues [77]. These results suggest that MAP infection (or
presence) is common but more frequent in CD. In contrast, another study found very
few positive results in control tissues, with MAP DNA detected in over half (52%) of
CD samples [78]. These results would propose that MAP infection (or presence) is not
common but its presence is strongly predictive of the disease. Standardization of the
PCR methods involving inter-laboratory comparisons are required to fully elucidate the
nature of the association.

2.2.2 Susceptihility - molecular evidence
In order to investigate whether mycobacteria contribute to Crohn's disease it is
important to start with what is known from clinical and epidemiological studies.
Although there are several human biomarkers associated with the disease there are no
simple assays that specifically indicate the presence of the disease. At the genetic level,
there is a list of genes associated with the development of IBD. However only three are
specifically associated with CD: NOD2, ATG16L1 and IRGM. Both genomic
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predictions and functional studies have confirmed that each of these genes encodes a
protein serving in the innate immune resp>onse to intracellular bacterial infection [79].
NOD2 is an intracellular pathogen recognition molecule. It is implied that defects in
NOD2 signalling would predispose individuals to bacterial infection [80]. ATG16L1 is
a protein that is essential for the formation of an autophagosome [81] an intracellular
recycling system implicated in the handling of mycobacteria and other intracellular
pathogens [82]. IRGM is a GTPase implicated in resistance to infection by intracellular
pathogens, including M avium and M tuberculosis [83]. Further research will
determine which bacteria can exploit mutations in these genes to initiate an infection
and provoke an inflammatatory immune response. It remains to be seen if these three
genes, which are linked through a common role in responding to intracellular
pathogens, control different infections or instead represent distinct steps during the host
response to the same intracellular infection.

2.2.3 Argument against MAP
A number of arguments have been presented against MAP being the cause of CD.
Although each argument has merit, none of them has conclusively refuted this potential
link.
The first argument is that farmers and veterinarians should be at increased risk
because of the livestock associated zoonosis. A recent study in the UK concluded that
there was no association between CD and behaviours likely to be linked with MAP
although this study did find an increased risk with consumption of more meat [84].
The second argument is that the use of TNF-a inhibitors used to treat Crohn's disease
patients is incompatible with a mycobacterial aetiology. These immunosuppressive
drugs have been introduced based on the presumption that CD represents an
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autoimmune disease eharacterized by excessive host-directed host inflammation. While
the use of such agents may appear counter-intuitive for a hypothesized infectious
disease, it must be recognized that anti-TNF drugs were originally developed to reduce
severe inflammation [85].
The third argument is that anti-mycobacterial treatment has limited efficacy in
treatment of CD. Peyrin et al. showed that anti mycobacterial agents were ineffective in
Crohn's disease patients in a large placebo-controlled trial [86]. The considerate trial
was a failure even though the drugs used were known to be efficacious against chronic
MAP infection. Although the authors reported a short-term benefit, the original report
claimed that this benefit was lost with time [87].

2.2.4 Hypotheses
In review articles, a number of hypotheses have been proposed to explain some of
the different observations outlined above.
For example, the high rate of PCR positive studies in the absence of microscopic
detection was compatible with organisms being present in a cell wall deficient form
[88]. It has also been suggested that human strains of MAP are potentially antigenically
distinct from bovine strains. If true, then the risk to humans may no longer be from
livestock but rather from other humans. Proof of such hypotheses would come from
demonstrating that MAP is genetically distinct from organisms circulating in the natural
hosts. To date, genetic studies have shown that human isolates have a molecular profile
shared closely with cattle strains [89]. The sequencing of a human isolate of MAP by
the University of Minnesota is expected to provide some definitive data towards
resolving this issue.
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2.2.5 Conclusion
The debate about MAP and Crohn’s disease has been continuing for almost 100
years. Advances in molecular techniques and culture methods combined with the
increased knowledge of MAP has enabled researchers to demonstrate that there is an
association between MAP and CD. However, the role of MAP as a cause of CD
remains controversial. For each study published that supports a role for MAP in CD, it
seems that another study appears with negative results

3 Diagnosis of MAP
Paratuberculosis can be diagnosed by several methods or tests. Because of the
pathogenesis of paratuberculosis (which is characterized by a slow progress of infection
and an inappropriate immune response) the choice of the test varies with the stage of the
disease. There are two main types of diagnostic tests; tests directed at the organism
itself or tests that examine the animal's immune response to MAP infection.

3.1 Identification of the organism
3.1.1 Microscopy / Direct examination / Histopathology
The examination of typical granulomatous lesions of the ileum and histopathological
lesions are only suggestive of paratuberculosis. The direct examination of faeces or
tissues samples stained by Ziehl Nielsen can be used to visualize clumps of small acid
fast bacilli. However, simple visualization cannot differentiate MAP from other
environmental mycobacteria, and the presence of acid fast bacilli in macrophages or
lymph nodes depends on the stage of infection. During early infection and subclinical
stages, there are usually very small numbers of acid fast bacilli. For these reasons,
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histopathology is of limited use in detecting the disease. Direct examination is therefore
not recommended for diagnosis [39].

3.1.2 Cultivation of MAP
Cultivation and identification of MAP is the definitive diagnostic test for Johne’s
disease. MAP is defined as an intracellular pathogen. For this reason, its precise
identification by cultivation is the benchmark for diagnosis of paratuberculosis at both
animal and herd level. Important aspects for the culture of MAP include the analytical
sensitivity of the particular method, the contamination rate, the cost of the test and the
time taken to report results. As culture of MAP is used as a gold standard to evaluate
other types of diagnostic tests, the performance of other diagnostic tests (including
polymerase chain reaction, serology and histopathology) is often questionable [90]. For
example, a report of a great diagnostic performance of an enzyme-linked
immunosorbent assay (ELISA) or a faecal PCR test to detect MAP in early infection
might be due to the use of an insensitive faecal culture protocol.

There are three critical steps for the cultivation of MAP:
1. The decontamination of clinical samples to destroy or suppress fast growing microbes
including both bacteria and fungi (present in vast number of faeces).
2. Prolonged incubation in an appropriate media containing antimicrobial agents to
suppress any remaining contaminants long enough for MAP to emerge.
3. Identification of typical MAP colonies on solid media or a particular sign of growth
in broth media. Equally, the identification of specific MAP phenotypic and / or
genotypic characteristics can be employed.
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3.1.2.] Decontamination of clinical samples
Faecal samples
The first attempts to cultivate MAP from clinical samples used a decontamination
protocol originally described for tuberculosis. Several chemicals were used to
decontaminate faecal samples. These included sodium hypochlorite, sodium hydroxide,
sulfuric acid, hydrochloric acid, oxalic acid (OA), phenol or a combination of NaOH
and OA. The detergent hexadecylpyridinium chloride (HPC) was first used in USA
(Merkal, 1968) and is now the basis for current methods in many countries.
Antimicrobial dyes such as malachite as well as particular antibiotics have often been
included in decontamination solutions [91]. Faecal samples present a particular problem
due their high load of enteric bacteria. Removal of these bacteria achieved by
suspending faeces in water or decontamination solution followed by filtration by light
centrifugation or more commonly by sedimentation can be performed [92,93]. The
filtrate or supernatant is then removed and is inoculated into culture media. Current
protocols have evolved independently in different laboratories over the years. In some
Europeans countries, the NaOH-OA decontamination protocol is used with LJ medium.
In the USA and most other countries, sedimentation method with HPC is combined with
HEYM or liquid media. A large study in Denmark compared the two most popular
types of solid media (HEYM and LJ) using NaOH-OA decontamination protocol and
found that the HEYM medium had slightly greater sensitivity. To increase the analytical
sensitivity of faecal culture, MAP may be concentrated during or after decontamination
of the sample by either centrifugation or filtration [94,95].
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Tissue samples

MAP is commonly isolated from intestinal tissues of infected animals and has
sometimes been cultured from human tissues [96]. Methods described for tissues are
simpler and usually involve only a single decontamination step. Incubation of
homogenized tissues overnight or up to 3 days in HPC is sufficient to remove most
contaminants from the intestinal wall or lymph nodes [97]. Usually fat is trimmed away,
and the remaining intestine is finely divided with scissors, ground, blended
mechanically or disrupted using a stomacher in solutions that may include protease to
disrupt tissue structure [98,99]. The homogenate is decontaminated by suspension in an
antimicrobial solution, and the sediment is inoculated.

Milk samples

The shedding of MAP into the milk of infected animals was recognized many years
ago [100]. A lot of effort has been made to detect MAP in samples of milk from
individual cows, from bulk tank milk and from pasteurized milk including retail
samples [70,101]. Reliable culture from milk is crucial to study the effects of
pasteurization on the viability of MAP [102]. Most culture protocols involve
centrifugation of milk to produce a pellet containing MAP. The cream layer may
sometimes be collected and pooled with the pellet for culture [103]. Immunomagnetic
separation of MAP from milk using specific antibody coated magnetic beads has been
developed to facilitate selective isolation of MAP cells from milk [104]. Several groups
have shown that decontamination using 0.75% HPC in a sedimentation protocol is
suitable to reduce contamination and is less damaging to MAP than double incubation
[103].
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Blood

Isolation of MAP from blood is not carried out routinely as there have been no
studies on suitable culture methods or on the prevalence of MAP in blood. There has
been only one study involving blood culture from livestock [105]. Heparinized buffy
coat-plasma preparation was decontaminated in 0.75% HPC and cultured on HEYM.
Only one culture was positive from 7 cows that had advanced disease.

3.1.2.2 Cultivation
Common culture media

Both solid and liquid culture m.edia can be used to cultivate MAP. Solid media are
probably more commonly used as they are cheaper and the identification of the
organism can be simpler. Culture media for MAP must include essential nutrients,
especially antimicrobials to inhibit growth of contaminants and may also include dyes
to assist recognition of the colonies.
Two solid media are commonly used: Herrold's egg yolk medium (HEYM) and
Lowenstein Jensen (LJ). Middlebrook 7H10 or 7H11 agar and 7H9 broth are also
suitable media but for optimal growth of MAP, egg yolk must be added. In most
circumstances mycobactin must be added to the media for primary culture. However
sufficient carry-over of mycobactin to the new media may disguise this need during
subculture [106].
Sodium pyruvate was reported to stimulate the growth of MAP and is included in
both LJ and HEYM media used by some laboratories [107,108]. Also, Jorgensen (1982)
showed that pyruvate enables MAP colonies to grow larger in LJ medium,
compensating for the inhibitory effects of antibiotics that are included in this medium
[109].
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Antimicrobials

such as

malachite

green,

cycloheximide, amphotericin

B,

vancomycin, nalidic acid, chloramphenicol, penicillin G, polymyxin B, trimethoprim,
azlocillin and ampicillin have been included in various media but meticulous evaluation
of their potential to inhibit growth of MAP has never been carried out [97,110]. Most
laboratories currently include vancomycin, amphotericin B and nalidixic acid in
HEYM.

Automated system

Other liquid culture systems designed for medical microbiology have been used to
grow MAP [111,112]. For example the BACTEC system culture (BACTEC 12), uses a
liquid broth with a nutrient source supplemented by the radioisotope '"*002. BACTEC
12 relies on the detection of the radioisotope through microbial respiration. The
bacterial growth is detected by automated equipment after 4-7 weeks of incubation.
However, the major problem with this process is the high costs and the disposal of the
radioactive waste. Another system, the BACTEC MGIT 960 (Beckton Dickinson) relies
on the detection of a fluorescent signal from an indicator during microbial respiration
[111]. EPS culture technology (Trek diagnostic) relies on the detection of a change in
pressure in the gas phase of a sealed culture vial. The MB/BacT system (Biomerieux) is
based on a colorimetric indication of carbon dioxide production. Each of these
automated culture systems enables early identification of microbial growth by incubated
culture vials within an instrument that monitors the growth signal. However, these
newer methods still require the formal identification of MAP when a growth signal is
detected.
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Incubation period
MAP grows very slowly; the generation times in liquid media usually range from 1.3
to 4.4 days compared to 20 - 30 min for E.coli [22]. Even when grown on the most
suitable media, typical MAP colonies do not appear for several weeks and some not for
several months. Incubation times of 12-20 weeks are standard for solid media but can be
more rapid in liquid media, usually 8-12 weeks [113]. The reasons for the very slow
growth rate compared with its close relative Mycobacterium avium subsp. hominissius
are still unclear [114].

3.1.2.3 Identification of MAP
MAP colonies
When typical mycobacterial colonies are identified on solid media or when growth is
reported in broth culture, the next challenge is to identify MAP. A presumptive
identification can be made based on slow growth; the colonies will develop after a
minimum of 8 weeks.
Twort and Ingram (1912) were the first to describe MAP colonies [41]. They
presented as round, smooth and white, and tended to heap up slightly, becoming light
yellow with wrinkling of the surface. Pigmentation of colonies was influenced by the
colour of the M. phlei or egg that was added to the medium. Colony morphology is
dependent on the medium and addition of supplements can dramatically alter it. For
example. Tween compounds, which may be hydrolysed and become a source of oleic
acid for the organism leads to otherwise irregular granular colonies on 7H9 agar
appearing instead as entire, smooth and domed [115]. In contrast, colonies of MAP
isolates recovered from sheep (type “S”) growing on 7H10 agar are white, circular,
raised and convex. They reach < 1 mm in diameter by 6 weeks [97].
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Figure 1.3: Pigmented ovine isolate
Pigmented colonies oj Mycobacterium avium suhsp. paratuberculosis on a Lowenstein-Jensen
slant, isolated from the yellow-colored intestines of one sheep with clinical paratuberculosis
from the Basque Country’ [116]

Figure 1.4: MAP colonies on a slope of Lowenstein-Jensen medium, supplemented with
mycobactin [117]
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Mycobactin dependency
One of the major phenotypic differences between MAP and most other mycobacteria
is its inability to produce the iron chelator mycobactin for growth in the laboratory
[18,19]. This phenotypic characteristic has been described above in the general
characteristics. Mycobactin dependence is a strong diagnostic indicator for MAP,
however, it has also been noted in M avium subsp. silvaticum and some other strains of
Mycobacterium avium [2] and therefore cannot yet be considered as a definitive
identification test.

Molecular confirmation
The discovery of IS900, an insertion sequence thought to be specific for MAP,
provided a molecular basis for identification [118]. 1S900 is a member of the family of
insertion sequences, some of which closely resemble 1S900 and so positive results can
be obtained from other mycobacterial species using primers and probes that are
commonly applied [119,120]. However, there are different strategies to resolve closely
related IS900-like insertion sequences. These include restriction endonuclease analysis
(REA) of the PCR products, sequencing the PCR product or use of internal probes and
specific primers in a real time PCR assay. Because the identification of MAP using the
IS900 sequence has been shown to be marginally less than 100% specific, it is
important that 1S900 PCR does not serve as a stand-alone test used for culture
confirmation.
The sequencing of the MAP genome enabled the identification of specific sequences,
unique to MAP that can be used for PCR identification. These new targets will be
discussed later.
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3.13 Polymerase chain reaction (PCR)
PCR has revolutionized the field of molecular diagnostics. Slow growing and non
culturable bacteria have become easier to identity and suspected bacterial growth by
culture methods has become very easy to confirm.
Diagnostic tests based on specific DNA sequences allow rapid and accurate
identification of MAP. PCR has been used to confirm positive results and to identify
MAP in faeces, milk and tissues fl21]. In diagnostic PCR, the DNA sequence used for
amplification needs to be chosen with an appropriate degree of specificity. Therefore
the identification of a unique DNA sequence that occurs specifically in the MAP
genome is crucial for the development of PCR based diagnostic test.

Choice of the target
The most frequently used target sequence (as already mentioned) is the IS900
element, first described by Green et al. and thought to be specific to MAP. The MAP
genome is reported to have 14 to 18 copies, and the reference strain KIO has 17 copies
[18]. The presence of this target in high copy number within MAP provides an
increased sensitivity compared to systems targeting single copy genes which makes it a
popular diagnostic target for MAP. However the accurate detection of IS900 is not
definitive for the identification of MAP as its specificity has been questioned in many
studies. This IS900 element has many similarities with insertion sequences in other
mycobacteria, which means that PCR detection of a conserved region of this sequence
may produce false positive results. Englund et al. showed that Mycobacterium strain
2333 contain one copy of a sequence sharing 94% sequence similarity with IS900 [119].
Several measures to increase the specificity of new PCR systems targeting the IS900
include the use of specific probes, the development of multiplex PCR or sequencing
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[77,122,123]. The presence of IS900-like sequences in other mycobacteria has led
researchers to identify alternative specific genetic targets for MAP diagnosis (Table 1.1).
Several MAP genes are currently used for PCR diagnosis of MAP and are shown in the
table below. These include F57, hspX, gene 255, IsMav2 and ISMAP02.

Gene

Copy no

IS900

14- 18

References

Bull et al., 2000 and Mobius et al., 2008

ISMAP02

6

Stabel et Bannantine, 2005; Irenge et al., 2009

ISMav2

3

Shin et al., 2008 and Mobius et al., 2008

Hspx

1

Ellingston et al., 2000 and Stabel ct al., 2004

Gene 255

1

Bannantine et al., 2002 and Mobius et al., 2008

F57

1

Vansnick et al., 2004 and Hertnek and Bolske, 2006

Table I.l: MAP genes usedfor diagnostic PCR

Poupart et al. first described the use of the fragment F57 as a diagnostic probe for
detecting MAP. This fragment has one copy in the genome of MAP and does not
hybridize with DNA from other mycobacterial species [124]. Stabel and Bannantinc
demonstrated that the sensitivity of the PCR targeting ISMAP02 for the detection of
MAP in faecal samples was similar to that achieved with IS900 target [121].
As expected, the use of targets with multiple copies will provide higher sensitivity than
is achieved with single copy target.
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Sensitivity
When applied to confirm the identity of a mycobacterial culture, the sensitivity of
the PCR assay was 100% [46], but when applied to clinical samples, the sensitivity was
low [125]. Initially, conventional PCR analysis has been unable to match the sensitivity
of faecal culture [126]. Collins suggested that at least 10,000 bacilli per gram of faeces
are necessary to achieve positive results by PCR [39]. Another study found sensitivities
varying from 3% to 23% in comparison to culture [ 127].
One of the reasons for this low sensitivity is the presence of inhibitory substances
(complex polysaccharides, certain salt and ions, urea and proteinases) in the sample
which usually interfere with the PCR and could lead to false negative results [128].
Immuno magnetic separation (IMS), a technique where specific antibody-coated
magnetic beads are used to selectively isolate MAP from the sample matrix was a
promising advance to overcome this obstacle [104]. Although this method was regarded
as the best method to detect MAP in milk [129] it did not work so well for faecal
samples [130].

Other PCR techniques
Other improved PCR methods have been developed to increase the low sensitivity of
the conventional PCR.
The use of nested PCR which consists of 2 consecutive PCR reactions with two
different set of primers, using the product of the first reaction as template in the second,
enables a number of potential advantages including specificity and sensitivity. As all
four primers have to match their target in the same DNA region to obtain a final
product, specificity is also increased [131]. PCR inhibitors if present in the first run will
be diluted when the product of the first PCR is used as template for the second PCR.
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However, the main disadvantage of nested PCR occurs during the transfer of
products from the first run to the second one. This step is extremely critical and may
cause cross contamination due to the high number of amplicons potentially produced
after the first run.
The high sensitivity of nested PCR is usually not needed for detection of MAP in
liquid culture as the amount of MAP should be sufficient after growth. However, this
technique has been proven extremely useful to detect MAP in clinical samples and milk
[77,103]. Stabel and Bannantine showed that the sensitivity of a nested PCR targeting
ISMAP02 to detect MAP from faecal samples varied from 94.4% to 98.9% [121].
In comparison to conventional PCR which only measures the final product, real time
PCR monitors the reaction throughout every temperature cycle by measuring the
fluorescence emitted by either a fluorescent dye that intercalates with the dsDNA or by
a target-specific fluorescent probe. Fluorescent probes bind to a specific site within the
desired product, therefore increasing the specificity of the assay. There are different
probe technologies, such as Scorpions, Molecular Beacons and FRET probes, but the
most widely used is the so-called Taq-Man probe. Real time PCR is also more sensitive
than the conventional PCR, due to the sensitive detection of fluorescent signal by the
instrument. Another advantage of this technique is that post process analysis of each
tube occurs in a closed environment.
In the past decade, there have been significant improvements in PCR based
detection of MAP including sample processing, amplification and detection methods.
The precise sensitivity of this method is still difficult to establish. However attempts to
increase the sensitivity of this diagnostic test have yielded promising results [121,132].
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3.2 Immune response
During MAP infection, animals develop humoral and cellular immune responses,
related to the stage of the disease. The tuberculous form of the disease is associated with
a strong cellular response at the early phase of the infection. High levels of cytokines
including IFN-g are secreted by peripheral blood mononuclear cells. In parallel, B-cells
proliferate and specific antibodies are produced in large quantities. The lepromatous
form arises at the late stages of the disease, characterized by the decline of the cellular
response and the increase of the humoral immune response [39].

3.2.1 Cellular Immunity Tests
The intradermal (skin) test was the very first to be utilized. In this test, a MAP
protein extract, (johnin) is inoculated in the neck of the animal. After 72 hours of the
inoculation,

the

inoculation

site is

inspected visually and the delayed-type

hypersensitivity reactions (DTH) caused by the cellular immune response, is evaluated
[133]. Besides the difficulty of interpretation and standardization of the results, the
presence of false-positive reactions represents a big problem. The test cannot
distinguish hypersensitivity reactions resulting from infection from those caused by
contact or infection by M hovis, M. avium or M tuberculosis. The exposure to other
mycobacteria including environmental saprophytes, can also result in false positives
[39]. Because of the importance in determining the infection status of subclinically
infected animals, research in this area has led to the development of a bioassay that
detects elevated IFN-y levels in response to M bovis infections. This test was further
modified for identifying MAP-infected animals [134].
This test measures the production of IFN-y of sensitized T-cells by enzyme-linked
immunosorbent assay (ELISA) [135]. Infected animals produce three-fold more IFN-y
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prior to shedding of the bacilli with the feces. Moreover, IFN-y levels induced by MAP
antigens are higher than those induced by other bacteria [136]. Evaluation of the IFN-y
test by using experimentally and naturally infected cattle and sheep demonstrated its
utility for distinguishing animals in the initial stages of infection. However, a study
conducted by McDonald et al. showed that all non-infected control animals tested
positive at least once during the course of their study, suggesting that the IFN-y ELISA
test may require further optimization [137]. Another study performed in Denmark
demonstrated

the

occurrence

of

cross-reactions

between

tuberculosis

and

paratuberculosis in animals older than 14 months. These results suggest the need to find
antigen formulations that are more specific for paratuberculosis. Until then, the
interpretation of the IFN-y test must be adjusted according to the incidence of the
disease. For paratuberculosis, this test seems to be more appropriate as a support tool to
evaluate young animals within a herd [138].

3.2.2 Humoral immunity tests
Humoral immunity usually develops 10 to 17 months after infection. Serology can be
used for the presumptive identification of infected animals, as well as for estimating the
prevalence of infection in a herd, or for confirming paratuberculosis in animals with
clinical signs.
Three different tests are currently available for measuring antibodies against MAP in
the serum of infected animals. These are the complement fixation test (CF), agar gel
immunodiffusion (AGID) and specific enzyme-linked immunosorbent assays (ELISA).
The latter is the most commonly used.
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Since a strong humoral response does not occur until the later stage of Johne’s disease,
the sensitivity of these tests is the highest for animals with clinical symptoms, or those
that shed large numbers of bacteria [139].
The complement fixation test is a valuable test for the confirmation of clinical cases
even though its standardization is difficult, and the technique showed unsatisfactory
results for detecting subclinical animals. The sensitivity varied from 21 to 52%, and its
specificity ranged from 95 to 97%. In comparison to CF, AGIO is easier to perform and
has similar sensitivity (18.9%) and specificity (99.4%) to the CF test [140].
ELISAs are easy to perform and are more sensitive than CF and AGIO, since they
are capable of detecting antibodies at low concentrations. However, this test is not good
enough to diagnose subclinically infected animals. ELISA should not be the only
diagnostic test used to indicate culling of reactive animals [50]. Therefore, serological
tests are not sufficient to control the disease, and are more useful as screening tests to
estimate the paratuberculosis prevalence of a herd or to monitor the herd after
eradication of the disease [141].
ELISA can detect specific antibodies in blood or milk with higher sensitivity than
AGIO and CF. However, some results demonstrated that ELISA is not a good
diagnostic test for milk samples. A study performed by Klausen et al. showed that
ELISA failed to identify positive animals from milk samples [142]. In another case,
MAP was isolated from milk samples, but ELISA was negative for the same sample
[143].
Many variations of the ELISA method have been used to detect antibodies against
MAP [144]. For example, the preabsorption of test sera with M. phlei antigens has
proven to increase ELISA specificity and sensitivity [145]. This step was included to
remove nonspecific antibodies against environmental mycobacteria that could
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potentially cross-react with MAP antigens. However, this modified approach cannot
discriminate paratuberculosis from tuberculosis infection. A commercial ELISA with
M. phlei preabsorption step was found to have a specificity of 95.4% to 99% and a
sensitivity of about 45%.
The results of ELISA tests can be expressed as numerical values, allowing the
classification of animals as positives, negatives, and suspects. This classification is
determined by a cut-off value adopted for each test. ELISA has been considered as a
fast, accurate, and cheap assay for paratuberculosis diagnosis [141].
The performance of commercial ELISAs is affected by the stage of MAP infection.
ELISA is very useful for identifying shedding animals, and therefore can assist in
reducing the contamination of the environment [146]. ELISA sensitivity is around 15%
when animals are not shedding MAP in faeces, while it achieves 87% in animals
presenting clinical symptoms of paratuberculosis. As the infection evolves, there is a
great production of antibodies. Therefore, high antibody levels can be correlated with
the emergence of clinical signs [136]. However, until now, it was not fully
demonstrated at which point of the disease faecal culture or ELISA could first identify
positive animals from an infected herd [147].
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4 MAP Genome
The complete genome sequence of Mycobacterium avium subsp. paratuberculosis
KIO has been published by Li et al., in 2005 [18]. The strain MAP KIO was isolated
from a Wisconsin dairy herd in 1990.

Figure 1.5: Circular representation of the MAP KIO genome
Figure generated with GENESCENE software (DNASTAR) [18]
Red arrow = rRNA operon; dark purple histogram = GC content; multicolored histogram —
MAP ORFs coded according to functional classification (small molecule metabolism in blue,
macromolecule metabolism in red, cell processes in purple, other processes in yellow,
hypotheticals in green and unknowns in orange).The outer colored histogram indicates the
same direction of transcription as the origin of replication and the inner colored histogram
indicates the opposite direction of transcription. Black arrows = 45tRNAs. The outer circle
represents the scale.

MAP K-10 has a single circular sequence of 4,829,781 base pairs with a GC content of
69.3%. The GC content is relatively constant throughout the genome. In the MAP
genome, a single rrn operon (16S-23S-5S) was identified along with 50 additional
genes coding for functional RNA molecules.
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Property of MAP genome
4,829,781 bp
Genome size
G + C content, %
3,346,971 bp
4587
Total genes
Protein coding gene
4538
Genes assigned a role category;
2713
Genes not assigned a role
category:
867
Conserved hypothetical genes:
693
Hypothetical genes:
265
46
tRNA genes:
rRNA genes:
3

100%
69.29%,
100%,
98.93%,
59.78%o
19.10%,
15.27%
5.83%
1.00%,
0.06%,

Table 1.2: Summary oj the complete genome of MAP KJO (The Comprehensive Microbial
Resource website)

4.1 Protein-Encoding genes
The K-10 genome was originally annotated as having 4,350 predicted open reading
frames (ORFs) with lengths ranging from 114 bp (a ribosomal subunit encoding gene)
to 19,155 bp (a peptide synthetase), which, in summary, account for 91.5% of the
entire genome. Subsequently automated analyses of the genome sequence have
annotated up to 4587 total genes (Table 1.2).
(http://cmr.jcvi. org/cgi-hin/CMR/GenomePage.cgi?org=ntma03).

The analysis showed that a total of 60% of the putative proteins in MAP had homologs
to other microbial proteins with known functions and 25% were homologous to
hypothetical proteins (Table 2 and Fig. 4, which are published as supporting information on
the PNAS web site [18]). A total of 39 predicted proteins are unique to MAP, with no
identifiable homologs in the current databases. Of the predicted proteins, 75% had
homology to those identified in MTB. The analysis of the MAP genome showed a large
number (n ~ 150) of genes with regulatory functions which is consistent with the ability of
MAP to survive in a wide range of environmental conditions [148].
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4J Metabolic pathways
The MAP genome encodes a complete set of enzymes for many metabolic pathways
including glycolysis, the pentose phosphate pathway, the tricarboxylic acid cycle, and the
glyoxylate cycle. However, there are genes and putative pathways missing in the MAP
genome that have been described for MTB.
Compared to Mycobacterium tuberculosis genome, MAP is lacking the flimarate
reductase complex members

as well as the nitrate reductase gene narX. These

genes are thought to be important for survival under anaerobic condition. Three members of
the aspartate family (asnB, dapA and lysA) are duplicated in the MAP genome [149]. The
genes dapA and lysA encode proteins involved in lysine biosynthesis and their duplication
may therefore be indicative of an increased requirement for lysine, while asnB has been
shown to facilitate natural resistance to antibiotics in Mycobacterium smegmatis [150]. The
MAP genome is lacking the urease operon (ureABC and ureDFG), which enables the
utilization of ammonia as a nitrogen source. Compared to other mycobacteria, the MAP
genome is lacking the genes atsBDFH which are used to generate sulfated glycolipids.
Relative to other M avium species the MAP genome contains an abundance of functionally
redundant lipid metabolism genes. In the MAP genome, the gene cluster (mbtA-J)
responsible for the mycobactin synthesis is similar to other mycobacteria with the notable
exception that mbtA is truncated by approximately 150 amino acids [18]. As mbtA is
thought to initiate mycobactin production, the truncation of this gene might explain the in
vitro growth requirement of supplemental mycobactin.

4.3 Virulence factors
The PE / PPE family proteins are putative virulence factors originally identified in
M. tuberculosis [148]. They often contain polymorphic sequences and are thought to be
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expressed on the cell surface and provide the antigenic variation that elicits varying
immunological responses in MTB depending on the type of PE / PPE proteins
expressed on the cell surface [151]. PE / PPE proteins have only been found in
mycobacteria where they comprise anywhere from 1% of the genome (MAP) to nearly
10% (MTB). The genome sequence of MAP KIO has identified 10 PE and 37 PPE
homologues compared to 38 and 68, respectively, in MTB [148]. This reduced number
of the PE / PPE proteins within the MAP genome may suggest a more limited, less
variable, and altered immune response toward MAP compared to MTB.
Intracellular pathogens often express proteins that alter the effects of the host's immune
response so as to evade destruction. Mycobacteria are assumed to selectively express
specific genes to allow for survival inside the host macrophage. One such gene, the
mammalian cell entry {nice) gene has been originally identified in MTB and has been
associated with survival within macrophages and increased virulence [ 152,153].
The MAP genome encodes 62 proteins containing conserved domain that have been
associated witli mce proteins, while the MTB genome contains 3. These coding sequences
are organized into eight clusters scattered around the MAP genome. The mce genes in
pathogenic mycobacteria have been hypothesized to play a role in modulating the host cell
envelope [154]. The contribution of mce genes to MAP pathogenesis is not fully
understood, but studies on homologous sequences in other mycobacteria suggest that they
are likely to be important contributors.
Mycobacteria were originally classified as such by the presence of mycolic acids [155].
These lipophilic molecules located primarily on the cell wall are thought to play a role in
pathogenesis in many mycobacterial species by their ability to allow entry into host cells, or
suppress or evade host immune defence mechanisms [156]. The analysis of the MAP
genome revealed approximately ~80 more genes in MAP (n ~ 266) involved in lipid
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metabolism than in MTB. This difference between the 2 organisms indicates there may be
variation in lipid metabolism and biosynthesis that may play a role in the virulence and host
specificity of the bacterium.

4.4 Repetitive DNA
Approximately 1.5% (or 72.2 kb) of the MAP genome is comprised of repetitive
DNA like insertion sequences, multigene families, and duplicated housekeeping genes.
The MAP genome encodes 12 proteins that are homologous to the REP13E12 family of
repetitive elements. This is a 1,400-bp repeated insertion sequence originally described
in the MTB genome [157]. These elements have been shown to be targets of phage
integration, and one of the copies (MAP 1432) is absent from sheep isolates of MAP
[158].
Insertion sequences (IS) are short segments of DNA that act as transposable
elements. A total of 58 insertion sequences have been identified within the MAP
genome including 17 copies of the previously described 1S900, seven copies of IS1311
and three copies of ISMav2 [18]. Many of these MAP IS elements are related to
previously described insertion sequences in other mycobacteria. For example
ISMAP02 which is present at 6 locations within the MAP genome is ~ 80% identical to
insertion sequences in Mycobacterium vanbaalenii and Mycobacterium gilvum,
although the sequences in these organisms contain a deletion of approximately 100 bp
relative to ISMAP02. ISMAP04 is present in four copies and is 80% identical to IS
elements reported in the genomes of Mycobacterium sp. MCS, MAH 104, M.
smegmatis and M. gilvum. MAP insertion sequences with no identifiable homolog in
other mycobacteria are of particular interest for their potential use as specific
diagnostic targets.
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The MAP genome was found to contain 185 mono, di- and trinucleotide repeats
dispersed throughout the genome [159]. A subset of these short sequence repeats or
SSR (11SSR) have proven to be useful for molecular epidemiology studies of MAP
isolates [160]. Diagnosis and strain characterization of MAP using such repetitive
sequences will be discussed later.
An additional 362 sequences representing either direct or indirect sequence repeats of 674 bp with a repeat number ranging from 2 to 16, and with a mutual homology of 67 - 100%
was identified in the MAP genome [ 18].

4.5 Unique genes
The MAP KIO genome contains several genes that are not found in any other
organisms for which the sequence information is currently available within public
databases.
Many of these unique coding sequences are grouped together in clusters. Initial
efforts have been made both to identify these sequences and to determine if they encode
proteins that are capable of eliciting an immune response [121,161,162]. Other than the
initial identification and immunological characterization, these unique genes have not
been subjected to a meticulous examination.
The sequences currently identified as being uniquely present within the MAP genome
are listed in the table below (Table 1.3).
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ORF

Size (bp)

MAP0094

285

None

MAP0852

546

Sugar transport

MAP0853

660

Aldehyde deshydrogenase

MAP0855

945

DNA repair

MAP0856C

1728

None

MAP0857C

318

None

MAP0858

549

None

MAP0860C

891

None

MAP0861

342

None

MAP0863

675

FAD/NAD binding domain

MAP0864

426

None

MAP1220C

336

FAD/NAD binding domain

MAP1636C

474

None

MAP1731C

270

Decarboxylase

MAP2149C

645

None

MAP2151

438

None

MAP2152C

375

None

MAP2154C

576

None

MAP2158

582

None

MAP2751

582

None

MAP2753

759

None

MAP2754

258

Repressor

MAP2757

282

None

MAP2761C

717

None

MAP2762C

441

None

MAP2763C

309

None

MAP2764C

450

None

MAP2767C

552

Ferredoxin

MAP3437C

843

DNA binding

MAP3815

855

None

MAP3816

243

Phage integrase

MAP4267

363

None

Conserved domains

Table 1.3: MAP unique genes

These unique sequences have considerable potential for the development of more
specific and sensitive diagnostic assays for detection of MAP with both molecular and
immunoassay based approaches.
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The completion of the MAP K10 genome sequence has opened the door to many new
areas of research such as: comparative genomic studies with other mycobacteria, new
insights into mechanism of virulence, design of diagnostic assays, strain differentiation
and molecular evolution studies.
However there is still a large segment of the genome (greater than 30%) that
encodes sequences with no identified function. Thus, much more work remains to be
done in order to elucidate further insights into MAP virulence and metabolism.
Other MAP genomes (sheep and human isolate) have also been subjected to wholegenome sequencing and should yield valuable information for comparative genomic
studies.

5 Strain characterization of MAP
Before the mid-1980s the ability to differentate MAP strains was extremely limited.
There was evidence from primary in vitro culture that strains which often infected sheep
were different from those that infected cattle [163J. Phenotypic characteristics such as
growth rate and pigmentation have been used to differentiate MAP strains. Two
phenotypes of MAP have been previously described based on culture characteristic. One
phenotype, usually associated with sheep isolates has a yellow pigment and is extremely
slow growing (more than 16 weeks incubation). The other phenotype is associated with
cattle, goat and other animal isolates and seems to grow faster in vitro (6 to 12 weeks).
However, these differences were not sufficient for determining the genetic stability or
geographical distribution of MAP strains. Until the advent of DNA techniques, there
was no way of reliably characterizing MAP strains into different types.
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Most of the current typing methods for MAP clearly distinguish strains into at least two
main groups; those that cause Johne’s disease in cattle in most countries (type C), and
those that cause the disease in sheep in New Zealand, Australia, Morocco, South Africa
and Iceland (type S). Other types emerged later. Use of terms Type C and Type S does
not imply absolute host specificity, as both types have been isolated, at least
occasionally, from all the common ruminant hosts, but the designation has
epidemiological value in many situations [164].
Current typing techiques for MAP can be broadly divided into two categories:
methods which analyse the total genomic DNA and the methods which analyse specific
sequences as outlined below.

5.1 Total genomic DNA method
5.1.1 Restriction endonuclease analysis (REA)

The first DNA typing system to be applied to MAP strains was restriction
endonuclease analysis (REA) [165]. This simple technique consisted of digesting the
purified genomic DNA from a selected strain with a suitable restriction endonuclease
and separating the fragments produced on the basis of size by gel electrophoresis. By
using specific enzymes (Bstell, Pvull and Bell) under optimized conditions the digested
fragments ranged in size from 5 to 15 kb. This approach had already been successufully
applied to typing strains of the related species, Mycobacterium bovis [166].
When REA was first applied to 3 reference MAP strains and 23 MAP strains from
New Zealand cattle, two of the references strains and all the cattle strains except one
had identical patterns.The remaining cattle strain had one fragment difference with one
enzyme pattern, indicating the very close genetic similarity of all these strains.
Subsequently, when REA was applied to a very diverse collection of 50 MAP strains
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from a range of host species in five countries, the strains were clearly divided into two
groups [167]; strains isolated predominantly from cattle (Type C) and the strains
predominantly isolated from sheep (Type S). This established the first genetic evidence
that many isolates from sheep were different from those of cattle. This had important
epidemiological implications as cattle and sheep graze the same pastures in some
countries, and the result indicated that infection between sheep and cattle might be
much less frequent than infection within the same host species.
Interestingly, REA also revealed a single fragment difference between a human
isolate of MAP and the most common type C strain found in several countries. The
results of this study raised the possibility that successful infection of humans with MAP
might only occur with strains that were slightly different genetically from those
commonly found in cattle [167].
Overall, REA divided 50 strains of MAP into eight different types. However, the
technique has not been further used for MAP strains because it is technically difficult to
perform and easier methods provide a better discrimination of MAP strains.

5.1.2 Pulse Field Gel Electrophoesis (PFGE)
Pulse Field Gel Electrophorsesis is a form of REA but differs from the latter by
several aspects. In PFGE, restriction endonucleases cut the genomic DNA infrequently
and produce 10-20 large fragments of 20-700 kb. The large fragments are then separated
through agarose gels over 12-24 h by periodically changing the direction of the electric
field during electrophoresis (Figure 1.6). While PFGE has become the gold standard for
food-borne pathogens it has only been used to a moderate extent to differentiate MAP
strains [168].
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In the first report of its application to MAP, six strains were characterized into three
types [169]. Although the differences observed in early studies were not clear, they
were sufficiently encouraging to use PFGE on a variety of MAP strains, mainly from
cattle, sheep and goats [23,70]. The recent improvements of the technique now allow a
clear discrimination of MAP strains. PFGE distinguishes Type C (Type II) and Type S
(Type I ) strains and is also able to further divide Type I isolates into Intermediate type
or Type III. However, like most other typing techniques PFGE does not distinguish
Type C strains from bison strains [116].
When PFGE has been compared with other typing methods, it has shown moderately
better discrimination than IS900-RFLP (discussed later) analysis for both Type S and
Type C strains isolated from sheep and goats [23] but only slightly better discrimination
for Type C strains isolated from cattle [70]. These findings support the results found in
a larger number of RFLP studies which concludes that there is a low degree of diversity
of Type C strains of MAP in cattle throughout the world [70].
The main reasons for the limited use of PFGE for MAP studies are that the method is
expensive, time-consuming and is only applicable to cultivable strains because it
requires large quantities of good quality DNA.
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Figure 1.6: Photographs of two gels showing the PFGE profile of 24 different MAP subtypes
detected after digestion using Spel enzyme. Numbers above the lanes correspond to the PFGE
nomenclature. Arrows and asterisks indicate differences (hand loss and new band, respectively)
between cattle type profiles, and sheep type profiles. MW = molecular weight standards, in
Kilobases (Kb) [116].

5.1.3 Amplified fragment length polymorphism (AFLP) analysis
Whereas PFGE and REA differentiate MAP strains based on large and moderate size
of DNA restriction fragments respectively, amplified fragment length polymorphism
(AFLP) analysis defines types based on small sized (50-700bp) DNA restriction
fragments. Because of the small amount of DNA in each fragment, the fragments are
amplified by polymerase chain reaction (PCR) in order to be visualized. Different
restriction enzymes can be used to digest the DNA and usually only a subset of digested
fragments are selected for analysis through the design of primers. Because of these
variations in the technique, it is often difficult to compare the results from different
AFLP studies. Three studies from the USA have used AFLP to type local MAP strains
mainly isolated from cattle [170,171,172]. The 2 larger studies, which between them
looked at 128 MAP isolates from cattle found that 73% and 90% of the isolates
analyzed were characterized into only 2 types [172,173]. However because different
isolates and different techniques were used in the two studies, it is not clear whether the
two types referred to are the same. One of the studies which applied AFLP to MAP
strains isolated from sheep as characterized by another technique found that one of these
strains had the most common type found for Type C strain isolated from cattle [173].
This inability of AFLP to clearly distinguish Type S strains from Type C as well as
repeatability and interlaboratory variation issues may indicate why this technique has
not been widely adopted.
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5.1.4 Random amplified polymorphic DNA (RAPD) analysis
Random amplified polymorphic DNA is based on PCR amplification of genomic
DNA using one or two short random sequence primers (10-22 bases) that are selected
arbitrarily. The profile of fragments generated is characteristic of the species or strain
from which the DNA was prepared. Once suitable primers have been identified, the
technique is simple and inexpensive to perform. However, because the primers do not
exactly match most target sites, the technique is very sensitive to small changes in
reaction conditions and results can be difficult to reproduce exactly. Two studies have
applied RAPD analysis to MAP strains isolated from cattle in Germany and the USA
and both report some differentiation of isolates [174,175]. In the larger study, 208
isolates from cattle were divided into six types, with two types representing 58% of the
strains. This supports the result found by other typing methods that determined that
there is a low degree of diversity of Type C strains of MAP in cattle. But because of its
limited reproducibility, it is unlikely that the RAPD technique can serve as as a suitable
MAP typing system.

5.2 MAP specific sequence
5.2.1 Insertion sequence
Insertion sequences are relatively short DNA sequences capable of transposing
within bacterial genomes. Use of insertion sequences provides discrimination due to the
tendency of this mobile element to insert randomly and occupy multiple sites in the
genome. In certain cases, the localization of specific insertion elements at defined places
in the genome is sufficiently stable to allow them to be used as markers for species
typing and for epidemiological studies [ 176].
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1S900
The repetitive DNA sequence, which is 1451 bp long and present in 15 - 18 copies,
was identified independently in two laboratories and was rapidly applied to the typing
of MAP strains [11,177,178].
Characterization of MAP strains by Restriction fragment length polymorphism
(RFLP) analysis with the insertion sequence 1S900 has been the most commonly used
typing system for MAP strains [179]. With this technique, genomic DNA is digested
with a restriction enzyme that does not cut within 1S900; the DNA fragments produced
are separated by agarose electrophoresis, blotted on to nylon and hybridized to a probe
made from part of the 1S900 sequences (Figure 1.7).
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Figure 1.7: IS900 RFLP patterns ofgenomic DNA digested with BstEII from MAP strains [ 180]
Lanes 1-4, common type C strains; lanes 5-7, Type S strains from New Zealand; lanes 8 10, Type S strains from the Faroe Islands, South Africa and Iceland respectively.

In some cases, the differences identified appear to be due to the presence or absence of a
copy of 1S900 in a strain, while in other cases they appear to be a consequence of DNA
sequence changes resulting from genomic rearrangements between adjacent 1S900 loci
[122,180]. As with other techniques that involve digestion of genomic DNA, the choice
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of restriction enzyme is important. Most studies have used one or more of the three
enzymes BstEII, Pvull and Pstl. By itself BstEII gives slightly better discrimination
than the other two enzymes but the best discrimination is obtained by combining the
results of two or three enzymes [23,181]. For example, Whipple et al., (1990)
characterized 34 MAP strains (mostly USA bovine isolates) into five BstEII types, four
Pvull types and four Pstl types and achieved a combined characterization of eight types
[182]. However, even with this combined characterization, 62% of the isolates had the
same type. The analysis of 47 isolates of type C from cattle, deer and goats in New
Zealand found that 94% had the same IS900 RFLP type (D.M. Collins, 2009,
unpublished data). This type was common in Australia [183] and was also the
predominant type in the Czech Republic and elsewhere in Europe [181]. In another
study, analysis of 61 MAP isolates from cattle and deer in Argentina found that 75%
had a single 1S900 RFLP type [184]. In this case the predominant MAP type was the
same as that in UK from which many Argentinian cattle were originally sourced [26].
International standardization of the IS900 RFLP profiles enabled the comparison of
results from many different countries [181]. A large comparative study analysed the
typing results of 998 isolates of Type C including 696 isolates from Czech Republic and
isolates from 16 other eountries. In most cases, the isolates had been typed using both
BstEII and Pstl. A total of 28 different subtypes of Type C were identified of which 19,
were represented by only one to five isolates. From the overall results, it is evident that
a small number of IS900 RFLP types predominates globally. Studies on the global
distribution and the stability of few types indicates that the RFLP types are very stable
and therefore very reliable for long term epidemiological studies.
Because IS900 typing is simpler than total genomic methods and gives similar or
only slightly lower discrimination of isolates, its use has been investigated in many
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countries. Its widespread application has enabled it to confirm the results from other
typing methods, that MAP can be characterized into two groups Type S and Type C.
Some recent studies have shown that IS900 RFLP further divides Type S into a new
sub-group called “intermediate type or type III”. Collectively Type S isolates are
designated as Type I and III. As with the total genomic techniques, the method is also
time consuming as it requires subculture of an isolate in order to obtain large amounts
of high quality DNA. While the speed of typing MAP strains by IS900 RFLP can be
improved by using a multiplex PCR for IS900 integration loci (MPIL), which requires
much smaller amount of DNA, MPIL does not detect all the differences found by IS900
RFLP technique [122].

IS1311
The insertion sequence 1S1311 is present in seven copies in MAP strains of Type C
and nine copies in MAP strains of Type S. Not surprisingly, RFLP analysis with IS1311
clearly differentiate Type C strains from Type S strains, but the method has been used
infrequently as a typing system [185]. This is because this technique did not
differentiate between strains of Type C in three separate studies although it clearly
divided six Type S isolates into four subtypes [185,186,187]. While IS1311 RFLP
analysis has not been found to be useful, a PCR restriction endonuclease (REA) analysis
that targets a point mutation in IS1311 sequences has been used to divide MAP isolates
into three groups: Sheep type, Cattle type and Bison type. MAP Bison type has been
reported for the first time from wild bison of Montana, USA [188] and later, has also
been reported from domestic ruminants and humans in India. Furthermore recent studies
have shown that Bison Type is the predominant type of MAP infecting the livestock
population in India [189]. This Bison type strain has genetic and phenotypic differences
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to both C and S types. Although IS1311 is not unique to MAP, ISO 11 PCR-REA is a
simple method which provides a high discrimination and can be be applied to nonculturable strains.

5.2.2 Repetitive sequences
Repetitive elements in bacterial DNA are frequently used as markers for the
differentiation and subtyping of bacterial pathogens associated with human and animal
diseases [190].

Variable number tandem repeats (VNTRs)
A variety of tandem repeated DNA sequences of 50-80 bp in length, have been found
to be very useful for typing strains of the Mycobacterium tuberculosis complex over the
last 10 years [191]. The typing is based on detecting the number of copies of a particular
repeat, as the copy number sometimes differs between strains. The sequences are
referred to as variable number tandem repeats (VNTRs). Based on particular
charcteristics, some VNTR are also designated as mycobacterial interspersed units
(MIRUs); for simplicity, the term MIRU will not be further used. Short sequence
repeats (SSRs), a special class of very small tandem repeats, are discussed separately in
the next section (2.2.2). The great advantage of VNTR typing is that, because it is based
on PCR amplification, it requires only small amount of DNA, which can potentially be
obtained from primary cultures. The four or five VNTR loci selected in early studies
gave only very limited discrimination of MAP strains [192,193]. More recent sudies
used six, seven or eight VNTR loci for typing MAP strains of type C [194,195,196].
The analysis of 183 MAP isolates including MAP strains from cattle, sheep and humans
from 10 different countries using eight VNTR loci generated 21 VNTR types [196].
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Another study using 6 loci differentiated 71 MAP strains from cattle in Germany into
15 VNTR types [195]. In these two studies, the overall discrimination of VNTR typing
was similar to that of IS900 typing, and the combination of the two typing methods
gave much better discrimination than either method separately. The third study obtained
no discrimination of MAP strains by VNTR typing [194]. These three studies cannot be
compared in detail, as in each case diffferent MAP strains were used and each study
used a different combination of VNTR loci; but taken together they provide an excellent
guide to the VNTR loci that have most potential to discriminate MAP strains.
Overall, VNTR typing is a rapid PCR-based method providing a high discrimination
of MAP strains. One of the main advantages of this technique is that it is results in
numerical genotypes and is therefore convenient for online comparisons and
phylogenetic analysis which arc greatly required in epidemiology studies.

Short sequence repeats

Short sequence repeats (SSR) consist of simple tracts of a single nucleotide or
multimers of di- or trinucleotide repeats. SSRs have been used as markers for
differentiation of several bacterial species, including Mycobacterium tuberculosis.
Results of multilocus short sequence repeat (MLSSR) sequencing approach by Amonsin
et al. (2004) offers an easy and reproducible high resolution typing method for MAP
strain differentiation [159]. The examination of 78 SSR loci in the MAP genome
revealed 11 that were polymorphic [159]. The analysis of these loci differentiated 33
MAP isolates into 22 distinct SSR types providing a higher discrimination than AFLP
and MPIL typing methods. Another study using 11 SSR loci distinguished 123 MAP
isolates from different host and geographic origin into 49 SSR types. These two studies
also showed that locus 1 and 8 (G and GGT repeats) were the most polymorphic among
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the loci tested. Hence these markers have been widely used to analyze MAP diversity
[89,197]. SSR typing has shown that certain sub-types are host-restricted and others are
shared among different host species. For example, the analysis of SSR of MAP isolated
from Crohn’s disease patients identified two alleles (7G - 4GGT and 7G - 5GGT), both
of which clustered with strains derived from animals with Johne’s disease [89] (Figure
1.8).

SSR typing has also shown that specific SSR types are associated with subclinical
disease and others are associated with clinically apparent disease (highly virulent) [89].
Cattle

Sheep

Goat

Figure 1.8: Allele distribution across various host species strongly suggests strain sharing and
interspecies transmission among M. avium subsp. paratuberculosis strains [89]

Recent studies reported that the four most discriminatory loci in the USA were stable
in three MAP strains tested over ten subcultures [198]. A very recent study also reports
that two of the most commonly used SSR sequences are invariant in 98 isolates of the
bison type from differents parts of North India [189]. The most recent comparisons of
SSR typing with other methods reported that using six SSR loci gave considerably
better discrimination than VNTR typing, which itself was more discriminating than
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typing based on IS900 and that using two SSR loci gave a similar discrimination to
PFGE [197,199].
However, despite its performance as a typing method, because of the potential
sequence errors due to strand slippage during either PCR or sequencing reactions, there
is a need to sequence each locus in both direction as well as testing duplicate samples.
These sequence errors are particularly directed at the two loci with mononucleotide
repeat G.

5.3 Conclusion
A comparison of the different methods discussed earlier is shown in Table 1.4. Four
methods of typing MAP strains predominate (PFGE, IS900-RFLP, VNTR and SSR).
1S900RFLP typing has been the most used method. It clearly separates MAP strains into
Type S and Type C but gives insufficient discrimination between strains within each
type for it to be useful for detailed epidemiological studies. It employs simple DNA
techniques that are available in many laboratories but it is slow because of the
requirement for a large amount of high quality DNA. PFGE is also a slow technique but
it gives a better discrimnination than IS900 typing. However, PFGE has not been as
popular as IS900 typing because it requires a level of skill and equipment that is not
available in many laboratories and the discrimination of MAP strains is not sufficiently
good for detailed epidemiological studies. VNTR is simpler and faster than IS900RFLP and PFGE typing and is easily performed in most laboratories, but does not by
itself give better discrimination than these other methods. SSR typing appears at first
sight to be a more discriminating typing method than any of the other three methods
when applied independently and may represent the future for molecular epidemiological
studies. Regardless of the method adopted internationally, there is an urgent
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requirement for standardisation, and the availability of an online international database
would be invaluable.
In the longer term, and probably in the near future for well-resourced laboratories,
the ability to rapidly sequence DNA fragments with high throughput will inevitably lead
to higher-resolution typing system being developed for MAP strains. The new
generation of sequencing techniques even raises the possibility of total genome
sequencing being used as a typing method. While such extensive and detailed
characterization is probably not necessary for some purposes, some improvement on the
current typing systems would undoubtedly lead to a more precise understanding of
MAP epidemiology.

Typing
methods

Ease of use

Discrimination

Reproducibility

Time

REA

Difficult

+

++++

Slow

PFGE

Moderate

+++

+++

Slow

AFLP

Moderate

+

+++

Moderate

RAPD

Very easy

++

+

Fast

IS900

Easy

++

++++

Slow

VNTR

Very easy

+++

++++

Fast

SSR

Very easy

++++

+++

Fast

Table 1.4: Comparison of available typing methods
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6 IMAP in Ireland
6.1 History and Prevalence
Johne's disease is a notifiable disease since 1955 in the Republic of Ireland and is
regulated by the Johne's disease order, 1955 [200]. All confirmed infected animals and
their immediate progeny are to be removed from the herds and slaughtered.
The first clinical case of paratuberculosis diagnosed in Ireland was in 1932 in a seven
year old cow originally imported from Great Britain. Historically, the prevalence of
paratuberculosis in the Republic of Ireland has been remarkably low, with only 92 cases
reported, primarily in imported animals from 1932 to 1982 [201].
Clinical cases of JD were only occasionally diagnosed and occurred almost
exclusively in a small number of pure-bred cattle herds [201]. In 1954, a survey carried
out on 100 mesenteric lymph nodes of 100 random Irish cattle and 300 British cattle
showed that MAP wasn't isolated from any of the Irish cattle whereas MAP was isolated
from 17% of the British cattle [202]. A similar study carried out the same year on 256
Irish cattle and 358 British cattle found the organism in 0.8 % of cattle from Ireland
whereas MAP was isolated from 7.5 % of the British cattle [203].
Prior to the 1990's, the importation of cattle from countries other than Northern
Ireland was prohibited in order to prevent the introduction of certain diseases. However
imports of pedigree bovine stock for breeding purposes were sometimes permitted.
Import controls included quarantine of the animal in the country of origin and also
similar quarantine arrangements in Ireland after importation. Furthermore the fulfilment
of specific veterinary health requirements, guarantees and tests relating to Johne's
disease were also required. The only animals that could be imported were the animals
not vaccinated against Johne's disease and without clinical evidence of paratuberculosis
for the three previous years. It appeared in the past that these controls did not always
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prevent the importation of Johne's disease. In 1980, paratuberculosis was diagnosed in 2
animals imported from France. [201]
Since 1992, when the single European market was introduced, free movement of
animals was permitted. The pre-import test certification requirements for JD and the
requirement for imported livestock to be placed in quarantine for up to six months after
arriving in Ireland were removed by the single European market. During quarantine,
imported animals were subjected to additional tests for Johne's disease. In many cases,
the minimum requirements to ensure freedom from paratuberculosis were a negative
complement fixation test (CFT) and the absence of signs of clinical disease in the herd
of origin in the preceding 2 years. Due to the low sensitivity of the CFT and the
unreliability of using the absence of clinical signs as evidence of freedom from disease,
there was concern that some subclinically infected animals could have been imported.
[204]
In the 12 years from 1992 to 2004, approximately 85,000 more cattle were imported
from Europe compared to only 8,383 animals imported between 1979 and 1990 which
represents a 10-fold increase (Central Statistics Office, Cork, Ireland, personal
communication). Most imported animals were used for breeding purposes and had come
from Netherlands (8,223), Denmark (6,832) and France (29,105). Paratuberculosis has
almost certainly then increased in Ireland through the importation of subclinically
infected animals from European countries where the incidence is higher. Brady et al.
(2004) found that in five infected herds, all had imported animals from Europe [205].
Between 1995 and 2002, 232 Johne's disease-infected cattle in 106 herds were
notified to the Department of Agriculture and Food [206].
In January 1997, a serological survey was conducted on 224 imported animals in 36
herds and at least one animal gave a positive reaction when tested by ELISA (CSL)
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from 36% of the herds [204]. Twelve of these herds and four additional herds suspeeted
of paratubereulosis infection were further investigated between May and November
1997. Faeces and serum were collected from 226 imported animals present in the 16
herds studied. MAP was isolated from the faeces of nine (4.1%) animals in 6 (37.5%)
herds. Seven of the culture positive animals had been imported from the Netherlands
and one animal each from France and Denmark. Four of these positive herds were then
tested again by ELISA. Eight animals (3.7%) were tested positive for paratubereulosis
by ELISA [204].
In 2000, the identification of JD infected animals in a dairy herd located in Munster
was followed by a series of serological and culture tests (2002 - 2004) to confirm MAP
positive animals, and develop a culling strategy. In 2002, 80% of ELISA (n=91) and
100% faecal culture tests (n=18) were positive. Between 2002 and 2004, 15% of ELISA
(n=657) and 20% of faecal culture (n=108) tested were positive [207].
During the national bovine paratubereulosis serosurvey conducted by DAFF in 2004
- 2005, blood samples were collected from 949 cows in 32 herds. Of the 949 cows in
the final dataset, 13 cows were sero-positive for MAP. Of the 32 herds tested, eight
herds were found to be “positive”, having two or more positive cows and eight herds
were found to be “non-negative”, having at least one positive animal.
As part of the same national serosurvey, serum samples from 2,333 cattle in 20 herds
selected but apparently free of endemic paratubereulosis were tested by ELISA. In total,
only 1% of the 2,333 serum samples tested positive by ELISA [208].
More recently. Good et al. conducted a random survey in Ireland during 2005 to
estimate the sero-prevalence of Johne's disease. Serum samples were collected from
20,322 animals in 639 herds and tested using a commercially available ELISA. The
overall prevalence of infected herds was 21.4% with at least one ELISA-positive animal
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(2 times more prevalent in dairy herds than beef herds). The prevalence among all
animals tested was calculated to be 2.86%. Most of the herds had only one animal
infected ELISA positive but 6.4% of all herds had more than one [209]. A summary of
all related prevalence studies for MAP in Ireland is shown in Table 1.5.
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6.2 MAP in Milk
Paratuberculosis infected animals shed MAP in milk and colostrum. The ingestion of
contaminated material is a significant risk factor for Johne's disease infection in new
bom calves. MAP has been of concern to the dairy industry worldwide in recent years
due to its possible association with Crohn's disease in humans [210,211] and studies
reporting that pasteurization does not effectively inactivate MAP if present in raw milk
[212]. If MAP is proven to be zoonotic, milk may be a vehicle of transmission of the
organism to humans.
Paratuberculosis is also a big concern for the Irish dairy industry. Compared to dairy
production worldwide, the Irish dairy industry is small, producing 5.2 million tonnes
equivalent to 0.94% of global production in 2006 (International Dairy Federation).
However, the export of milk and dairy products is a major contributor to the national
economy; approximately 85% of annual production is exported by the industry [213].
According to the Department of Agriculture and Food (2005), the value of Ireland’s
Dairy exports per annum amounted to €1,997 million. Irish milk is used in powdered
milk formula and Ireland produces 15% of the world's infant formula milk (Irish
Business and Employers Confederation 2007).

6.2.1 Detection of MAP in milk
Much modem research on the island of Ireland has focused on the development of
molecular assays for MAP in Ireland. For example, in 1998, an immunomagnetic
separation (IMS) technique was developed to facilitate selective isolation of
Mycobacterium paratuberculosis cells from milk [104]. Studies showed that IMS
selectively recovered MAP from inoculated milk containing as few as 10 CFU of MAP
per ml. The use of the IMS in combination with PCR or ELISA can provide a rapid and
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selective detection method for MAP in milk [214]. Another assay, using GITC lysis to
isolate MAP DNA in milk, followed by a real-time PCR using a molecular probe
targeting IS900 was developed by O'Mahony (2004) to detect MAP DNA in milk. This
rapid real-time PCR assay was able to detect <100 organisms per ml of milk [215].

6.2.2 Incidence of MAP in milk and pasteurization
Several studies have been carried out in Ireland to determine or to investigate the
presence of MAP in milk, the effectiveness of the pasteurization and the impact of JD
infection on milk production.
The thermal inactivation of MAP at pasteurization temperatures was investigated by
Grant et al. (1996). Viability of MAP after pasteurization was assessed by culture on
Herrold's egg yolk medium (HEYM) and BACTEC liquid culture. MAP cells were
isolated in S5% (n=34) of pasteurized milk samples treated by high-temperature-shorttime (HTST, 71.7 °C/15 s) method when initially inoculated with MAP at 10^ to 10^
cfu.ml '. When spiked with 10^ to lO'^ cfu.ml ', MAP was recovered in 58% (n=33)
[216].
A similar study was carried out 2 years later (1998). Grant et al. investigated the
efficacy of high-temperature, short-time (HTST) pasteurization (72 °C/15 s) when low
numbers of MAP (< 10^ cfu.ml ’) are present in milk. BACTEC liquid culture detected
acid fast bacteria (AFB) in 14.8% and 10% of HTST pasteurized raw milk, previously
spiked with 10 and 10 cfu.ml' MAP whereas solid medium HEYM detected AFB in
only 3.7% and 6.7% of the same milk samples. However, no viable MAP were isolated
from HTST-pasteurized milk containing 10 cfu.ml ’ and 2 x lO ’ cfu.ml ’. Those results
indicate that MAP may survive pasteurization when present in large numbers in milk
[217].
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Two separate studies were carried out in 1999 and 2000-2001 to determine the
incidence of MAP in raw and pasteurized milk in Ireland to verify the effectiveness of
the pasteurization. In one study, 396 milk samples (including 310 raw cow milk
samples, 77 pasteurized cow’s milk samples and 9 goat's milk samples) were tested by
culture on HEYM and BACTEC liquid culture. All 396 samples (0%) tested negative
for culture of MAP [218]. In a second study, the Food Safety Authority of Ireland
(FSAI) carried out a

surveillance of Irish milk. 389 raw-milk samples and 357

pasteurized-milk samples were tested by immunomagnetic separation-PCR (IMS-PCR)
and culture. MAP DNA was detected by IMS-PCR in 12.9% of raw-milk samples tested
and in 9.8% of pasteurized milk samples but MAP was only cultured from one raw-milk
sample [219]. As no viable MAP was isolated from commercially pasteurized milk, the
current pasteurization procedure was considered to be effective in the Republic of
Ireland.
However further evidence of the resilience of MAP in milk was demonstrated by
Grant et al. (2002) [212]. When raw cow's milk naturally infected with MAP was tested
for the presence of MAP after pasteurization with a commercial-scale pasteurizer on 12
separate occasions, the bacteria was detectable by culture in either raw or pasteurized
milk on 10 of the 12 processing occasions. Overall, viable MAP was cultured from
6.7% and 6.9% of raw and pasteurized milk samples respectively. This study provided
clear evidence that MAP in naturally infected milk may be capable of surviving
commercial HTST pasteurization when present in raw milk in sufficient numbers [212].
In 2004, milk sock filter residue (MFR) from 59 selected dairy farms (apparently free
of endemic paratuberculosis) was assessed on six occasions over 24 months for the
presence of MAP using culture and IMS-PCR. In total, 20% and 44% of the samples
were MFR culture and IMS-PCR positive respectively [220].
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6.23 Consequence of MAP in milk
Currently, little data are available about the impact of JD on farm production in
Ireland. One study which examined the economic impact of JD in a dairy farm in the
province of Munster showed the decline of the farm performance between 1993 and
2003 (as a result of reduced milk yields, increased culling and reduced cull cow values)
after the introduction of JD through the purchase of Dutch cattle [206]. This same dairy
herd was also investigated by Richardson (2009) to describe the impact of JD and the
effect of animal JD status on several measures of production. The study was conducted
over 11 years from 1994 to 2004. Direct impacts of JD on production included a
decreased milk yield and cull price in animals with clinical signs. A reduction of 1259.3
kg of milk per year and a significant lower culling price (€516 on average) were
observed compared to the control group. Indirect impacts of JD reported in this herd
were high levels of culling for infertility and changes to parity structure [207].
Comparable JD infection levels are likely to have similar economic implications for
Irish farmers, based on related results from several studies [221,222].
Another study on the impact of paratuberculosis sero-status on milk yield, fat,
protein, somatic cell count (SCC) and calving interval in Irish dairy herds was
conducted by Hoogendam et al. (2009). Milk somatic cell count is a key measure of
milk quality and is also an indicator for national and international regulation. Serology
results were obtained from the national serosurvey (2004-2005) and milk and
reproduction records were retrieved from the Irish Cattle Breeding Federation (ICBF)
database. They found there was no significant effect of herd paratuberculosis sero-status
on milk yield, milk fat or protein production, somatic cell count score (SCCS) or
calving interval. However, this study only examined the effects of paratuberculosis
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sero-status but did not examine the clinical effects of Johne’s disease at the farm or
dairy industry levels. [223]

6.4 Risk factors

The risk factors associated with the introduction of MAP into dairy herds in Ireland
were investigated by Cashman et al., (2008). This study was conducted over 2 years on
59 randomly selected farms. Using milk sock filter residue as a source material, all 59
herds were tested by IMS-PCR and conventional culture. When questioned, farmers
from these herds were largely unaware of the importance of biosecurity in preventing
MAP infection [220].
In 2009, Barrett et al. conducted a joint DAFF/UCD/Teagasc national survey of the
risk factors associated with the occurrence of JD in Irish dairy herds. This study
included 67 suspected herds with one or more positive faecal cultures and 85 control
herds that were sero-negative in the national JD serosurvey. A questionnaire on herd
management factors possibly associated with the introduction and transmission of
paratuberculosis was designed. This study found that the incidence of JD in Irish dairy
herds was associated with expansion of the herd and introduction of cattle as a result of
depopulation episode and calf management practices. As the prices of dairy products are
increasing worldwide, and with the imminent abolition of milk quotas within the
European Union (2015), it is likely that the expansion of dairy herds will increase in
Ireland. Partial or full depopulation due to disease outbreaks (Bovine spongiform
encephalopathy, BSE in this study) necessitate the purchase and introduction of
livestock to the herd. As JD infection generally occurs in the first month of life, young
calves have the highest susceptibility to paratuberculosis. The exposure to adult faeces
in the first six weeks of life is considered to be one of the most significant risk factors.
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The common practice in Ireland for dairy herd managers of feeding pooled
colostrums and milk to calves increases the risk of transmission through contaminated
milk. It is imperative that control programs include measures for the management of
newborn calves to prevent contact between contaminated adult material and susceptible
calves. Transplacental infection is reported to occur in 9% of foetuses from subclinically infected cows and in 39% of foetuses from clinically infected cows [224].
In summary, the main risk factors in Ireland and elsewhere are the exposure of
contaminated material in the first weeks of life, the expansion of the herd, the
introduction of cattle as a result of depopulation episode, the practice of feeding calves
with colostrums and milk and lack of awareness among the farmers.

6.5 Control Programmes

Due to the increasing prevalence of MAP in Ireland after the introduction of the
single european market, the importance of concentrating the efforts at both farm and
national level is crucial to create an adequate control programme. Between 2000 and
2002, several meetings were held around the country with the Department of
Agriculture, Fisheries and Food (DAFF), farm organisations, dairy co-ops and
Veterinary Ireland. The aim of these meetings was to to improve the general awareness
of MAP and requirement for better farm management practices.
The case study of the economic impact of JD in a dairy herd located in the Munster
region was followed by the creation of a JD programme [206]. Herd investigation and
testing management, including documentation of clinical signs, faecal culture and
ELISA testing on individual animals was started in 2002 to create a suitable control
programme. Faecal samples were cultured on HEYM agar and serums were tested using
the ELISA Bovine Paratuberculosis Serum Verification Kit (Institut Pourquier, France)
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in the Central Veterinary Research Lab of the DAFF. The identification of an infected
animal was followed by its strategic removal and the implementation management
changes to reduce within-herd transmission in order to keep a viable milking enterprise
[207],
Afterwards DAFF conducted a national bovine paratuberculosis serosurvey in 2004
and 2005 using blood samples collected for the brucellosis eradication scheme.
Serology results from 949 cows in 32 herds were available.
In 2005 a "Pilot herd health programme" was established with staff from the
veterinary college, UCD, ICBF, Teagasc, Irish Farms Association, DAFF and 35
veterinary practitioners. This training module was concentrated on JD, bovine viral
diarrhoea (BVD) and infectious bovine rhinotracheitis (IBR). A risk management
project including farmers was developed to identify the risk factors associated with
these 3 diseases in order to apply biosecurity measures. The Johne's pilot control
programme was conducted on 58 herds with different JD prevalence based on herd
history (47% = Low, 35% = Moderate, 18% = High/Very high). Fifteen herds were
tested positive between 1994 and 2005. Current and future source(s) of herd
replacement was also analysed.
More recently. Animal Health Ireland (AHI) was created in 2009 to provide a
partnership approach to national leadership of animal health issues which were subject
to national and / or Eli regulation. A study was conducted by More et al. from the UCD
school of Agriculture "to elicit opinion from experts and farmers about non-regulatory
animal health issues facing Irish livestock industries, including prioritisation of animal
health issues and identification of opportunities to maximise the effective use of AHI
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resources". Further information was also sought to improve education, prevention and
management of animal diseases [225].
Non-regulatory diseases were prioritised by experts and farmers based on their
impact on international competitiveness. They both gave highest priorities to 3 diseases
with a biosecurity risk: bovine viral diarrhoea, infectious bovine rhinotracheitis and
paratuberculosis. For each of these 3 biosecure diseases an assessment based on cost,
impact, international perception, hindrance to international market access and current
resource usage effectiveness was carried out by experts [225].

6.6 Conclusion
Due to the slow nature of the disease, eradication of paratuberculosis from infected
herds can be a long process. Accurate and reliable testing at individual and herd level is
crucial to protect the herd. Negative test results must be interpreted with caution and
additional or repeated testing must be undertaken if there are any signs for suspecting
exposure to MAP. Removal of offspring of any positive animal from the herd is
important as the exposure to infected animals is one of the most significant risk factors.
Farmers should make every effort to maintain a closed-herd policy and continue to
improve biosecurity measures in their herds to prevent the introduction of Johne's
disease.
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2.1 Abstract
Mycobacterium

avium

subsp.

paratuberculosis

(MAP)

causes

a

chronic

gastroenteritis affecting many species. Johne’s disease is one of the most widespread
and economically important diseases of ruminants. Since 1992 and the opening of the
European market, the exposure and the transmission of MAP in cattle herds increased
considerably. Improvements in diagnostic strategies for Ireland and elsewhere are
urgently required. In total, 290 cattle from seven Irish herds with either a history or a
strong likelihood of paratuberculosis infection were selected by a veterinary team over 2
years. Faecal samples (290) were collected and screened for MAP by a conventional
culture method and two PCR assays. In order to further evaluate the usefulness of
molecular testing, a nested PCR was also assessed. MAP was isolated and cultured from
23 faecal samples (7.9%) on solid medium. From a molecular perspective, 105 faecal
samples (36%) were PCR positive for MAP specific DNA. A complete correlation
(100%) was observed between the results of both molecular targets (IS900 and
ISMAP02). Sensitivity was increased by ~10% with the inclusion of a nested PCR for
ISMAP02 (29 further samples were positive). When culturing and PCR were
retrospectively compared, every culture positive faecal sample also yielded a PCR
positive result for both targets. Alternatively, however not every PCR positive sample
(n=105, 36%) produced a corresponding culture isolate. Interestingly though when
analysed collectively at the herd level, the correlation between culture and PCR results
was 100% (ie every herd which recorded at least 1 early PCR +ve result later yielded
culture positive samples within that herd). PCR is a fast reliable test and should be
applied routinely when screening for MAP within herds suspected of paratuberculosis.
Nested PCR increases the threshold limit of detection for MAP DNA by approximately
10% but proved to be problematic in this study. Although slow and impractical,
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culturing is still regarded as one of the most reliable methods for detecting MAP among
infected cattle. Finally, the significance of detecting environmental mycobacteria among
the herds during the study is also noted and discussed.

2.2 Introduction
Johne’s disease which is caused by Mycobacterium avium subsp. paratuberculosis
(MAP) is one of the most widespread and economically important diseases of
ruminants. It is a chronic granulomatous enteritis affecting primarily ruminants and
many other species [ 1 ], which is characterised by persistent diarrhoea, weight loss and a
protein enteropathy, followed eventually by death [2]. Most cattle are infected early in
life by the ingestion of faeces, milk or MAP contaminated water. The relatively long
incubation period is characterized by the excretion of MAP in faeces for months and
years before clinical symptoms develop [3]. The exposure to contaminated faeces
constitutes one of the main risk factors for MAP transmission within the herd.
Johne's disease causes worldwide economic losses to farmers and dairy industries in
terms of milk and meat production. It is considered a serious disease for dairy cattle as
there is no effective treatment and its control is difficult due to the long latent period. In
dairy herds, losses are associated with reduced milk yield and weight gain, lower
reproductive efficiency, premature culling and reduced values of culled cattle [4]. The
effect of paratuberculosis on dairy operations in the USA is estimated at around $200 to
$250 million a year [5].
Paratuberculosis has been a scheduled and notifiable disease in Ireland since 1955.
Prior to the 1990s, the low number of notified clinical cases (only 92 diagnosed between
1932 to 1992, mostly in imported animals) indicated that MAP wasn’t widely
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established in the country. The importation of 85,000 cattle from continental Europe
between 1992 and 2004 (Central Statistics Office, personal communication) as a
consequence of the opening of the single European market in 1992 coincided with an
increase in the prevalence of MAP infection in Ireland. Recent studies have shown that
the risk of MAP exposure and transmission increases annually [6]. Between 1995 and
2002, 232 animals infected with MAP among 106 Irish herds were reported [7]. Also, in
2005, the seroprevalence of infected herds in Ireland was found to be 21.4 % [8].
Currently, the prevalence of paratuberculosis among herds in Ireland is lower than that
reported in many countries in Europe (Denmark 55%, France 68% and Netherlands
54%) [9], probably because of the late introduction and establishment of JD in Ireland.
However it is likely that the prevalence in Ireland will continue to rise to match rates
seen elsewhere, unless appropriate preventive and control measures are taken.
Similarities between Johne's disease in ruminants and Crohn's Disease (CD) in
humans [10] as well as studies which identified MAP in CD patient [11] have led to
speculation that MAP may be a aetiological agent in Crohn's disease. Many reports
showed the pathogenesis of CD is complex and multi-factorial with genetic and
environmental contributions [12,13]. The causative link between MAP and CD is still
controversial and the zoonotic potential of MAP remains a subject of debate [14]. The
identification of viable MAP in pasteurized milk [15,16] and meat [17] should be
regarded as a significant issue in terms of bio-security.
Detecting the presence of MAP is difficult because of the slow growth and the lack
of sensitive tests to identify subclinically infected cattle. The existence of two hostassociated types (cattle strain or "C" type and sheep strain or "S" type) is one more
concern for the detection and the control of MAP [18]. Specific and sensitive diagnostic
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tools as well as a better understanding of the pathogenesis of JD are needed to develop
control programs to eradicate the disease.
This study was carried out on bovine faecal samples from 7 Irish herds which either
had a history of or a likely exposure to MAP within 2 years of this study. The aim of
this project was to evaluate a diagnostic strategy for MAP in targeted Irish herds.
Specifically, we set out to compare a conventional culturing method with PCR, to
evaluate the reliability of 2 different molecular targets and finally, to assess the
improved sensitivity of a nested PCR assay.

2.3 Material and methods
2.3.1 Sample collection
290 individual bovine faecal samples were collected over 2 years (11/06 to 10/08)
from 7 Irish herds which were strategically selected by a veterinary team. The location,
the type of the herd, the breed and number of animals from each sampling period are
summarized in Table 2.1. All the faecal samples were from individual animals, and
were kept at 4°C up to 48 hours prior to processing for culture and DNA extraction. A
flowchart illustrating how the samples were processed is shown in Figure 2.1.
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Herd
ID

Location

Type

No.
animals

Breed

Sample
date

n=

HI

Munster

Beef

140

"Mix

11/2006

4

HI

Munster

If

If

05/2007

22

H2

Munster

Dairy

180

Holstein Fr

05/2007

44

H2

Munster

tl

It

fl

04/2008

73

H3

Munster

Dairy

630

Holstein Fr

07/2007

35

H4

Ulster

Beef

200

Mix*

07/2007

62

H5

Munster

Dairy

150

Holstein Fr

04/2008

17

H6

Munster

Dairy

150

Holstein Fr

04/2008

2

H7

Munster

Dairy

M

Holstein Fr

10/2008

31

Table 2.1: Information on the selected herds
Herd identification, location, type, breed and number of animals as well as the date and the
number of samples tested.
‘'mix ofCharolais, HerfordandSimmental breeds,
n = number ofsamples tested
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Cattle

Faecal
sample

Decontamination

DNA extraction

Culture

PCR

PCR

16S typing

IS900

LSP^20

ISMAP02 (1)

ISMAP02 (2)

Figiire 2.1: Illustration oj the sequential steps used as part oj the sampling strategy’ for each
animal.
Each faecal sample was spilt upon collection in the lab and processedfor culture (left arm) and
molecular analysis (right arm).
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2.3.2 Sample preparation and culture (left arm)
A modified centrifugation method was used to

Cattle

cultivate MAP [19]. Briefly, one gram of faeces was
added to 20 ml of sterile distilled water, tubes were

Faecal
sample

vortexed for 1 min and then allowed to stand
undisturbed for 30 min. Five ml of the supernatant
Conventional culture

-r a!'

were added to 25 ml of 0.9% HPC and allowed to
stand undisturbed overnight at room temperature. Tubes were centrifuged at 1700 g
(4300 rpm) for 20 min, the supernatant was decanted and the pellet was resuspended in
1 ml of 50 fig/ml amphotericin B. HEYM agar containing vancomycin, nalidixic acid
and amphotericin B at 50 pg/ml were inoculated with 0.2 ml of the suspension and
incubated in sealed 25cm^ tissue culture flasks (Sarstedt) at 37 °C for 24 weeks.
After incubation, a single colony of each mycobacteria was subcultured into 10 ml of
7H9 broth with 0.2% glycerol, 5% Oleic Albumin Dextrose Catalase (OADC)
supplement and Mycobactin J and incubated at 37 °C.

2.3.3 Characterisation of cultured mycobacteria
A slow growth rate and typical colony morphology was first used to indicate the
presence of mycobacteria. Subsequently, all mycobacterial isolates were divided into 2
groups based on their growth rate: the strains growing in more than 6 weeks ("suspect
MAP") and other "slow growing mycobacteria", culturing in less than 6 weeks.
Isolates which took longer than 6 weeks to culture (suspect MAP) were tested for
mycobactin

dependency

and

acid-fast

Vasanthakumar et al. (1983) [20].
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staining

as

previously

described

by

2.3.4 Preparation of Mycobacterial DNA from pure culture

Ten ml of MAP culture, propagated as above, was centrifuged at 5,000 rpm for 10
min and the pellet was resuspended with 750 pi of fresh GITC lysis buffer (50 mM Tris
HCl, 10 mM EDTA, 2%Triton X-100, 4M GITC, 0.3M sodium Acetate) [21] and
transferred to a 2 ml screw capped tube containing lOOmg acid washed glass beads
(150-212 pm. Sigma). The samples were sheared in a Ribolyser (MagNA Lyser, Roche)
for 45 sec at 6500 m.s ' and then boiled for 5 min. The tubes were then spun at 12,000
rpm for 3 min and the supernatant was transferred to a fresh tube. The disrupted cell
extract was then mixed with an equal volume of phenol:chloroform:isoamyl alcohol
25:24:1. The samples were shaken manually for 5 min and centrifuged at 12,000 rpm
for 10 min. The aqueous layer was transferred to a fresh tube containing an equal
volume of chloroform:isoamyl alcohol and shaken for 5 min. Following centrifugation
at 12,000 rpm for 10 min, the DNA was precipitated with 2 vol of 100% ethanol and 0.5
vol of ammonium acetate (7M) at -20 °C overnight. After 2 washes with 70% ethanol,
the DNA pellet was dried and resuspended with 50 pi 10 mM TE buffer. All the DNA
samples were then normalized to 50 ng / pi.

2.3.5 Molecular analysis of purified culture

Using a concurrent molecular approach, all isolates were subjected to 16S rRNA
gene typing (Section 2.4.1.1 and 2.4.1.2) [22]. Furthermore the presence of the MAP
bovine specific large sequence polymorphism LSP^20 was screened for by PCR
(Section 2.4.1.1) [23], (Figure 2.2). At this stage the other "slow growing mycobacteria"
were not characterised further once they were confirmed as being "non MAP" following
16S rRNA gene analysis.
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MAP Isolates (HE^TiI aga)

Slow growth and typical colony
Mycobactin dependency

16S sequences aligitinait
(Meg.-\ligii)

Acid Fast Stain
Mycobacterial species
LSF>^20 PCR
ZidilNeelsai Stain

LSf>^20 PCR

Figure 2.2: Confirmation of MAP culture
Confirmation of MAP culture based on growth rate, phenotypic characteristic and molecular
analysis
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16S rRNA gene typing
The 16S rRNA gene is approximately 1,500 bp and is composed of both variable and
conserved

regions.

Two

hypervariable

regions

that

exhibit

species-specific

characteristics in mycobacteria have been previously characterized within the 16S
rRNA gene [22]. These regions provide a rapid genotypic method for identification of
the mycobacterial species. A representative phylogenetic tree of the mycobacterium
genus based on 16S rRNA gene is shown in Figure 2.3.

[i

J M. gastrl DSM 43505 T
__ P M. bnsasil DSM 44162 T (sqv. I) & M. kansasii DSM 43221 (sqv. IV)
I— M kansasii Bo 10492/38 (sqv V)

M kansasii S221 (sqv. II)
M kansasii Bo 539/99 (sqv III) & M kansasii Bo 5160/97 (sqv VI-2)
M kansasii DSM 44431 (sqv VI-1)
M kansasii Bo 8875/99 (^v. VI-3)
M. haemophilum ATCC 29548 T
------------- M leprae AHM104/96
M malmoense DSM 44163 T
M hnhemimm DSM 44277 T
M avium subsp avium DSM 43216 (sqv II)
M. avium sutep. avium DSM 44156 T (sqv. I)
MAC Complex
M. avium sub^. paratuberculosis DSM 44133 T (sqv. I)
M. avium aubap. sllvaticum DSM 44175 T (sqv. I)
M. lepraemunum LKU
M. intracellulare S350 (sqv. IV)
M inlrricellulare ATCC 35847 (sqv II)
M intracellulare ATCC 35772 (sqv. V)
M intracellulare DSM 43223 T (s^. I)
M. intracellulare ATCC 35770 (sqv. Ill)
M conspicuum DSM 44136 T
M. szulgai DSM 44166 T
M. africanum ATCC 25420 T (subtype I) ft M. afrlcanum AHi 15/69 (subtype ii)
M. bovis subsp. bovis ATCC 19210 T ft M. bovis BCG DSM 43990
M. bovis subw. caprae CiP105776 T
M. microti ATCC 19422 T
M. tubercuiosis ATCC 27294 T
M. martnum DSM 44344 T
M. uicerans ATCC 19423 T
M asiaticum DSM 44297 T
pT* M. gordonae Bo 11340/99 (sqv. Ill)
rH M gordonae DSM 43212 (sqv. II)
—I M gordonae DSM 44160 T (sqv. I)
H~ M mrdonae Bo 10681/99 (sqv. IV)
M gordonae Bo 9411/99 (sqv. V)
M scrofulaceum DSM 43992 T
r-i“ M xenopi DSM 43995 T (sqv I)
[ M. xenopi S91 (sqv. Ill)
M xenopi S88 (sqv II)
-------- M botniense ATCC 700701 T
M heckeshomense Wue Tb0687/99
M. celatum DSM 44243 T
M. branderi ATCC 51789 T
M shimoidei DSM 44152 T

d

1?

M tnviale DSM 441.5.3 T

~ M. nonchromogenicum DSM 44164 T
M. terrae S281 (sqv. Ill)
M. hibemiae DSM 44241 T
M. terrae DSM 43227 T (sqv. I)

M. terrae complex

D5W 43541 {iq; II)-----

4

M chitaeATCC 19627 T
M fallax DSM 44179 T
M. murale DSM 44340 T
M. tokaiense ATCC 272B2 T
M. gadium DSM 44077 T

Figure 2.3: I6S rRNA gene based phylogenetic tree oj the genus Mycobacterium
(Adaptedfrom Harmsen et al. [24])
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All mycobacterial DNA samples were tested in a PCR assay targeting the 16S rRNA
gene using a previously optimized method [22] with modifications. Primer sequences
for the amplification were 5’- GAGAGTTTGATCCTGGCT CAG

-3’ and

5’-

TGCACACAGGCCACAAGGGA -3’ and yielded a 1026 bp product. The reaction
mixture consisted of 2X LightCycler® 480 SYBR Green I Master (Roche) (containing
the FastStart Taq DNA Polymerase, reaction buffer, dNTP mix, SYBR Green I dye and
MgCl2), 0.5 pM of each primer and PCR grade water. Sample tubes contained 50 ng of
DNA. Controls consisted of the reaction mixture alone (negative control) and a positive
control containing 50 ng of genomic DNA from M. avium suhsp. paratuberculosis
(strain 19698). Samples were run according to the following conditions: 1 cycle at 95
°C for 10 min and 35 cycles at 95 °C for 10 s, 58 °C for 10 s, and 72 °C for 40 s. All
PCR positive samples were then assessed by melting curve profile and conventional gel
analysis. PCR products were purified by the High Pure PCR Product Purification Kit
(Roche) and were later sequenced by the Eurofins MWG Operon Company. Analysis of
each sequence was then carried out by interrogating the Ribosomal Differentiation of
Medical

Microorganisms

(RIDOM)

database

(http://www.ridom.de)

illustration of the 16S rRNA gene typing method is shown in Figure 2.4.
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[24].

An

Figure 2.4: 16S rRNA gene typing methodfor the identification of mycobacterial species

The 16S rRNA gene sequenee of all eonfirmed MAP strains was also aligned using
MegAlign program (DNASTAR) to check for the presence of any polymorphism within
MAP isolates.

LSP^20 PCR

The large sequence polymorphism LSP'^20 is present in MAP cattle strains but not in
sheep strains. A multiplex PCR using 3 primers (LSP20F1, LSP20R1 and LSP20R2)
was designed by Scmret et al. (2006) [23] to differentiate between the 2 main types of
MAP (cattle and sheep) based on the size of the amplicon. A PCR product of 197 bp
indicates the presence of the LSP'^20.
"Suspect MAP" DNA samples were tested in a multiplex PCR (LightCycler® 480;
Roche). The reaction mixture, samples and controls were prepared as described for the
16S rRNA gene typing PCR. Samples were run according to the following conditions: 1
cycle at 95 °C for 10 min and 35 cycles at 95 °C for 10 s, 55 °C for 10 s, and 72 °C for
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12 s. All PCR positive samples were then assessed by melting curve profile and
conventional gel analysis.

All 290 faecal samples were screened for MAP by conventional culture. As this
study was designed to compare culturing with PCR, a representative sample from the
same faecal sample was removed and processed for direct molecular analysis as
outlined below (see Figure 2.1)
Cattle

Faecal
sample

DecoiitainiiiatioTi

DNA extraction

▼

Cultuie

Real-time PCR

Real time PC R

6S typing

LSP^20

ISMAP02 (2)

Adaptedfrom Figure 2.1: Each faecal sample was processedfor molecular analysis (right arm)
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23.6 DNA extraction from faeces
One gram of faecal sample was added to 5 ml of 10

Cattle

mM TE (pH 8.0), which was vortexed for 1 min and then
allowed to stand undisturbed for 30 min. 750 pL of the

Faecal
sample

suj>ematant was transferred to a 2 ml screw capped tube
containing acid washed glass beads and 750 pi of fresh
Molecular analysis

GITC lysis buffer (50 mM tris HCl, 10 mM EDTA,
2%Triton X-100, 4M GITC, 0.3M sodium Acetate) [21 ]. The samples were sheared in a
Ribolyser (MagNA Lyser, Roche) for 45 sec at 6500 m.s ’ and then boiled for 5 min.
The tubes were then spun at 12000 rpm and the supernatant was transferred to a fresh
tube. The disrupted cell extract was then mixed with an equal volume of
phenol:chloroform:isoamyl alcohol 25.24.1. The samples were shaken manually for 5
min and centrifuged at 12000 rpm for 10 min. The aqueous layer was transferred to a
fresh tube containing an equal volume of chloroform: isoamyl alcohol and shaken for 5
min. Following centrifugation at 12000 rpm for 10 min, the DNA was precipitated with
2 Vol of 100% ethanol and 0.5 Vol of ammonium acetate (7M) at -20 °C overnight.
After 2 washes with 70% ethanol, the DNA pellet was dried and resuspended with 50 pi
10 mM TE buffer.

2.3.7 IS900 PCR
The insertion sequence IS900 was the first characterised example of a mycobacterial
insertion element [25]. It consists of 1451 bp and is present in 14 to 18 copies on MAP
genome. The IS900 element is much utilized for MAP identification [11,26].
Samples were analysed by a PCR assay targeting the IS900 element, using the
method of OMahony (2002) [27], with modifications. Primer sequences for the
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amplification

were

5’-GAAGGGTGTTCGGGGCCGTCGCTTAGG-3'

and

5’-

GGCGTTGAGGTCGATCGCCC ACGTGAC-3’ (reverse primer) and generated a 400
bp product. The reaction mixture consisted of 2X LightCycler® 480 SYBR Green I
Master (Roche) (containing the FastStart Taq DNA Polymerase, reaction buffer, dNTP
mix, SYBR Green I dye and MgCb), 0.5 pM of each primer and PCR grade water.
Sample tubes contained 5 pi of faecal extract DNA. Controls consisted of reaction
mixture alone (negative control) and a positive control containing 1 pi of genomic DNA
from M avium suhsp. paratuberculosis (strain 19698). Samples were run according to
the following conditions: 1 cycle at 95 °C for 10 min and 35 cycles at 95 °C for 10 s, 60
°C for 10 s, and 72 °C for 16 s. All PCR positive samples were then assessed by melting
curve profile and conventional gel analysis.

2.3.8 ISMAP02 PCR
The ISMAP02 element is an insertion sequence identified by Paustian et al., (2004)
[28]. It's a non coding sequence of 1674 bp, present in 6 copies on the MAP genome.
ISMAP02 is unique for MAP and can be used as a specific diagnostic target.
Samples were tested by PCR targeting ISMAP02, a modified method of the PCR
described by Stabel and Bannantine (2005) [29]. Specific primer sequences for the
initial

amplification

were

5’-GCACGGTTTTTCGGATAACGAG-3'

and

5’-

TCAACTGCGTCACG GTGTCCTG-3’ and generated a 278 bp product. The reaction
mixture, samples and controls with the exception of the primers were prepared as
described for the IS900 PCR. Samples were run according to the following conditions:
1 cycle at 95 °C for 10 min and 35 cycles at 95 °C for 10 s, 58 °C for 10 s, and 72 °C
for 12 s. PCR results were confirmed as described above for the IS900 PCR.
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23.9 ISMAP02 Nested PCR
To evaluate the performance of a nested PCR, the products resulting from the initial
ISMAP02 PCR were re-tested with a second set of primers. The nested primers used for
this second amplification reaction were 5’-GGATAACGAGACCGTGGATGC -3' and
5’-AACCGACGCCGCCAATACG-3’ and yielded a 117 bp product. The reaction
mixture, samples and controls were prepared as above. One pi of the amplicon from the
first PCR was used as the template for the second amplification: 1 cycle at 95 °C for 10
min and 30 cycles at 95 °C for 10 s, 60 °C for 10, and 72 °C for 5 s. The size of the
PCR amplicons was then confirmed as described above. To confirm (eliminate false
positives) ISMAP02 nested PCR positive results, two alternative nested PCRs targeting
IS900 (TJl-4) f 11] and F57 [30] were carried out on independent DNA extracts for each
individual ISMAP02 PCR positive sample.
All the primers used for the confirmation and the detection of MAP are listed in the
Table 2.2 below:
Name

5' Sequence 3*

Gene / Target

Reference

285F

GAGAGTTTGATCCTGGCTCAG

16S rlWA gene

Kirsej^er et al., 1993

264R

TGCACACAGGCCACAAGGGA

16S rRJjf.A gene

lyrsc^er et al.. 1993

LSP20F

GGCGTTACAGAATTGCCITG

LSPA20

Semret et al.. 2005

LSP20R1

GCTCGAAGTTGGAGATCAGG

LSPA20

Semret et al.. 2005

LSP20R2

GTACGTGGTGACCAATGTCG

LSPA20

Sejngret et al.. 2005

ISMAP02F1

GCACGGTTTTTCGGATAAOGAG

ISMAP02

Stabef. 2005

ISMAP02R1

TCAACTGCGTCACGGTGTCCTG

ISMAP02

Stabd., 2005

ISMAP02F2

GGATAACGAGACCGTGGATGC

ISMAP02

Stabel.. 2005

ISMAP02R2

AACCGACGCCGCCAATACG

ISMAP02

StabjcL. 2005

P90

GAAGGGTGTTCGGGGCCGTCGCTTAGG

IS900

Moss et al., 1992

P91

GGCGTTGAGGTCGATCGCCCACGTGAC

IS900

Moss et al.. 1992

TJl

GCTGATCGCCTTGCTCAT

IS900

BuU et al., 2003

TJ2

CGGGAGTTTGGTAGCCAGTA

IS900

BuU et al., 2003

TJ3

CAGCGGCTGCTTTATATTCC

IS900

Bull et al., 2003

TJ4

GGCACGGCTCTTGTTGTAGT

IS900

Bull et al., 2003

F57

CCTGTCTAATTCGATCACGGACTAGA

F57

Vans^ck et al., 2004

F57

TCAGCTATTGGTGTACCGAATGT

F57

Vangtiick et al., 2004

Table 2.2: Nucleotide sequence oj the primers used for the detection and the confirmation of
MAP
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2.4 Results
2.4.1 Confirmation of cultured mycobacteria

Caltle

Out of the 290 faecal samples decontaminated and
cultured, 45 putative mycobacteria were isolated on

Faecal
sample

solid media. 22 of these isolates were cultivated
within the first 6 weeks of incubation whereas the
Conventional culture

ill ulai tiaP si.-

other 23 were cultured between 6 and 24 weeks.

2.4.1.1 ’’Suspect MAP” isolates (> 6 weeks)
Of the 45 tested, 23 were initially identified as MAP on the basis of the phenotypic
characteristics: (1) Slow growth, (2) Mycobactin dependency and (3) Acid fastness
(Figure 2.5).

Figure 2.5: Phenotypic characterization of MAP isolates:
a. Typical MAP colonies on HEYM.
b. Acidfast stain (Ziehl Neelsen stain) on MAP isolate.

Using a molecular approach, the species of the 23 slow growing mycobacteria were
identified using 16S rRNA gene typing. A 1026 bp product was generated in all cases.
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All the strains were identified as Mycobacterium avium. This rapid method does not
discriminate the subspecies of the Mycobacterium avium complex (MAC) (Figure 2.6).
M avium subsp avium DSM 43216 (sqv. II)
M. avium subsp. avium DSM 441S6 T (sqv. 0
M. avium subsp. paratubercidosis DSM 44133 T (sqv. I)
M. avium subsp. silvaticum DSM 44175 T (sqv. I)

MAC Complex

Figure 2.6: Mycobacterium avium complex is composed of 4 Mycobacterium avium species

The similarity search analysis gave an equal % identity to the other member of the
MAC complex {Mycobacterium avium subsp. avium and Mycobacterium avium subsp.
silvaticum) (Figure 2.7).
Stram

identity

alignment

1. DM. aviumoara FDSM441331

100.0%

100.0%

1. DM. avium silv. TDSM 441751

100.0%

100.0%

1. DM. avium aviu IDSM441561

100.0%

100.0%

4. DM. avium aviu FDSM 432161

99.77%

100.0%

Figure 2.7: Example of a R1DOM similarity search result for a "suspect MAP" isolate.

The alignment of the 16S rRNA gene sequence didn't show any polymorphism among
the 23 MAP strains which indicates that the 16S rRNA gene is conserved within MAP
cattle strains (Figure 2.8).

^ TEanslac« V Consensus GATAAGCCT6CCUUICTGCCTCTAATACCGGATJLCGACCTCAAGACGCATGTCTTCTGGTGGAAA0CITl'IGCGCTGTGCGJn'COCC
HAP ?2(1>1032)
GATAAGCCTOGGAAACTGCCTCTAATACCGCATACGACCTCAACACCCATGTCTTCTGOT&GAAAGCcTTTGCGGTGTCGOATCCGC
HAP 39(1>1034)
GATAACCCTGGCAAACTGCCTCTAATACCGGATACGACCTCAAGACCCATCTCTrCTGCT&GAAACCcnTGCGCTGTGCGATCCCC
HAP 1480(1>1022)
GATAACCCTGGCAAACTGCCTCTAATACCGGATAGGACCTCAACACGCATCTCTTCTGCTGGAAACLI I'l'lGCGCTCTGGGATGCGC
HAP 92(1>1088)
GATAAGCCTCGCAAACTGCCTCTAATACCGCATACCACCTCAACACGCATCTCTrCTGOTGGAAACl111IGCGCTCTGGCATCCGC
HAP 510(i>1033)
HAP 14S0(1>1031)
GATAACCCTCCCAAACTGCCTCTAATACCGGATAGGACCTCAAGACGCATGTCTTCTGCTGGAAAGC1111GCCCTCTGCGATCCCC
HAP 1A(1>1032)
GATAAGCCTGCCAAACTGCCTCTAATACCGGATAGCACCTCAAGACGCATGTCnCTGOTGCAAACCcnTGCGCTGTGCGATGCGC
HAP S22(l>1031)
GATAAGCCTCGCAAACTGCCTCTAATACCGGATAGGACCTCAAGACGCATCTCTTCTCGTGGAAAGCTnTGCGCTGTGCGATGGCC
HAP 3(1>10I7)
GATAAGCCTGGCAAACTGCGTCTAATACCGCATACGACCTCAAGACGCATGTCTTCTGGTGGAAAGCtTTTGCGCTCTGGGATGCGC
HAP il0(l>1005)
GATAACCCTGGCAAACTGCCTCTAATACCGGATAGGACCTCAAGACGCATCTCTTCTGGrGGAAAGCtTTrGCGCTCTGCGATGGGC

Figure 2.8: Example of an alignment of the 16S rRNA gene sequence of 10 MAP isolates
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The presence of the MAP bovine sp)ecific LSP'^20 was also confirmed by PCR for all
the 23 MAP strains, as indicated by the presence of a 197 bp PCR product (Figure 2.9).
Therefore all the isolates were confirmed as being MAP cattle strains.

Figure 2.9: 3% Agarose gel showing a 197 hp indicating the presence of LSP^20 for 17 MAP
isolates.

2.4.1.2 Other ’’slow growing” mycobacteria (< 6 weeks)
Twenty-two mycobacteria other than MAP were isolated on solid medium. Using 16S
rRNA gene typing, 20 samples were identified as Mycobacterium non-chromogenicum,
one sample was identified as Mycobacterium terrae and one sample as Mycobacterium
hiberniae. Even though these 3 mycobacteria are part of the Mycobacterium terrae
complex, the 16S rRNA gene typing was able to differentiate them based on the
polymorphism of the hypervariable regions of 16S rRNA gene (Figure 2.10).
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uinMcncccAAirrcocTrnATACcduTAccACC ncA-rc-crc-—
cmMCCTCccjuuM-rcoCTmATarcciaTAccAccccATC-c-rr—c.
6m»aTTCCCJUACTCCCTmUTAfCO-4TACCACCCC ^ ^C

mccc
tCCtTTTCCCCTCTCCCATCCCC
ATCCCC

wccnccccrTgnuuccTCiTTU simsfccmmcKiCC-TiTr-ci^YccmacAcocnGcn^ juMucauccnccun
cccccmccciTCTURmt mu ciCMCMCCMCOTCC1/ CC-TITT- CT- LSCATTMCOCTMCTWi wCAAMACCACCCSCCAAC1
CCCCCTTCCCCTTPIMRmHHUCiCnCUCCJUCCTCCC -cc-ttit- CT' CCCATTSACCCTMCrCC klCMSAACCACCCSCCAACI
cccccmcccrTcnuuccicmu caaouctiMcrcc o -cc-tttt- CT>CCGATI6ACCCnC6T0G UCJUUAACCACCCCCCAACI
CMCSJICCUCCTCC 0 -CC-TTR- CT'CCCATICACOCnCCTCC CAACAACCACCCCCCAACI
CCCCCnCCCCTT6BUUCCTCnTC4CiCntSACCUCOTCC 0 -CC-TTIT- CT-C«CATIBACOCrACCTCC \tCAACAACCACCCCCCAACl
CCCCXmtCCCTTCmjkCCTCrtTCJ CTKItSOCCAACCTCCCAJCC-TTTT- CTTTtCGOTGACOCTACCTAC UAAACAACCACCGSCCAACI
cccccTTccccrrcnuuccicrr t4CTATCCCCCJHC<TCCmC-TnT- nTTCCr-iTIBACOCTACCTAf kCAACAACCACCCGCCAAn
cccccnccccnciIIMJR.tH.IHUCTKTCCOCfeUCrrCCCXACC-TTTT- CTTTCC«rreACOOT*«T*r lCAACAACCACCCCCCAACI
TUACCH.IIIUCt>.TC6<XC*ACC
CTCC**CC TTTT crmccirrcACOCTACCTAiC tCAACAACCACCCCCCAACI
ceccCTTOcecnvT

)t

iTCCAACC TITT crmcc ncAcocTACCTAc. tCAACAACCACCCSCCAACI
C4CTjmSOCMAaCTCCO COaTTTTI rr-T«0< •• •TMCOOTACOTAI>C kOAACAACCACCOOCCAACl

CC<CCTTC<<W1TPT>AACCTCTrn^jm»<X6*AC>TtC f.ICO-TTTT- CTC- *0 rreACCCTAOgTAckAACAAOCACCWCCAAa

Figure 2.10: Example oj an alignment oj the 16S rRNA gene sequence of 5 MAP isolates, 5
Mycobacterium non-chromogenicum, 1 Mycobacterium terrae and 1 Mycobacterium hiberniae
showing the 2 hypervariable regions within the mycobacterium genus, framed in red.
Nucleotides in red indicate the polymorphism within the different mycobacterial species.

A summary of all the cultured mycobacteria and their characterization is shown in Table
2.3 below.
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No.

Samples
ID

Herd

Mycobactin
dependency

Growth

Acid Fast
Stain

16S rRNA gene typii^

1

181

M terrve

2

190

M. nonchromogenicum

3

193

M. nonchromogenicum

4

197

M. nonchromogenicum

5

204

M. nonchromogenicum

6

205

M. nonchromogenicum

7

217

M. nonchromogenicum

8

218

9

220

10

225

11

226

12

227

13

228

M. nonchromogenicum

14

229

M. nonchromogenicum

15
16

232
235

M. nonchromogenicum
M. nonchromogenicum
M. nonchromogenicum

M. nonchromogenicum
i

H2

M. nonchromogenicum
M. nonchromogenicum

<6
weeks

+

M. nonchromogenicum
M. nonchromogenicum

17

236

18

237

M. nonchromogenicum

19

239

M. nonchromogenicum

20

250

21

253

22

287

23
24

502

25

522

LSP'^lO

115

NA*

M. hiberniae
M. nonchromogenicum

117

M. nonchromogenicum

510

26

1

27
28

3___
4

29

5

30

6

31

15

32

17

33

38

34

39

35

40

36

41

37

42

38

43

39

72

40

84

41

92

42

96

43

98

44

110

HI

>6
weeks
112

+

+
Mycobacterium
avium

113

114

Table 2.3: 45 Mycobacterial isolates were cultured and characterized
These include 16 M. nonchromogenicum, 1 M. terrae, 1 M. hiberniae and 23 MAP strains.
The sample and herd identification, the phenotypic characteristics (Growth, Mycobactin
dependency and Acidfast stain) and the molecular analysis (16S rRNA gene typing and LSP^20
PCR) are provided.
*NA = Not applicable
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2.4.2 Examination of culturing results from the perspective of individual herds
The culture results for all 290 faecal samples and their associated herds tested during
this study are summarized in Table 2.4 and Table 2.5. MAP was cultured from 23 of the
290 samples tested (7.9%). Four herds (HI, H2, H3 and H4) were positive for MAP
culture with at least 2 samples positive from each herd while the other 3 herds (H5, H6
& H7) were MAP culture negative. The percentage of MAP positive culture ranged
from 3% (herd H4) to 75% (herd HI, 2006). The first 4 samples collected in 2006 from
the herd HI showed the highest percentage of culture positives and the presence of
MAP in this herd was confirmed with the second batch, where typical MAP colonies
were detected on solid media for 7 samples (30%). In relation to H2, 13.6% of samples
tested in the first batch were MAP positive. The 73 samples tested 10 months later from
the same herd were MAP culture negative but positive for other mycobacteria (18
isolates) as seen in Table 2. Using 16S rRNA gene typing 17 samples were identified as
Mycobacterium non-chromogenicum and 1 Mycobacterium terrae. Five cultures from
herd H3 were confirmed to be MAP positive and only 2 samples (3.2%) in herd H4
showed MAP colonies indicating only a small number of viable MAP. As mentioned
above, MAP wasn't cultivated from samples recovered from herds H5, H6 and H7 but 4
other mycobacterial isolates were isolated in herd H5 (2 M. non-chromogenicum; 1 M.
hiberniae) and H6 (1 M. non-chromogenicum).
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No. of samples positive
Herd Id

Sampling
11/2006
05/2007
05/2007
04/2008
07/2007
07/2007
04/2008
04/2008
10/2008

HI
H2
H3
H4
H5
H6
H7
Total

No. of
samples
4
22
44
73
35
62
17
2
31
290

Culture

MAP
3(75)
7 (29.7)
6(13.6)
0
5(14.3)
2 (3.2)
0
0
0
23 (7.9)

Other
0
0
0
18(24.6)
0
0
3(17.6)
0
1 (3.2)
22 (7.5)

Table 2.4: Culture result for each herd
The significance of these isolates will be discussed in more detail in Chapter III.

The 290 bovine faecal samples were screened for MAP

Cattle

by conventional culture and 45 mycobacterial isolates
were characterized using both phenotypic and molecular
Faecal
sample

approach. As outlined in the method, a replicate sample
from the same 290 faecal samples were also processed
for direct molecular analysis using two PCR assays.
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Molecular analysis

2.43 Molecular analysis from faecal material
2.43.1 IS900 PCR
The PCR results obtained for the faecal DNA extract (n=290) are summarized in
Table 2.5. The 1S900 target was detected in 105 samples representing 36% of the 290
samples tested. This target was detected in 4 herds H1, H2, H3 and H4, which correlates
with the herd culture positivity rate. The percentage of positive samples varied from
100% (Herd HI and H2) to 34% (Herd H4). PCR-positive results were found in all 26
samples (100%) collected in herd HI in 2006 and 2007. Similarly, all 44 samples tested
(100%) from herd H2 were PCR positive in 2006. For the second batch of H2 samples
collected 10 months later, MAP DNA was not detected, which coiTclates with the lack
of culture positives from the same sampling period. In total, 14 and 21 DNA samples
from H3 and H4 herds respectively were positive for MAP whereas all the samples
from the 3 herds (H5, H6 and H7) were negative for the 1S900 target.

2.43.2 ISMAP02 PCR
Part of this study was to evaluate the performance and reliability of molecular
testing. Consequently, in order to validate the results from above, a second MAP
specific DNA target was chosen (ISMAP02). As with IS900, 105 samples were PCR
positive as shown in Table 2.5 which indicates a complete correlation between the PCR
results of both targets. In summary, of the 290 individual samples tested from 7 herds
over 2 years, 105 were positive for ISMAP02 PCR. 100% of the samples in herd HI
(2006 and 2007) and H2 (2007) were ISMAP02 positive, whereas all the samples from
the 3 herds (H5, H6 and H7) were negative. As seen previously for the IS900 PCR, 6,
14 and 21 DNA samples from H2 (2008), H3 and H4 herds were also positive for MAP
respectively.
Ill

2.433 ISMAP02 Nested PCR
As part of this study, the threshold limits of detection for MAP DNA was
investigated by performing a nested PCR. In total 134 of 290 samples (46%) were
positive after nested PCR. This number included 29 additional samples (10%) which
were positive only after nested PCR. Of these (29), 6, 1 and 3 ISMAP02 positive
samples were detected in the herds H2 (2008), H5 and H7 respectively. Interestingly,
these 3 herds were all PCR-ve based on the first round analysis of both targets. The
remaining nested PCR +ve samples, (6 and 13) were identified in herds H3 and H4
respectively. An example of a melting curve profile is shown in Figure 2.10.

Figure 2.10: Melting curve profile showing detection of 1SMAP02 target in 5 faecal extracts

To confirm the validity of the nested PCR results, DNA from the 29 additional
positive samples were re-tested with two independent nested PCR assays namely IS900
(with alternative primers, TJl-4) and F57. Twenty one of these samples were confirmed
as being true positives after the second run of the nested IS900 and F57 assays while 8
samples (all from the same herd H4) were negative, indicating a high likelihood of false
positive nested PCR results among this cohort only.
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Herd Id SanipUng
HI
H2
H3
H4
H5
H6
H7

11/2006
05/2007
05/2007
04/2008
07/2007
07/2007
04/2008
04/2008
10/2008
Total

samples
4
22
44
73
35
62
17
2
31
290

Xo. of sanofiles positive (percentage)
Cnkiire
PCR
MAP
Otker
1S900
ISMAP02 (1) IS\1AP02 (2)
4 (100)
3(75)
0
4(100)
4(100)
7 (29 7)
0
22 (100)
22 (100)
22 (100)
0
44 (100)
44 (100)
44 (100)
6(13.6)
0
18(24.6)
0
0
6 (8.2)
20 (57.1)
0
14(40)
14(40)
5 (14.3)
21 (33 9)
21 (33.9)
34 (54 8)
2 (3.2)
0
3(17 6)
1 (5 9)
0
0
0
0
0
0
0
0
0
0
0
3 (9.6)
1 (3.2)
23 (7.9) 22 (7.5)
134 (46.2)
105 (36.2)
105 (36.2)

Table 2.5: PCR and Culture Results
Data illustrating the results for each herd grouped according to PCR (IS900 & ISMAP02),
nested PCR (ISMAP02), culture and non-MAP culture. In total seven herds were sampled over
the 2 year period and the number of animals sampled ranged from 2 - 73. When examined
collectively on a herd basis a 100% correlation was shown to exist between PCR and culture, ie
the overall first round PCR results could be used to predict whether any animal in that herd
would show up later as being culture positive (HI, H2 [‘07], H3, H4) or negative (H2[‘08], H5,
H6, H7).

2.5 Discussion
Due to the late introduction and establishment of JD in Ireland, there are relatively
few publications on Paratuberculosis in this country. This study set out to evaluate a
diagnostic strategy for MAP in selected Irish herds by comparing culture and molecular
assays. This has relevance in terms of implementing future screening strategies for vets
in Ireland and elsewhere. It is important to state that due to the logistical problems
associated with obtaining samples, and the difficulty involved in enlisting willing
farmers to participate, it was impossible to standardise the testing among herds in terms
of obtaining equal samples from each herd. However, given this shortcoming, some
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important observations and conclusions can be made at the individual animal level and
within each herd.
In general, we found a poor correlation between culture results from individual
animals (7.9%) and the corresponding first round PCR results (36%). This may be due
to the degree to which an animal was shedding the organism, the current disease status
of the animal at the time of sampling, or the significant loss of viable cells during the
harsh de-contamination step. Collectively however, it was interesting to note that all
herds that tested positive by culture were also PCR positive (HI, H2, H3 and H4)
whereas the other 3 herds were negative using both methods. This is significant in terms
of how PCR may be used to manage and detect Johne’s disease rapidly within a herd,
i.e a quick and relatively cheap PCR test from a representative number of animals could
provide an early indication of the disease status of the overall herd.
Two herds were sampled twice in this study (HI and H2) and both produced
interesting results. For example, in the herd H1, the percentage of MAP culture-positive
results varied from 75% in 2006 to 30% in 2007 (although the sample size was not
comparable). In terms of Herd H2, the difference between culture and PCR results in
2007 and the same herd one year later was striking (n=44 and n=0). This may be
explained by the culling of infected animals and the possible introduction of “JD free”
cattle in 2008, as seen previously by Richardson et al. (2009) [31]. It may also be
explained by the selection of an alternative cohort of animals by the vets during the
second visit. Due to the sensitivities associated in dealing with farmers involved in this
voluntary study, limited information was made available to us regarding the degree to
which the herd had been re-populated during the intervening year.
There is a significant lack of comparable studies in Ireland, and although the purpose
of this project was not to draw conclusions regarding the prevalence of MAP in Ireland,
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it is interesting to note that our percentage recovery is almost double that seen in a
similar study by O’Doherty et al. (2002) [32]. Using a similar experimental strategy
this group tested 221 animals from 16 herds suspected of paratuberculosis infection and
found a prevalence rate of 4.1%.
As seen in other studies, the difference between the culture results in two dairy herds
(H2, 13% and H3, 14%) and a beef herd (H4, 3%) was significant. The common
practice in Ireland for dairy herd managers to feed pooled colostrums and milk to calves
causes a relative increase in the risk of transmission through contaminated milk.
Cashman et al. (2008) [33] reported a lack of awareness among Irish farmers regarding
the containment practices and the risk of MAP transmission.
In terms of PCR and the reliability of molecular testing, a complete correlation was
observed between the results of the IS900 and ISMAP02 targets. This was surprising
but not unusual as observed in a similar study [29].
The nested ISMAP02 PCR detected 29 further positive samples increasing the
sensitivity of the assay by 10%. However, among these additional samples, when re
examined, 8 from herd H4 were found negative by 2 other specific nested PCRs (IS900
and F57) based on independent triplicate results. The presence of these false positive
test results may come from a single assay problem for H4, or may be representative of a
larger reliability issue with nested PCR in this context. As well as the 8 putative false
negatives, 10 of the remaining extra positives came from herds H2 (2008), H5 and H7
which were negative by both culture and first round PCR (Table 2). This may of course
represent the excellent added sensitivity afforded by nested PCR for these 10 samples or
it could be indicative of potential problems with this extra test. We feel that the need for
increased sensitivity must therefore be balanced with the risk of producing false
positives among the results.
115

The presence of environmental mycobacteria {Mycobacterium non-chromogenicum
and Mycobacterium terrae) within certain herds is another important finding although
how it impacts on an animal’s susceptibility to MAP infection is difficult to assess.
These mycobacteria belong to the M. terrae complex and were originally classified as
non-pathogenic saprophytes, but their pathogenic status is changing. They have been
isolated from soil and are usually present in clinical samples as an environmental
contaminant. Mycobacterium non-chromogenicum has also been isolated in cattle
infected by bovine tuberculosis [28]. Interestingly, the 18 samples from which
Mycobacterium non-chromogenicum and Mycobacterium terrae have been isolated
were PCR negative for MAP DNA which indicates that these two insertion sequence
1S900 and 1SMAP02 are not present in these mycobacteria.
Infected animals shed MAP in milk but also in the environment where MAP persists
and survives in the soil, water and sediment [34]. To minimise exposure of the human
population as described previously by Hermon Taylor (2009) [13], there is a need to
understand all the potential reservoirs and all the transmission routes for MAP. If this
pathogen is proven to be zoonotic the implication for the dairy industry worldwide
would be enormous [35] especially in countries like Ireland where exported milk and
dairy products are significant for the national economy. It follows therefore that all
countries with a paratuberculosis related problem should be working towards a rapid,
standardised and reliable indicator of infection. Based on our experience, PCR should
play a significant role in this.

In this study culturing of MAP was characterised by poor recovery (7.9%) but high
specificity. In contrast, the PCR produced faster results with improved sensitivity
(36%). The correlation between the culture and PCR result was poor at the individual
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animal level but in complete agreement at the herd level. Based on our experience, the
choice of test employed by veterinarians should be guided by their objectives; a PCR
test will produce a rapid result which may act as an "early warning" for the disease
status of the herd especially if multiple animals are tested concurrently and periodically.
As seen with other studies, IS900 and ISMAP02 are equally reliable as DNA targets for
MAP, and the added sensitivity afforded by a nested PCR must be balanced with the
potential for introducing false positive results. Despite the obvious advantages of
introducing routine molecular testing for potentially infected animals, the culturing
method (liquid or solid based) still remains the gold standard despite its logistical and
practical limitations.
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3.1 Abstract
The aim of this study was to characterize 38 bovine strains of Mycobacterium avium
subsp. paratuberculosis isolated in Ireland using 11 multi locus short sequence repeat
(MLSSR) loci and 8 variable number of tandem repeat (VNTR) loci. The discriminatory
power of these two typing methods alone and combined was evaluated, as was the
epidemiology of the isolates and the genotypes obtained.

Using the VNTR typing

method (8 loci analysed), only 3 subtypes were detected with a discrimination index
(Dl) of 0.540. In contrast the MLSSR method (using 11 loci) differentiated the 38 MAP
isolates into 18 types with Dl of 0.921. Among these 18 types 6 have not been recorded
previously. The combination of the 2 methods (VNTR and MLSSR) produced 22
distinct genotypes giving a maximal Dl of 0.941. According to the allelic diversity,
some markers are more polymorphic than others and must be applied in priority for the
differentiation of MAP bovine isolates. This is the first report of genotyping data for
MAP on the island of Ireland and will be very useful for analysing its epidemiology,
transmission and virulence.

3.2. Introduction
Mycobacterium avium subsp. paratuberculosis (MAP) is the etiological agent of
Johne’s disease (or paratuberculosis), a chronic gastroenteritis of ruminants. Johne’s
disease is prevalent in domestic livestock and is considered a serious animal pathogen.
The disease occurs worldwide and causes considerable economic losses to the animal
industry [1,2]. MAP is also considered a potential significant public health threat due to
its possible association with Crohn's disease in humans [3].
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MAP persists in the environment and has a wide host range including domestic and
wild ruminants, farm animals, birds, mammals, primates and humans [4]. Control of
paratuberculosis requires a better understanding of the genetic diversity of the pathogen.
Strain differentiation by genotyping is useful for studying epidemiology, pathogenesis
and interspecies transmission. The use of molecular typing methods has increased in the
last 2 decades [5,6], providing a better depiction of the genetic diversity of MAP.
Popular methods include restriction fragment length polymorphism (RFLP), Pulse
field gel electrophoresis (PFGE) and multiplex PCR. IS900 RFLP and PFGE are the
most widely used [7,8,9], but are only applicable to cultivable strains (large amount of
high quality DNA needed), require analysis of complex banding pattern and have a
limited discriminatory power.
More recently, multilocus short sequence repeat (MLSSR), mycobacterial
interspersed repetitive units (MIRU) and variable number tandem repeat (VNTR) have
been used to differentiate subtypes based on the polymorphism of repetitive elements.
Short sequence repeats (SSR) consist of mono, di or tri nucleotide repeats and the
variability of the repeats is identified by a sequencing approach. Tandem repeats (TR)
are defined by a repeat unit size in the range of 10 to 100 bp and the allelic differences
can be easily resolved by agarose gel electrophoresis (Figure 3.1).
The utility of the MLSSR and VNTR typing approach for MAP strain differentiation
has been evaluated in previous studies [7,10] and has been shown to be rapid and highly
discriminatory.
In this study, 38 bovine MAP strains isolated in Ireland were typed using MLSSR (11
SSR loci) and VNTR typing (8 TR loci). The aim of this study was to evaluate the
discriminatory power of these 2 typing methods used alone or in combination and
evaluate the epidemiology of the genotypes obtained.
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Figure 3.1: Short sequence and tandem repeats
The number of short sequence repeats is identified by sequencing whereas the number of
tandem repeats is determined by conventional gel analysis.

3.3 Materials and Methods
3.3.1 MAP Strains
A total of 38 Mycobacterium avium subsp. paratuberculosis isolates were assembled
in this study (Table 3.1). The cultures were isolated on Herrold’s egg yolk medium by
the centrifugation method according to the protocol of Ristow et al. (2006) [11]. One
single colony of each individual MAP isolate was subcultured in Middlebrook 7H9
broth supplemented with OADC (Becton D), 2 pg/ml of Mycobactin J and 0.2 %
glycerol and incubated at 37 °C for 6 to 10 weeks. MAP DNA was extracted as
previously described in Chapter II. All 38 cultured MAP isolates were tested by PCR
for the presence of the IS900 element [12] and the presence of the MAP bovine specific
large sequence polymorphism LSP'^20 [13].
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3.3.2 Epidemiological analysis

All the strains were isolated in Ireland from bovine faeeal samples between 2006 and
2008. MAP isolates were recovered from 18 distinct herds from 5 different locations in
Ireland. 24 isolates were recovered from 4 herds (HI - H4) whereas the other 14
isolates were individual strains from 14 different herds. The number of isolates, herd
identification and location of the herds are shown in Table 3.1.

No. of
isolates
1
1
1
1
1
1
1
1
1
1
1
1
1
1

11
6
5
2

Isolates ID

Location

MOO
VI
V2
V3
V5
V6
V7
V8
V9
VIO
Vll
V12
V13
V14
V4, 502,510, 522, 1,
3,4, 5, 6, 15, 17
38, 39, 40,41,42, 43
72, 84, 92, 96, 98
110, 144

Region 1
Region 2
Region 2
Region 1
Region 1
Region 3
Unknown
Unknown
Region 3
Region 3
Region 3
Unknown
Region 4
Region 1

Herds
ID
HA
HB
HC
HD
HE
HF
HG
HH
HI
HJ
HK
HL
HM
HN

Region 4

HI*

Region 2
Region 2
Region 5

H2*
H3*
H4*

Table 3.1: Isolates used and herds information.
Geographic location, number and identification (ID) of 38 MAP isolates recovered from 18
Irish Herds (5 regions). Three isolates from herds HG, HH and HL were donated from a
previous study (2005). It was not possible to assign an original source to these isolates and they
are recorded as source “unknown ” in this figure.
* These isolates were recoveredfrom 4 herds (HI, H2, H3 and H4) in Chapter 2 study.
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After molecular confirmation of MAP, the 38 bovine strains isolated in Ireland were
typed using 11 SSR and 8 VNTR PCR, as described in Figure 3.2. The discriminatory
power of these 2 typing methods used alone or in combination and the epidemiology of
the genotypes were also evaluated.

Figure 3.2: MAP typing strategy’
Two genotyping methods were used to type 38 MAP strains isolated in Ireland: Multilocus
short sequence repeat at 11 SSR loci and Variable number of tandem repeat at 9 TR loci.
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333 MLSSR Typing

Eleven short sequence repeat loci were analysed as described by Amonsin et al.
(2004) [10], with modifications. The reaction mixture consisted of 2X LightCycler®
480 SYBR Green 1 Master (Roche) (containing the FastStart Taq DNA Polymerase,
reaction buffer, dNTP mix, SYBR Green I dye and MgCb), 0.5 pM of each primer, 5%
dimethyl sulfoxide (SIGMA) and PCR grade water. Each PCR reaction included 50 ng
of MAP DNA. Controls consisted of reaction mixture alone (negative control) and a
positive control containing

1

paratuberculosis (strain 19698).

pi of genomic DNA from M avium subsp.
Samples were run according to the following

conditions: 1 cycle at 95 °C for 10 min and 35 cycles at 95 °C for 10 s, 60 °C for 10 s,
and 72 °C for 10 s.
PCR products were analysed by melting curve profile and conventional gel analysis.
The PCR amplicons were then sequenced by the DNA services at the University of
Dundee, Scotland (http://www.lifesci.dundee.ac.uk/sequencing). The sequence of each
SSR locus for all 38 isolates was aligned and the number of short sequence repeat was
identified using MegAlign program (DNASTAR Lasergene). MLSSR types were then
allocated on the basis of the unique combination of alleles for each locus.

33.4 VNTR typing

Eight specific Tandem Repeat markers (VNTR32, 292, X3, 25, 3, 7, 10 and
VNTR47) were analysed using the same specific primers, annealing temperature and
buffer that as previously described [7]. The reaction mixture consisted of 2X
LightCycler® 480 SYBR Green I Master (Roche) (containing the FastStart Taq DNA
Polymerase, reaction buffer, dNTP mix, SYBR Green I dye and MgC12), 0.5 pM of
each primer and PCR grade water. Each PCR reaction included 50 ng of MAP DNA.
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Controls consisted of reaction mixture alone (negative eontrol) and a positive eontrol
containing 1 |il of genomic DNA from M avium subsp. paratuberculosis (strain 19698).
Samples were run according to the following eonditions: 1 cyele at 95 °C for 10 min
and 35 cycles at 95 °C for 10 s, [55 - 64 °C]* for 10 s, and 72 °C for 14 s. To detect
differences in repeat numbers, PCR products were analysed by melting curve profile
and conventional gel analysis (3 % agarose gel). VNTR types were then assigned as
described for MLSSR.
* Primers for each individual tandem repeat had specific annealing temperature assigned
between 55 to 64 °C [7].
All the nucleotide sequences of the primers used for the t>'ping of MAP (MSSR and
VNTR typing) are listed in the Table 3.1 of the supplementary material.

3.3.5 Calculation of discriminatory power
The discriminatory power is the average probability that the typing system will
assign a different type to two unrelated strains randomly sampled in the microbial
population of a given taxon.
The index of discrimination (HGDI) described by Hunter and Gaston (1988) [14]
was used as a numerical index for the discriminatory power of MLSSR and VNTR
typing methods. This index (DI) was calculated using the following equation:
i

D/ = l-

^

------- 7 ”i(”i ~ t)

N(N-l)

>=1

Where N is the total number of isolates in this study, s is the total number of distinct
types, and

is the number of isolates belonging to the f' type.

To differentiate all the types obtained, a dendrogram was constructed using the program
DendroUPGMA (http://genomes.urv.cat/UPGMA) [15].
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3.4 Results
3.4.1 MLSSR typing
The sequence of each SSR locus for all 38 isolates was aligned and the number of
short sequence repeat was identified using MegAlign program (Figure 3.3). MLSSR
types were then allocated on the basis of the unique combination of alleles for each
locus (Table 3.2).

^Consensus
10 Sequences

ICCWCGCCCCOOOOOOGX- ■ • CCOTACCTOC

1L1
3L1
4L1
5L1
6L1

ICCOACOCCCCOCOOOOG- • - - CCGTACGTOC
ICCOACGCCCXOGOOOOO- • ■ • CCGTACGTOC
ICCOACOCCCOOOGOOOO- • • ICCOACGCCCXOOOOOOO- • ■ •
jCCOACGCCCCOGGOOOG.-00- CCGTACGTOC

V6L1
V7L1
V8L1
V9L1
V10L1

iCCOACGCCCOOGGOOOGiO- • •
jCCOACGCCCOOGGOGOG - • •
ICCOACGCCCCOGOOOOG - • •
ICCOACGCCCOOGGOOOG- • • •
i CCOACGCCCOOGGOOOOOGG

300

310

CCGTACGTOC
CCGTACGTOC
bCOT

ATOOTOCCCAOCOCOCOCOCCAOCOCCCAO

17 Sequences

;00

1L4
3L45L4
6L4
17L4
39L4
40L4
41L4
43L4
72L4

^Conwnsus
USeQuerxes

SU
6LI

43L8

I

'

'

'I

AT GOT OCCCAWOCOCGCOCf^OCOCCCAO
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GC (LOCUS 4)
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CCGAGGCOCOOOT|OOTOOTOOTGGTOOCOCACOOG Trinucleotidc repeat

CCOAGGCOCOOOT^TOOTOOT. .-OOCOCACOOG

84L8

CCOAGGCOCOOOT^TOOTOOTOGI OOCOCACOOO

17L8
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Mononucleotide
repeat G(Locus 1)

CCGTACGTOC
CCGTACGTOC

^Consensus

I

a

320

^

GGT (LOCUS 8)

Figure 3.3: Example oj sequence analysis of three representative SSR loci for 10 MAP isolates
(a.) Locus 1 with (G) repeats. Isolates I, 3, 4, 5 and V9 contain seven copies of G. Isolates V6,
V7, V8 contain 8 copies of (G) and isolates 6 and VI0 contain 10 and II repeats respectively,
(b.) Locus 4 with (GC) repeats. All the isolates contain 5 copies of GC (no discrimination)
(c.) Locus 8 with (GGT) repeats. Isolates 5, 43, 84, 96 and 98 contain 4 copies of GGT, while
isolates 6, 15, 17, 39 and 40 contain 3 repeats
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No. of copies of SSR
MLSSR
type
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

N*

%

1

2

3

4

5

6

7

8

9

10

11

2

5.2
10.5
5.2
23.6

7
7
7
7
7
8
8
8
7
7
7
7
7
7
7

10
9
11
10
11
12
11
9
11
12
12
10
13
13
11
11
11
11

5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5

5
5
5
5
5
5
5
5
5
5
5
5
5
5
5

5
5
5
5
5
5
5
5
5
5
5
5
5
5
f;

4
4
4
4
4
4
4

4
4
4
4
4
4
4

4
4
4

5
5
5

5
5
5

5
5
4

5
5
5
5
5
5
6
5
5
5
5
5
5
6
6
5
5
5

5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5

5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5

4
2
9
3
1
1
1
3
3
1
1
1
1
1
1
2
1

7.8
2.6
2.6
2.6

7.8
2.6
2.6
2.6
2.6
2.6
2.6
2.6
5.2
2.6

11

7
10

5

4
4
4
4
5

4
4

5
5

5
5
5
5
5

4

4

5

5
5
5

4
4

4
4
5
5

4

5
5
5
5
5
5

Table 3.2: Allelic profile at 11 SSR loci for 38 MAP isolates
Analysis of 11 SSR loci described by Amonsin et al. (2004) [10] among 38 MAP bovine strains
isolated in Ireland. The number of SSR of each locus was identified and the MLSSR types were
allocated on the basis of the unique combination of alleles for each locus. The number of
isolates with each specific MLSSR type and the associated percentage of isolates sharing that
type are also represented.
N* represent the number of isolate with this MLSRR type.

The 11 SSR loci were characterized for all 38 MAP isolates. The analysis identified 18
types among the 38 MAP isolates recovered from the bovine faecal samples (Table 3.2).
Out of the 18 MLSSR types detected, 10 were unique for one isolate (2.6%). The other
8 genotypes where shared among the remaining 28 isolates. The most prevalent type
(MLSSR type 4) was identified for 9 isolates which represented 24% of the strains
characterized. Loci 1 and 2 were highly polymorphic with four and five different alleles
respectively whereas loci 3, 4, 5, 10 and 11 didn’t show any polymorphism. Two
variable alleles were observed for the loci 6, 7, 8 and 9.
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Six of the MLSSR types detected in this study (6, 7, 8, 9, 12 and 13) have not been
recorded elsewhere to the best of our knowledge. The MLSSR profile of all 38 Irish
bovine MAP strains is shown in Table 3.2 of the supplementary material.
The Unweighted Pair Group Method with Arithmetic mean (UPGMA) algorithm
from the program "DendroUPGMA" divided the 18 MLSSR types into two main
clusters A and B (Figure 3.4). The cluster A contained 92% (35 of 38) of the isolates
recovered from cattle from 16 Herds located in different areas in Ireland. MAP strains
were further divided into two groups A1 and A2. A1 contained 32 isolates divided into
13 subtypes whereas A2 only distinguished 3 isolates into 2 types (MLSSR 13 and 17).
The cluster B contained three unique patterns, MLSSR t>TDes 8, 16 and 18. The 6
previously unidentified types (6, 7, 8, 9, 12 & 13) did not cluster and were well
distributed among Al, A2 and B as seen in Figure 3.4.

Location

Herd

2

Region 2- Region 4
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MI5SK:

4

Region 2

HC-H2-H3

4MI5Slt9

3

Region 3 • Region 2
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Figure 3.4: MLSSR dendogram. Dendogram representing the genetic relationships among 38
Irish MAP isolates determined by the analysis of 11 SSR loci. The dendogram was generated by
the Unweighted Pair Group Method with Arithmetic mean (UPGMA) algorithm from the
program "DendroUPGMA" (http://genomes.urv.cat/UPGMA) [I5J.
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3.4.2 VNTR typing
To detect differences in repeat numbers, PCR products were analysed by melting
curve profile and conventional gel analysis (Figure 3.5). VNTR types were then
assigned on the basis of the unique combination of alleles for each locus (Table 3.4).

Figure 3.5: Example oj a VNTR profile for a number of MAP strains
The PCR products were analyzed by electrophoresis using 3% agarose gel, as described in the
materials in methods. The size of the amplicons were determined using the molecular weight
marker (HyperLadder V, Bioline)
a. VNTR profile at TR 292 for 19 MAP strains. 8 strains have 3 copies ofTR 292 (300 bp) and
11 strains have 4 copies (353bp)
b.VNTR profile at TR25 for 19 MAP strains. Only 1 strain has 2 copies of TR 25 (292 bp)
whereas all the other strains have 3 copies (350bp).

VNTR
type
1
2
3

No. of
%
isolate
47.4
18
19
50
1
2.6

292

X3

25

47

3

7

10 32

3
4
4

2
2
2

3
3
2

3
3
3

2
2
2

2
2
2

2
2
2

8
8
8

Table 3.4: Allelic profile at 8 VNTR loci for 38 MAP isolates
Analysis of 8 TR loci described by Thibault et al. (2007) [7] among 38 MAP bovine strains
isolated in Ireland. The number of TR of each locus was identified and the VNTR types were
allocated on the basis of the unique combination of alleles for each locus. Number of isolate for
each VNTR type and the percentage among the isolates are also given.
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The analysis of the 8 TR loci identified 3 subtypes among the 38 MAP strains isolated
from different location in Ireland (Table 3.4). Resjjectively, VNTR type 1 and type 2
were present in 47% and 50% of the MAP isolates whereas VNTR type 3 was only
characterized for 1 strain (2.6%). Only 2 loci (TR 292 and TR 25) were iK)lymorphic
with two variable alleles (3-4 and 3-2) but the allelic distribution for these markers was
not equal. Only one isolate contained 2 TR at the locus 25 giving a unique type (VNTR
type 3, 42232228). Due to the rarity of this allele (at locus 25), the PCR product was
sequenced to confirm the validity of this result (Figure 3.5).

ATCC
V 7

IGGOtlGGGGTCCAICnGGaaGCYCATAaaOASTCGGTGACGlUtCGGGItlGCXI 6G

AICC

CGCGCcfccGGCGAGTCGGCCCGaCCTGCGOlCCCCGCTGCGCGGWlTGCnCGlCGCCG 120

V

CGCGCqXGGCGAGlCSGCCCGaCCTGCGCACCCCGCTGCGCGGAATGCnCGTCGCCG 120

TGGaiTGG5GTCCMCTTGGCTCTGCYCATXCTaCJJU;TCGGT»CGWlCGG(aTGCM 60

3tbp______________________
7

58 bp
____
OAICACCCAacaGCKJlTCCCGCTGCGCGG^GCnCCTCGCCGGG 160
TCXCCCACTCCTGCGCATCCCGCrGCGCGGAAIGCTTCGTCGCCGGG 160

______

_______

58 bo

________________

AICC

C&lCCCauaCGCCTGCTCaGCGCXICCCGaACGCGGAATGCnCOTCGCCGGGail^O

V

Cl...................................................................................................................................................... 1162

7

r?
AICC
V

7

AICC
V 7

.

j

ACGTTATCCGCaAIGACaaGCCCCGaCACCGTnACACCACGTCGTGGTGCGGaA 300
ACSnATCCGGaAIGACCTaGCCCCGaCACCGTnACACCACGTCGTGGTGCGGaA 242

CTGCCACCGGaGAIGACCGIGCTCAAGICCAA 333
CrGCCACCGOaGAIGACCGIGCTCAAGICCAA 275

Figure 3.5: VNTR Profile at locus 25 for MAP isolate V 7
Sequences of the isolates V7 and ATCC strain containing the tandem repeat 25 were aligned
using ClustalW. Tandem repeat of 58 bp are framed in red. MAP ATCC strain contains 3 TR at
locus 25 while Vet 7 contains only 2.
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For the locus 292, 3 tandem repeats were observed for 18 isolates (47.4 %) and 4 for 20
isolates (52.6 %) respectively. The program "DendroUPGMA" couldn't divide the 3
VNTR types into clusters because the number of variables was too low. The VNTR
profile of all 38 Irish bovine MAP strains is shown in Table 3.3 of the supplementary
material.

3.4.3 Calculation of the discriminatory power
The index of discrimination index (DI) was calculated on the basis of the allele
frequency and the number of alleles. The DI of the MLSSR loci ranged from 0 (No
discrim.ination for the locus 3, 4, 5, 10 and 11) to 0.746 (locus 2) and gave an overall DI
ofO.923.
The index of discrimination of the VNTR loci was 0.512 for the locus 292 and 0.053
for the locus 25 with an overall DI of 0.540. The allelic distribution and DI of the
polymorphic loci are given in Table 3.3 and Figure 3.6.

1
7 (33)
8
(3)
10 (1)
11 (1)
N"
Df

4
0.244

2
9
10
11
12
13

(5)
(12)
(14)
(5)
(2)
5
0.746

Allelic distribution
MLSSR typing
6
7
8
4 (33) 5 (35) 4 (27)
5 (5) 6 (3) 5 (11)

2
2
2
0.234
0.422
0.149
0.923
0.941

9
4 (14)
5 (24)

2
0.477

VNTR typing
292
25
3 (18) 3 (37)
4 (20) 2 (1)

2
2
0.512
0.053
0.540

Table 3.3: SSR and VNTR allelic distribution and discrimination index
The number of alleles, the number of MAP strains () and the discriminatory power (DI) were
described for each polymorphic loci (6 SSR and 2 TR). The discriminatory power of the two
typing methods alone and combined was also calculated.
No discrimination for MLSSR locus 3, 4, 5, 10 and 11 and TR X3, 45, 3, 7, 10 and 32.
“N, Number of alleles
^DI was calculated using the equation described by Hunter and Gaston [14]
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Allelic distributioB of SSR aod ^'NTR Lod

Disdibotim

Figure 3.6: SSR and TR allelic distribution for 6 polymorphic SSR and 2 TR
The numbers on each segment represent the number of repeats for that particular locus e.g. TR
292, 50% had 4 repeats and 50% had 3 repeats
MLSSR loci: One allele appears predominant for every locus in over 60% of the strains except
for locus two in which 4 out of 5 alleles are more or less equally represented.
VNTR loci: Only one isolate contain 2 TR at the locus 25. For the locus 292, 2 alleles were
almost equally distributed (47 and 53%).
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3.4.4 Combination of MLSSR and VNTR typing
The combination of the two methods based on the most useful 8 markers (6 SSR and
2 TR) created 22 distinct subtypes. Upon analysis, 6 MLSSR-VNTR types appeared
more than once (Table 3.5). Of these, the most prevalent type, MLSSR-VNTR 20 was
detected in 8 isolates (21 %). The addition of 2 polymorphic TR created an extra 4 types
(18 MLSSR types and 22 MLSSR-VNTR). An overall D1 of 0.941 was obtained by
using SSR and VNTR typing in combination compared to 0.540 for VNTR typing alone
and 0.923 for MLSSR typing alone (Table 3.3).
Interestingly, one sample generated a unique VNTR type 3 which also generated a
unique MLSSR type 7 which thereby validated the consistency of both methods (Table
3.6).
MLSSR*
SSR-VNTR
Types

1
2
3
4
5
6
7

8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

No. of
isolate

2
4
1
1
1
1
1
1
3
3
1
1
1
1
1
1
1
1
1
8
2
1

VNTR**

%

1

2

6

7

8

9

25

292

5.2
10.4
2.6
2.6
2.6
2.6
2.6
2.6
7.8
7.8
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
21
5.2
2.6

7
7
7
7
7
8
8
8
7
7
7
7
7
7
7
11
7
10
7
7
7
7

10
9
11
10
11
12
11
9
11
12
12
10
13
13
11
11
11
11
11
10
11
11

4
4
4
4
4
4
4
5
4
4
4
4
5
4
4
5
5
4
4
4
4
5

5
5
5
5
5
5
6
5
5
5
5
5
5
6
6
5
5
5
5
5
5
5

4
4
4
4
4
4
4
5
5
4
5
5
5
4
4
5
5
4
4
4
4
5

4
4
4
5
5
5
5
5
4
5
4
4
5
5
5
5
5
5
4
5
5
5

3
3
3
3
3
3
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

3
3
3
3
3
4
4
3
3
4
3
3
3
4
4
3
3
4
4
4
4
4

Table 3.5: Allelic profile at 6 SSR loci and 2 TR loci for 38 MAP isolates
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*MLSSR described by Amomirt et al. (2004) [10], SSR loci 3, 4, 5. 10 and II not polymorphic,
data not shown
**VNTR described by Thibault et al. (2007) [7]. TR loci X3, 47, 3, 7, 10 and 32 not
polymorphic, data not shown
MLSSR - VNTR types were obtained by the combination of SSR alleles and TR alleles for each
locus. Number of isolate for each MLSSR - VNTR type and the percentage among the isolates
are represented.

3.4.5 Genot>'ping and epidemiology
During this study 38 individual MAP cultures were recovered from 18 different
herds. Fourteen herds yielded a single MAP isolate. The remaining four herds produced
multiple isolates ranging from 2 (H4) to 11 (HI) (Table 3.6). Two main VNTR types
were detected across the 18 herds (VNTR 1 and 2) accounting for 97.4% of all the
isolates. In contrast, 18 MLSSR types were recorded. In some herds a predominant
MLSSR type emerged. For example in herd HI, 73% were recorded as type 4, whereas
in others (H2 and H3) no single dominant type was detected.
As the discriminatory power of VNTR is less informative, limited epidemiological
information was obtained from these results. MLSSR typing on the other hand proved
far more useful. Some types such as 2, 4, and 5 were each detected in three unrelated
herds. Other types (e.g. 6, 7, 11, 12 and 15) were unique across this study and were only
detected once.
Collectively, the largest cohort in this study was 13 isolates recovered from 4 herds
in the county of Region 2 (which comprises 11% of the Irish state). When this group
was analysed using VNTR results the majority (77%) belonged to VNTR 1. When the
same cohort was analysed using MLSSR typing, 8 MLSSR genotypes were recorded,
the most predominant of which was MLSSR type 2 (31%) occurring in three of the
herds (Table 3.6 and Figure 3.7).
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N
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Herd Id
HA
HB
HC
HD
HE
HF
HG
HH
HI
HJ
HK
HL
HM
HN

Location
Region 1
Region 2
Region 2
Region 1
Region 1
Region 3
Unknown
Unknown
Region 3
Region 3
Region 3
Unknown
Region 4
Region 1

11

HI

Region 4

6

H2

Region 2

5

H3

Region 2

2

H4

Region 5

MLSSR *
07-11-4-5-4-4
07-10-4-5-4-4
07-09-4-5-4-4
07-11-4-5-4-4
07-11-4-5-4-5
08-12-4-5-4-5
08-11-4-6-4-5
08-09-5 -5 -5 -5
07-11-4-5-4-5
11-11-5-5-5-5
07-11-4-5-5-4
07-11-5-5-5-5
07-10-4-5-4-4
07-11-5-5-5-5
07-10-4-5-4-5
07-10-4-5-4-5
07-10-4-5-4-5
07-10-4-5-4-5
07-10-4-5-4-5
07-12-4-5-4-5
07-12-4-5-5-4
10- 11 -4-5-4-5
07-10-4-5-4-5
07-10-4-5-4-5
07-10-4-5-4-5
07 -09-4-5 -4-4
07 -09-4-5 -4-4
07-12-4-5-4-5
07-11-4-5-4-5
07-12-4-5-4-5
07-10-4-5-4-5
07 -09-4-5 -4-4
07-10-4-5-5-4
07-11-4-5-5-4
07-11-4-5-5-4
07-13-5-5-5-5
07-13-4-6-4-5
07-11-4-6-4-5

Type
3
1
2
3
5
6
7
8
5
16
9
17
1
17
4
4
4
4
4
10
11
18
4
4
4
2
2
10
5
10
4
2
12
9
9
13
14
15

VNTR**
3-3
3-3
3-3
4-3
4-3
4-3
4-2
3-3
3-3
3-3
3-3
3-3
3-3
4-3
4-3
4-3
4-3
4-3
4-3
4-3
3-3
4-3
4-3
4-3
4-3
3-3
3-3
4-3
4-3
4-3
3-3
3-3
3-3
3-3
3-3
3-3
4-3
4-3

Type
1
1
1
2
2
2
3
1
1
1
1
1
1
2
2
2
2
2
2
2
1
2
2
2
2
1
1
2
2
2
1
1
1
1
1
1
2
2

Table 3.6: MLSSR and VNTR profile with geographic distribution
N, number of isolates
*SSR loci 3, 4, 5, 10 and 11 not polymorphic, data not shown
**TR loci X3, 47, 3, 7, 10 and 32 not polymorphic, data not shown
The geographic distribution of MLSSR and VNTR types identified for 38 MAP isolates
recoveredfrom 18 herds in Ireland.
The first 14 strains were recovered as single isolates from different individual herds. The
remainder (24) were isolatedfrom 4 distinct herds (H1-H4). Three isolates from herds HG, HH
and HL were donated from a previous study (2005). It was not possible to assign an original
source to these isolates and they are recorded as source “unknown ” in this figure.
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lMLSSRTvpe2
IML5SR Type 9
IMLSSR TypelO
IMLSSRType 1
I

MLSSR Type 4

I

MLSSR Type 5

I

MLSSR Type 12

I

MLSSR Type 13

I V^^^R Type 1
I VNTR Type 2

Figlire 3.7: Genotypes of region 2 isolates
a: MLSSR types for MAP strains isolated in region 2.
h: VNTR types for MAP strains isolated in region 2.
8 MLSSR types and 2 VNTR types were identified among the 13 MAP isolates recoveredfrom 4
herds located in region 2.

3.5 Discussion
Short sequence repeats (SSRs) or variable number of tandem repeat (VNTR) have
been used to differentiate many mycobacterial species including Mycobacterium
tuberculosis [16], Mycobacterium leprae [17], Mycobacterium ulcerans [18] and MAP

[7,10,19].
VNTR types 1 and 2 accounted for 97.4% of all isolates characterized. These 2 types
were also the most represented in a previous study [7] (70% of all the isolates tested). In
our collection, only TR 292 and 25 were polymorphic with a discrimination index of
0.512 and 0.053 respectively and an overall DI of 0.540. VNTR type 3 (which was
found in a single isolate here) has also been detected in one cattle strain isolated in
Germany recently [8].
In this study 18 MLSSR subtypes were identified among the 38 MAP isolates.
According to the allelic distribution, some SSR loci were more polymorphic than
others. As seen in previous studies [7] and [10] the SSR loci 3, 4, 5, 10 and 11 were not
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variable for cattle strains and therefore were not able to differentiate any of the 38
strains. In relation to the discrimination index, the best SSR markers for this strain
collection were 2, 9, 8, 1,6 and 7 in decreasing order. The DI of the highly polymorphic
locus 2 was 0.746 and the overall Dl of the SSR typing was 0.923. Similar results were
found by previous studies [20,21].
Traditionally, loci 1 and 8 are seen as the most discriminatory of the 11 SSR
available [10]. Hence these markers have been widely used to analyze MAP diversity
[22,23]. In our study, only 6 sub-types were generated using loci 1 and 8 among the 38
isolates giving a DI of 0.532. By using the most discriminative SSR markers in this
study (SSR markers 2 and 9), nine sub-types were detected v/ith a DI of 0.86 which
highlights the importance of selecting multiple loci (Table 3.4 of the supplementary
material).
Out of the 18 MLSSR types obtained among the 38 Irish cattle strains, 2 types were
previously characterized for American cattle strains [ 10] and 11 from cattle strains
isolated in France [20]. These findings could be explained by the fact that most Irish
cattle are traditionally imported from Europe.
Recent studies have combined two or three genotyping methods to improve the
discrimination power to differentiate MAP Strains. Sevilla et al. (2008) combined pulse
field gel electrophoresis and MLSSR at locus 1 - 8 and found a DI of 0.855 [23].
Mobius et al. (2008) combined IS900-RFLP, 3 MIRU and 6 VNTR and found a DI
0.997 [8]. The combination of the 2 typing methods in our study based on the 8 most
discriminative markers produced 22 distinct genotypes giving a maximal DI of 0.941
(Table 3.3).
In general the VNTR typing method described here was found to be useful for
producing broad epidemiological data especially in terms of establishing the inter-
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relatedness of strains. For example, within the herd H1 VNTR type 2 was found to be
predominant (91% of all isolates, n= 10). Furthermore, all isolates from H3 (VNTRl)
and H4 (VNTR 2) shared the same VNTR type (n=5 and n=2 respectively). When
examined for geographic trends this technique proved that within the largest cohort of
samples collected (Region 2, n=13), VNTR type 1 was 2.5 times more prevalent than
VNTR type 2 (77% and 23% respectively). In contrast, VNTR Type 2 was found in
91% of all isolates recovered from Region 3 (n =10) (Table 3.6).
MLSSR

typing

proved

to

be

much

more

extensive

and

informative

epidemiologically, particularly for producing unique genetic fingerprints. For example
in herd H3, all 5 isolates were found to be VNTR type 1 which suggests that the isolates
were genetically identical. When examined using MLSSR analysis these 5 isolates were
classified under 4 distinct MLSSR types (Table 3.6). Furthermore, upon initial
investigation of the Region 5 isolates both strains were typed as VNTR 2. This implies a
close link with the other 17 Type 2 isolates recovered throughout the country. MLSSR
analysis was more discriminative and generated 2 distinct types (14, 15) which were not
recorded elsewhere in this study (Table 3.6) indicating that although these 2 isolates are
related to other VNTR type 2 isolates they are not identical (Table 3.6). This highly
discriminative data is invaluable when attempting to track the transmission and
persistence of a particular genotype nationally and internationally.
Furthermore, although a predominant MLSSR type emerged in herd HI (type 4), the
presence of 3 other MLSSR types within the same herd may reveal the introduction of
many infected animals with different genotypes (MLSSR types 10, 11 &18) within the
same farm (Table 3.6). This highly discriminative epidemiological data could not be
picked up by VNTR typing alone in this study.
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This is the first molecular epidemiology study for MAP in Ireland. A better
knowledge of the genetic diversity of the pathogen is critical to control the disease
nationally and internationally. Strain differentiation using MLSSR and VNTR typing
will be invaluable to track infected animals and monitor strain diversity and virulence.
In conclusion, despite the limited number of samples available, combined SSR and
VNTR typing is highly discriminative for Irish MAP isolates. Both methods produce
numerical genotypes and are therefore convenient for online comparisons and
phylogenetic analysis which are greatly required in epidemiology studies. Some
markers are more polymorphic than others and should be applied routinely for
genotyping. The introduction of an internationally standardised genotyping system for
MAP is urgently needed.
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3.6 Supplementary' material
Name

Sequence

Tai^et

SSRIF

TCAGACTGTGCGGTATGGAA

SSRIR

GTGTTCGGCAAAGTCGTTGT

SSR2F

GTGACCAGTGTTTCCGTGTG

SSR2R

TGCACTTGCACGACTCTAGG

SSR3F

ATCCAACGCCATGTACTCGT

SSR3R

GAGCAGCATCGAGGTGAAAC

SSR4F

GTTCTCGATGGACAGCTTGC

SSR4R

GGAGGACGAACCACACTCAT

SSR5F

TGTCGAACTTGCTCTTGGTG

SSR5R

CGTCCTGCAACATCTTCTCC

SSR6F

GAATCGTCTTGCCTCACTGC

SSR6R

TCGAGCAACTGATCTCCACA

SSR7F

CGGCAATACCTCGAACAGAT

SSR7R

GCTGAAGAGGTCGTGCAGAT

SSR8F

AGATGTCGACCATCCTGACC

SSR8R

AAGTAGGCGTAACCCCGTTC

SSR9F

GACAAGTTCGGGTTGACCAC

SSR9R

AGTTCCTCGACCCAGTCGT

Locus 1
Locus 2

SSRllF CTGGAGTGGAAGAGCAGTCC
SSRllR GCTGCGTTACCTCAACACC
CCACAGGGTTTTTGGTGAAG
GGAAATCCAACAGCAAGGAC

Locus 4

Locus 6

Aironsni ct aL, 2004

Locus 7
Locus 8
Locus 9
Locus 10

SSRIOR GTATTCGGTGCGGATCTCCT

TR32R

Locus 3

Locus 5

SSRIOF CTGGAACGTGTCCGAATTG

TR32F

Reference

Locus 11
Locus 32

TR292F CTTGAGCAGCTCGTAAAGCGT
TR292R GCTGTATGAGGAAGTCTATTCATGG
TRX3F

AACGAGAGGAAGAACTAAGCCG

TRX3R

TTACGGAGCAGGAAGGCCAGCGGG

TR25F

GTCAAGGGATCGGCGAGG

TR25R

TGGACTTGAGCACGGTCAT

TR3F

CATATCTGGCATGGCTCCAG

TR3R

ATCGTGTTGACCCCAAAGAAAT

TR7F

GACAACGAAACCTACCTCGTC

TR7R

GTGAGCTGGCGGCCTAAC

TRIOF

GACGAGCAGCTGTCCGAG

TRIOR

GAGAGCGTGGCCATCGAG

TR47F

CGTTGCGATTTCTGCGTAGC

TR47R

GGTGATGGTCGTGGTCATCC

Locus 292
Locus X3
Locus 25
Thibault ct aL, 2007
Locus 3
Locus 7
Locus 10
Locus 47

Table 3.1: Nucleotide sequence of the primers used for MLSSR and VNTR typing
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Isolates Location

LOCI

MLSSR Type

Moo

HA

07 -11 -5 -5 -5 -4 -5 -4 -4 -5 -5

3

VET 1
VET 2
VET 3
VET 4
VETS
VET 6
VET 7
VET 8
VET 9
VET 10
VET 11
VET 12
VET 13
VET 14

HB
HC
HD
HI

07 -10 -5 -5 -5 -4 -5 -4 -4 -5 -5
07 -09 -5 -5 -5 -4 -5 -4 -4 -5 -5
07 -11 -5 -5 -5 -4 -5 -4 -4 -5 -5
07 -10 -5 -5 -5 -4 -5 -4 -5 -5 -5
07 -11 -5 -5 -5 -4 -5 -4 -5 -5 -5
08 -12 -5 -5 -5 -4 -5 -4 -5 -5 -5
08 -11 -5 -5 -5 -4 -6 -4 -5 -5 -5
08 -09 -5 -5 -5 -5 -5 -5 -5 -5 -5
07 -11 -5 -5 -5 -4 -5 -4 -5 -5 -5
11 -11 -5 -5 -5 -5 -5 -5 -5 -5 -5
07 -11 -5 -5 -5 -4 -5 -5 -4 -5 -5
07 -11 -5 -5 -5 -5 -5 -5 -5 -5 -5
07 -10 -5 -5 -5 -4 -5 -4 -4 -5 -5
07 -11 -5 -5 -5 -5 -5 -5 -5 -5 -5

1
2
3
4
5
6
7
8
5
16
9
17
1
17

07
07
07
07
07
07
07
10
07
07
07
07
07
07
07
07
07
07
07
07
07

4
4
4
4
4
10
11
18
4
4

502
510
522
1
3
4
5
6
15
17
38
39
40
41
42
43
72
84
92
96
98
110
144

HE
HF
HG
HH
HI
HJ
HK
HL
HM
HN

HI

H2

H3

H4

-10
-10
-10
-10
-10
-12
-12
-11
-10
-10
-09
-09
-12
-11
-12
-10
-09
-10
-11
-11
-13
07 -13
07 -11

-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5

-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5

-5
-5
-5
-5
-5
-5
-5
-5
-5
-5

-5
-5
-5
-5
-5
-5
-5

-5
-5
-5
-5
-5
-5
-5

-5
-5
-5
-5
-5
-5

-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -5 -4
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -4
-4 -5 -4 -4
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -5
-4 -5 -4 -4
-4 -5 -5 -4
-4 -5 -5 -4
-4 -5 -5 -4
-5 -5 -5 -5
-4 -6 -4 -5
-4 -6 -4 -5

Table 3.2: MLSSR profile of 38 Irish bovine MAP strains
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-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5
-5 -5

2
2
10
5
10
4
2
12
9
9
13
14
15

Isolates Location

LOCI

VNTR Type

Moo

HA

3-2-3-3-2-2-2-8

1

VET 1
VET 2
VET 3
VET 4
VETS
VET 6
VET 7
VETS
VET 9
VET 10
VET 11
VET 12
VET 13
VET 14

HB
HC
HD
HI

3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-2-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8

1
1
2
2
2
2
3
1
1
1
1
1
1
2
2
2
2
2
2
2
1
2
2
2
1
1
2
2
2
1

H3

3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8
3-2-3-3-2-2-2-8

1
1
1
1
1

H4

4-2-3-3-2-2-2-8
4-2-3-3-2-2-2-8

2
2

502
510
522
1
3
4
5
6
15
17
38
39
40
41
42
43
72
84
92
96
98
110
144

HE
HF
HG
HH
HI
HJ
HK
HL
HM
HN

HI

H2

Table 3.3: VNTR profile of 38 Irish bovine MAP strains

145

a. MLSSR profile at 2 Loci (1-8)
1 ~8
7 4
8 4
8 5
7 5
11 5
10 4
Dl=

b. MLSSR profile at 2 Loci (2 - 9)

No. isolates
25
2
1
8
1
1
0.532

2~9

No. Isolates

10 4
9 4
11 4
10 5
11 5
12 5
9 5
12 4
13 5
Dl=

3
4
5
9
9
4
1
1
2
0.86

Table 3.4: MLSSR profile and discrimination index at 2 loci (I -8) and (2 - 9)
Six MLSSR subtypes were found using the two highly polymorphic locus 1 and 8 (a) with a
discrimination index of 0.532 while 9 subtypes were identified using locus 1 and 9 (b) (with a DI oj
0.86).
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Chapter 4

Chapter 4

Analysis of the mycobactin operon within the
Mycobacterium avium subsp. paratuberculosis
genome using bioinformatics and PCR to evaluate
its potential as a diagnostic target

To be submitted for publieation
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4.1 Abstract
The Mycobacterium avium complex (MAC) comprises a group of closely related
organisms that includes pathogens of birds, livestock and opportunistic pathogens of
humans. Among the pathogenic clone of MAC, Mycobacterium avium subsp.
paratuberculosis (MAP), causes Johne’s disease, a gastroenteritis of ruminants which is
prevalent in domestic livestock worldwide. Accurate diagnosis of MAP using molecular
assays is difficult because of the similarity with other members of MAC (> 97% with
Mycobacterium avium subsp hominissius or MAH genome). However, MAP organisms
are unable to produce mycobactin for in vitro cultivation. This phenotypic characteristic
is used to distinguish MAP from other mycobacteria. A cluster of genes (mbtA-mbtl),
responsible for the mycobactin synthesis were first found in Mycobacterium
tuberculosis, and homologs have been identified in MAP and MAH. Significant
differences in primary structure and length within the mycobactin operon were shown
between MAP and MAH. The aim of this project was to screen the entire mycobactin
operon using bioinformatics and subsequent PCR to evaluate its potential as a
diagnostic target. In total, 37 genes were screened by in silico analysis. Of the 37 genes
analyzed, 5 genes (end of mbtA gene, MAP2179, MAP2180, MAP2187 and MAP2196)
were predicted to be unique to MAP and were then tested by PCR after designing
primers for each individual new target. To evaluate specificity, targets were tested by
PCR against 30 MAP isolates and 26 MAC isolates (20 MAH, 4 Mycobacterium
intracellulare, 1 Mycobacterium avium subsp. avium or MAA and Mycobacterium
avium subsp. silvaticum or MAS). Among these five targets, one (MAP2196) was not
MAP specific and produced a positive PCR result for MAH and MAS. The other 4 were
found to be MAP specific but 3 targets were not ideal (not positive for all MAP isolates
or produced either primer-dimer or nonspecific products) leaving one target (MAP
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2179) with the best speeifieity. The sensitivity of this target was then evaluated by PCR
and the limit of detection was found to be one genome equivalent detected after 35
cycles of real time PCR.

4.2 Introduction
The Mycobacterium avium complex (MAC) comprises a group of closely related
slow growing mycobacteria including M. avium subsp. paratuberculosis (MAP), M
avium subsp. avium (MAA), M avium subsp. hominissuis (MAH), M. avium subsp.
silvaticum (MAS) and M. intracellulare. Mycobacterium avium isolates are highly
prevalent in the environment and are associated with infection in humans and livestock
fl]
MAP is the causative agent of paratuberculosis, a chronic granulomatous enteritis
affecting mainly ruminants but also other species [2]. Paratuberculosis causes economic
losses to fanners and dairy industries worldwide [3]. MAP is also implicated as a
possible cause of Crohn's disease in humans and the zoonotic potential of the organism
represents a significant public health threat [4].
Accurate diagnosis of MAP has been hampered by the lack of specific assays mainly
because of its high degree of genetic similarity to other members of the MAC. A
previous study showed the genomes of MAP and MAH share greater than 97%
nucleotide identity [5], The variability within MAP and the existence of two hostassociated types (cattle strain or "C" type and sheep strain or "S" type) is one more
concern and the capacity to differentiate between them is essential for the detection and
the control of MAP [6]
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The sequencing of the genome of MAP (Strain KIO) [7] and the closest related MAH
(Strain MAH 104) has enabled direct nucleotide-nucleotide comparison to examine
genetic relatedness of the two organisms. These genomic comparisons are particularly
important to develop specific diagnostic assays to detect MAP.
Previous work has identified several genetic markers present in MAP: IS900, F57,
ISMav2, 1SMAP02, ISMpal [8]. Although most of these sequences are proven to be
unique to MAP and are widely used for diagnosis, their specificity remains unclear
[9,10]. Consequently, there is a need to find alternative PCR targets to confirm the
presence of MAP.
One of the major phenotypic differences between MAP and most other mycobacteria
is its inability to produce mycobactin, a key requirement for growth in the laboratory
[7]. Mycobactin is a siderophore which facilitates the acquisition of extracellular iron,
which is essential for the growth and virulence of mycobacteria. A cluster of 10 genes in
Mycobacterium tuberculosis (mbtA-J) has been shown to be responsible for the

production of mycobactin and the transport of iron [11] Homologs to the mycobactin
synthesis operon mbtA-J were identified in MAP and MAH genomes. However, a direct
comparison of the mycobactin cluster in MAP with MAH showed significant
differences in the composition and length of the amino sequence [7] (Figure 4.1).

The objective of this study therefore was to thoroughly analyze the mycobactin operon
in the MAP genome and using bioinformatics and subsequent PCR, evaluate its
potential as a diagnostic target for MAP.
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4.3 Materials and Methods
4.3.1 Bioinformatic analysis

In the MAP KIO genome (NC_002944.2), all the genes of the mycobactin operon
were analyzed using bioinformatics.

Protein BLAST

The putative function of each individual protein was first assessed by Protein
BLAST. The amino acid sequence of each protein was searched against the nonredundant protein sequence data using the default parameters of the "Position-Specific
Iterated BLAST" (PSI-BLAST) program.

Nucleotide BLAST

Subsequently, all the individual genes were tested for uniqueness by nucleotide
BLAST (Basic Local Alignment Search Tool) analysis against all the identified genes
deposited in GenBank.
The "megablast" program which compares highly similar sequences was first used on
all the gene sequences. The degree of coverage and the percentage identity between
MAP genes and other members of MAC was recorded. A gene was considered
homologous when the similarity between sequences was higher than 70% for a
minimum coverage of 70%. A gene was considered specific when no similarity other
than MAP was found. When genes were found to be MAP specific, a second program
"blastn", which compares somewhat similar sequences was used to confirm the
specificity. All analysis using megablast and blastn were carried out with default
parameter settings.
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An alignment between MAP KIO and MAH 104 (NC_008595) was also performed
using ClustalW (EBI website) over all homologous genes of the mycobactin cluster.
In order to test the specificity of the genes predicted to be unique for MAP, primers
were designed using PrimerSelect (Lasergene® v7.0, DNASTAR) and tested
subsequently by PCR.

4.3.2 Bacterial strains
To evaluate the specificity of the different PCR assays, 30 MAP isolates, 20 MAH
isolates, 4 M intracellulare, 1 MAA isolate and 1 MAS isolate were used (Table 4.1).
MAA (ATCC 25291), MAS (ATCC 49884) and MAP (ATCC19698) were obtained
from the DSMZ strain collection in Germany. Nineteen MAP strains were isolated from
Irish cattle and were characterized as "C type" as previously described in Chapter III.
Ten MAP isolates were obtained from the Basque Institute for Agricultural Research
and Development, Neiker-Tecnalia (Spain) and were characterized as "Sheep type"
according to IS1311 PCR-REA [12]. The presence of the IS900 sequence was also
confirmed by PCR for every MAP strain. MAH and M intracellulare were isolated
from clinical samples from St James Hospital (Dublin) and were confirmed using 16S
typing and IS 1245/IS1311 PCR typing [13].
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No. of strains Species
1
1
1^
I9A

8®
2®
20*^
4^

MAA (ATCC 25291)
MAS (ATCC 49884)
MAP (ATCC 19698)
MAP
MAP
MAP
MAH
M. intracellulare

Type Source

"C"
"C"
"S"
"S"

Origin

Germany*
Germany*
Cattle Germany*
Cattle Ireland
Sheep Spain
Goat
Spain
Human Ireland
Human Ireland

IS900 PCR*^
.

+
+
+
+
-

-

Table 4.1: Bacterial strains used
* DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH) collection strain
20 MAP strains were identified as cattle type or "C" as previously described in Chapter III
^10 MAP were identified as sheep type or "S" according to ISI311 PCR-REA [12]
^20 MAH and 4 M. intracellulare were identified according to IS1245/IS1311 PCR [13]
^ The presence of the IS900 element was confirmed by PCR for all MAP strains [14]

4.3.3 Culture and preparation of mycobacterial DNA

Mycobacterium avium species (MAH, MAA and MAS) and M. intracellulare strains
were grown in 10 ml of 7H9 broth supplemented with 10% (vol/vol) oleic acidalbumin-dextrose-catalase (OADC; Becton Dickinson, UK) and 0.2% Glycerol. This
medium was supplemented with 2 pg/ml of Mycobactin J (Synbiotics Europe) to grow
MAP. The cultures were incubated at 37°C on a shaker at 200 rpm for 2-3 weeks for the
non MAP isolates and for at least 6 weeks for MAP.
Mycobacterial DNA was prepared using the GITC lysis buffer and phenol chloroform
extraction as previously described in Chapter 11. All the DNA samples were then
normalized to 25 ng / pi.

The identification of putative specific MAP genes (using BLAST analysis) was
followed by the design of primers to evaluate the specificity of each new target by PCR.
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43.4 PCR

Specificity'
To evaluate the specificity of each new target, a PCR was performed on 26 non-MAP
isolates (20 MAH isolates, 4 M intracellulare isolates, 1 MAA isolate and 1 MAS
isolate) and 30 MAP isolates (20 cattle strains and 10 sheep strains)
Each reaction mixture consisted of 2X LightCycler® 480 SYBR Green I Master
(Roche) (containing the FastStart Taq DNA Polymerase, reaction buffer, dNTP mix,
SYBR Green I dye and MgCb), 0.5 pM of each primer, and PCR grade water. Each
PCR reactions included 25 ng of mycobacterial DNA. Negative controls consisted of
reaction mixture alone. Samples were run according to the following conditions: 1 cycle
at 95 °C for 10 min and 35 cycles at 95 °C for 10 s, [61 - 64 °C]^ for 3 s*, and 72 °C for
[6 - 22 s]^. PCR products were analysed by melting curve profile and conventional gel
analysis.
* The annealing time was less than 5 s as recommended by the kit to increase the
specificity of primer binding.
Primers for each target had different annealing temperature ranging between 55 to
64 °C and specific extension time ranging between 6 to 22 s (depending on the size of
the products) (Table 4.5).

Sensitivity
The sensitivity of each specific assay was evaluated with known amounts of MAP
DNA. The concentration of purified MAP DNA was determined using a Nanodrop®
spectrophotometer (ND-1000) and the number of copies of a template was estimated
using the "dsDNA copy number calculator" (URI Genomics & Sequencing Center). The
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number of copies required (10^ 10^, lO'*, 10^, 10^, 10* and 1 copy) were then obtained
by serial dilution. PCR targeting MAP specific genes was carried out in duplicate on all
the DNA extracts and amplified products were analyzed using melting curve profile and
gel electrophoresis.

4.4 Results
4.4.1 Preliminary results
In a previous study, the direct comparison of the mycobactin operon (mbtA-J) in
MAP with the operon in MAH revealed significant differences which are described
below [7] (Figure 4.1).

Figure 4.1: Mycobactin operon oj MAP and MAH genomes
The name oj the genes is shown and the size (nucleotide) is indicated below.
Comparison of the MAP mycobactin cluster with MAH revealed 3 regions presenting
differences:
(1) Amino acid sequence of the mbtA-J cluster
(2) The sequence separating mbU and mbtl: ~5.7 kb in MAH / 7.2 kb in MAP
(3) LSPU in MAH/LSP^12 in MAP
This figure was adapted from the homology comparison of the mycobactin cluster betw^een
MAP, MAH and Mycobacterium tuberculosis [7]
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The first difference (1) was observed in the primary structure of the mycobactin
genes. In MAP, the mycobactin operon is composed of 12 genes compared to 11 in
MAH and some genes (MAP2176, mbtA and mbU) differ in size. Although the
comparison of the amino acid sequence in the mbtA-J cluster between MAP and MAH
showed a high homology (from 84.5% for MbtA to 100% for MbtH), differences at the
nucleotide level may be present.
The second difference (2) is the size of the sequence separating mbtl and mbU genes.
In MAH they are separated by a ~ 5.7 kb sequence whereas in MAP, there is a ~ 7.2 kb
gap between the 2 genes.
The third and most important difference (3) between MAP and MAH is the large
sequence (now identified as large sequence polymorphism or LSP) separating mbtA and
mbtJ [15]. In MAH, LSP‘^4 is ~197kb long, while in MAP KIO this sequence is
replaced by a 19kb insert (now called LSP*’12) which truncates the mbtA gene and
encodes a 400 aa-protein compared to 551 residues in MAH 104.

The 12 genes of the mycobactin operon and the two sequences separating mbtA, mbU
and mbtl have not been analysed in detail at the nucleotide level for the development of
a diagnostic assay to detect MAP.
The objective of this study was to screen the entire mycobactin operon using
bioinformatics and subsequent PCR to evaluate its potential for MAP diagnosis.

4.4.2 Bioinformatics
In the MAP KIO genome (NC_002944.2), the 12 genes of the mycobactin operon as
well as all the individual genes present between mbU, mbtl and mbtA (LSP*’12) were
first tested for uniqueness by nucleotide homology analysis to find specific MAP genes.
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(1). Mycobactin operon (12 genes cluster)

mbtH

M-\P
KIO

mb(G

MAP2I76

MAP2I72
I

L

mb(E

mbtF

mbtD

mbtJ

D□

mbtB
mbiC

mbtl

mbcA

(0-

Figure 4.2: Mycobactin operon

The mycobactin cluster in the MAP genome is composed of 12 genes (from mbtH_3 to
mbtl) and is 24760 bp long (Figure 4.2 and Table 4.2).

Name

location

mbtH 3
mbtG
mbtF
MAP2172C
mbtE
mbtD
mbtC
MAP2176C
mbtB
mbtA
mbtJ
Mbtl

2400353 - 2400568
2400549 - 2401835
2402034 - 2406272
2406269 - 2407534
2407531 - 2412810
2412812 - 2415853
2415850-2417178
2417175 - 2417939
2417948 - 2421445
2421552 - 2422754
2442083 - 2443087
2450285 -2451637

Size
(nt)
216
1287
4239
1266
5280
3042
1329
765
3498
1203
1005
1353

% coverage
100%
100%
100%
100%
100%
100%
100%
100%
100%
84%
100%
100%

megablast
% identity to MAH 104
99%
99%
98%
99%
98%
98%
99%
99%
98%
99%
98%
99%

Probable function
Unknown function
lysine-N-oxygenase
putative suUbtransferase
linear gramicidin synthetase subunit D
bnear gramicidin synthetase subunit D
acyl transferase
erythronobde synthase
phenyloxazoline synthase
phenyloxazoline synthase
2,3-dihydroxybenzoate-AMP ligase
alpha/beta hydrolase
salicylate synthase

Table 4.2: BLAST analysis of the mycobactin cluster mbtA-J
The degree of coverage and the percentage of identity with the members of MAC are indicated
for the 12 genes of the mycobactin operon.
The location, the size and the probable function of each individual gene is also show in the
Table.

The probable function of the genes was predicted from the best hit of the protein psiblast. Most of the proteins are enzymes involved in the synthesis (synthase or
synthetase) of mycobactin. No function has been assigned to the mbtH_3 protein. The
putative function of the 2 proteins (MAP2172c and MAP2176c) was the same as mbtE
and

mbtB

proteins

repectively (linear gramicidin

phenyloxazoline synthase).
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synthetase

subunit

D

and

All MAP genes present in the mycobaetin operon were found to be homologous with a
pereentage of identity greater than 98% to the MAH mycobaetin genes (Figure 4.3).

MAPKIO

AICJAGCGCCAACCCCTTTGACGACGACACCGC3ACCTTCGTGCTGCTGGTCAACGACGAG

MAV104

ATGAGCGCCAACCCCTTTGACGACGACaCCGCSACCTTCGTGGTGCTGGTCJVACGACGAG 60

60

)su>iao

GACCAGCACAGCCTGTGGCCGACCTTCGCCGASACGCCCCCGGGCTGGCGCGTGGTCnC 120

MAV104

GACCAGCACAGCCTGTGGCCGACCTTCGCCGAGACGCCCCCGGGCTGGCGT6TGGTCTTC

120

MAPKIO

GGTGCGGCCGGCCGCGCCGACTGCCTGCAGTACGTGGAGCAGAATTGGTCGGATATCCGG 180

MAV104

GGTGCGGCCGGCCGCGCCGACTGCCTGCAGTACGTG6AGCAGAATTGGTCGGATA1CCGG

KAPKIO

CCXAAGAGCaGATCGAGGCGCTCGCCGGCGAGTAG 216

MAV104

CCCAAGAGCCTGATCGAGGCGCTCGCCGGCGAGTAG 216

180

Figure 4.3: Representative nucleotide alignment oj mbtH gene in MAP KIO and MAH 104
showing 99% nucleotide similarity.

Only mbtA gene presents a degree of coverage lower than 100% (84%) to MAH 104
due to the truncation of the mbtA gene in MAP. This gene is 1203 bp long (400 amino
acid or aa) in MAP compared to 1656 bp (551 aa) in MAH genome (Figure 4.4). Over
the 1203 bp, the homology is close to 100% and therefore this target is not a suitable
candidate for a MAP-specific PCR-based diagnostic.
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lomo MSpmppAsviiiGmFPAi3UJJiy»A%6unsiuai:riiLiryuutRHFi»iAviiASGG 60
MAV104 MSPmPPAGVIOGmFPAEIUJAYIUASUfTQUIIlTlLIDMBian^ORTAVIQASGG 60

MAPKIO T6r5YAGU£QAMRAAAGUJ)ASlAP6!»VLIQIPHGCQrAVAlJALlJtASAIPVMCIPG 120
MAV104 TGFSYAGLIEQAKIUJUlGIAIAGIAP&IlRVU^LPKGCQIAVAIJrAURASAlPVMCIPG 120

MAPKIO BIUkA£L6EFAALS0AIALLIAD7AAGFDYRIKAAGLIE£B£AIAEVIVI)6DPGPFlSNAQ 160
MAV104 BRAAELGHFAALSQATAUIADTAAGmRTMAAGIVEEHEAlAEVrVDGDPGPIXSHAQ 180

MAPKIO LCERAPAGRPATPVDPGSPALLLVSGGnGTPKLlPRlHKDYVraATASAELCGLTRDDV 240
MAV104 LaRAPAGRPATPVDPGSPALUVSGGnGTPKLIPRIHDDYVFHAMASAElCGLTRDrfV 240

MAPKIO yLAVLSAGHHrPlACPGUGAMTVGATTVrGTDPSPtAAfATIARHGVTVIALVPALAKL 300
MAV104 YlAVLSAGHNFPLACPGUGAMTVGATTVTGTDPSPEAArATlARHGVTVrALVPALAia 300
MAPKIO MA0ACEIffDNPPKSIiUiC^’t5GAKLEADrSARVIRSALR................................................336
MAV104 MAHACEWEIMPPKSIJUiQVGGAKLEADDARVlRSALTPGLQOVrGMAEGUlIYTRLDDP 360

MAPKIO ........................................... VRPAKIASSSATQAAQLMR................... RAETP.......... EP 364
MAV104 PEITEHTQCaPLSTADCVRWDAAGNPVAPGQEGEUVRGPnniGYfRAERKIQRCfllA 420

MAPKIO QGTSRH........................................................................ -........................SVTAMPQ— 377
MAV104 QGrTRSGDLVRVRDDGYLWTGRVKrVlCRGGETISAADLEEQMLSHPAirSAAAVPLPD 480

MAPKIO ................... -................................................ AEONFAGMSATITHIXS-............ KKAS 398
MAV104 PYLGEKICAAWFEGPALSLAEUIGYLDCRGVAAHARPD'/LAAMPSLPrrPIGKIDKKAI 540

MAPKIO CK——.......... 400
MAV104 ANQVSARNRRF 551

Figure 4.4: Representative amino acid alignment ofmhtA gene in MAP KIO and MAH 104
In MAH 104, the mhtA gene encodes a 551 aa protein whereas in MAP the protein is truncated
and encodes a 400 aa protein.

Because of the very high DNA homology between the mycobactin cluster in MAP and
MAH, it was decided that it was not feasible to design a specific MAP PCR assay.
For this reason the attention turned to the second differential region: sequence
separating mbU and mbtl genes.
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(2). Sequence between mbtl and mbtl

mbU

mbtl

MAP
KIO

mbiA
^ -

MAP2202C
1
1

12000
MAP219a>|

IMP2199 :i

14000

MM>2200

>1

MM>2201 >

MAP2204C''
IfiOOO

< ____K

_____!<.______ 1

Figure 4.5: Sequence between mbU and mbtl

The sequence separating mbU and mbtl is 7197 bp long and is composed of 7 genes
listed in the Table 4.3 below;
Name

Location

Size (nt)

MAP2198
MAP2199
MAP2200
MAP2201
MAP2202
MAP2203
MAP2204

2443089 - 2443937
2443962 - 2444882
2444798- 2446381
2446396 - 2447322
2447656 - 2448204
2448201 -2449421
2449462-2450145

849
921
1584
927
549
1221
684

megablast
Probable function
% coverage % identity’ to MAH 104
100%
98%
oxidoreductase
100%
99%
putative reductase
flavin-binding monooxygenase
100%
99%
100%
98%
transcriptional regulator
100%
96%
Fatty acid desaturase
99%
83%*
IS900 transposase
74%
100%
Fatty acid desaturase

Table 4.3: BLAST analysis oj the sequence separating mbU and mbtl
The degree of coverage and the percentage identity with the members of MAC are indicatedfor
the 7 genes separating mbU and mbtl.
The location, the size and the probable function of each individual gene is also shown in the
Table.
*83% identity to MAA (IS1613).

The probable function of all individual genes was assigned by protein blast. These
include 5 enzymes (involved in the energy and lipid metabolism), a transcriptional
regulator and a mobile element (or insertion sequence).
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Of the 7 MAP genes separating mbU and mbtl, six were found to be homologous to
MAH with a percentage of identity greater than 96% in (Table 4.3 and Figure 4.6) and
one gene (the IS900 sequence) was homologous to the IS 1613 element in
Mycobacterium avium subsp. avium (MAA).

taLP2202

-------------------------------------------------------------------------------------------------------------- TTiacaACCTC

MAV1793

11
TTCAGCCCCGGCC&CAATCAGCAGGGCG&CATGTTCGCCGAGAGCCTGTTCGACTCGGTC 4BD

MAP2202

ATTGAGAATCTCaTTCCAGCJ^TTCGCCACCCGCCTCTCCCACCCCAACACCGGCAAACT 71

MAV1793

&T-CTATCTCTC3LTTCX3lCGAATTCCCC3iCCCCCCTCTCCCACCCC3J^CCCGC3UUlCT

MAP2202
MAV1793

CTCCAACGACCCSATCCCCGACCACTTCXTCGCCACCGTCTCCCACGACaAAXACCTGCA 131
CTCC&ACGACGCGATCGCCGAGCACTTCATCGCCAGGGTCTCGCACGACCAAAACCTGCA 599

KU>2202
MXV1793

CATGATCTTCTACCGGGACGTCAGCGCCGCGGGCCTGGXTATCGCACCGAATCAAGCCAT 191
CATCXTCTTCTACCCGCXCCTCaCCSCCSCCCCCCTCGATXTCCCACCSAXTCXXCCCAT 659

KXP2202
MAV1793

SAACTCCCTCCACCCGXTTCTCCGCAATTTCAASATCCCCGG&TTCACGGTGCCCGACTT 251
GAACTCCCTCCACCCCATTCTCCCC&ATTTCAACATCCCCCGATTCACCCTCCCCGACIT 719

MU>2202
MXV1793

TCCCCGCAACCCCCTGATCATCCCCCTCCCCCCTCTCTATCACCCACCCATCCATCTCCA 311
TCCGCCCAACGCSGTCATCATCCCCCTCCCCCCTCTCTATCACCCACCCATCCATCTCCA 779

)aiP2202
MAV1793

CGAGGTCCTCATGCCCCTCCTCAASAAATSCCCCATCTTCGAACGCSAASACTTTACCSC 371
CCASCTCCTCATCCCGGTCCTCAAGAAATGGCGCATCTTCGAACGCCAACACTTTACCCG B39

MA.P2202
MXV1793

CGAGGCCGCCCSAATGCGCGACGATCTCCGCCTGCTGGTCAAGGAGCTCCAGGATGCGTC 431
CGAGGCCGCCCGAATGCGCCACGATCTCGGCCTGCTGGTCAAGGACCTGCAGGATGCGTC B99

MM>2202
MAV1793

CCASAAATTCCASCAATCCAACCACCCCTACCTCCAACCTCACCCACCCASCACCGASAA 491

MAP2202
MAV1793

AATCACCGCCACCAAACTCTTCCAAACCAAASGAACCCTCACGCTCAGCCGCCArrCA S49
AATCACCGCCAGCAAACTGTTGCAAACGAAAGGAACGCTGACGCTGAGCCGGCATTGA 1017

S39

CGASAAAXTCGACCAATCCAACCAGCSCTACCTCGAACGTCASGCACCCASSACCSASAA 959

Figure 4.6: Representative nucleotide alignment between MAP (MAP2202) and MAH
(MA V_1793) genes, showing 96% identity.

The main difference of the sequence separating mbtJ and mbtl therefore between the
MAP and MAH genome is the presence of the IS900 element (encoded by MAP 2203)
which divides the gene encoding for fatty acid desaturase into 2 genes (MAP2202 and
MAP 2204) (Figure 4.7).
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Figure 4.7: Representation oj the insertion sequence (13900) dividing the fatty acid desaturase
gene in MAP into 2 genes MAP2202c and 2204c. Homology’ between these 2 genes and the fatty
acid desaturase in MAH (MA V_1793) is also shown in the figure.

Because of the multiple examples of diagnostic PCR which targets the 1S900 element, it
was found that this region (2) was not a suitable location for a PCR test. This focused
the attention on the third region LSP^'H.

(3). LSP*^!!
LSP^12 is located in the mycobactin operon between mbtA and mbtJ. LSP^12 is
19441 bp long, starts in the mbtA gene at the position 2422564 of the MAP genome and
finishes just before mbtJ gene at the position 2442004 (Figure 4.8). It is composed of
18 genes (MAP2179-MAP2196) listed in the Table 4.4 below:

Figure 4.8: Large sequence polymorphism LSP'^ 12
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Gene

IxtcatioB

Size

megaUast

endofnnbtA
2179
2180c
2181c
2182c
2183c
2184c
2185c
2186c
2187c
2188c
2189
2190
2191
2192
2193
2194
2195
2196

2422564 - 2422754
2422801 - 2423262
2423251 - 2423676
2423686 - 2424372
2424369 - 2424803
2424796 - 2426086
2426043 - 2426828
2426828 - 2428057
2428054 - 2428482
2428504 - 2429586
2429625-2431169
2431456 - 2432691
2432688 - 2433713
2433698 - 2434777
2434774 - 2436108
2436134-2437276
2437270 - 2438850
2439276 - 2440622
2440707 - 2441528

191
461
426
687
435
1251
786
1230
429
1083
1545
1236
1026
1080
1335
1137
1581
1347
822

MAP*
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAP
MAH 104''
MAP
MAP
MAP
MAt»

blastn
% coverall | % identit> to MAH 104
MAP
MAP
MAP
14%
38%
30%
98%
60%
90%

100%
84%
87%
100%
93%
77%
MAP

35%
91%
91%
91%
87%
85%
91%
53%

96%
89%
72%
74%
74%
94%
72%
95%
MAP

Probable faBction

Unknown finction
Unknown finction
trarncrptional regulator. TetR &nily
Uikmwn finction
Cytochrome P450
short-chain dehydiogenase/reductase SDR
amidohydrolase 2
Aldehyde Dehydrogenase
Alddiyde Detaydn^euse
AMP-dependent synthetase and figase
Virulence factor Mce fam^ prot
Vhifcnce factor Mce family prot
Virulence fiictor Mce fitmily prot
Viulence factor Mce family prot
Virulettce factor Mce family prot
Virulence factor Mce family prot
Unknown finction
diiydrodipicoliDate reductase

Table 4.4: BLAST analysis of the large sequence polymorphism LSP' 12 in MAP genome
The nucleotide homology between MAP KIO and other members oj the MAC using "megablast"
and "blastn" is given in percentage (% coverage and % identity). MAP specific genes are
highlighted in blue whereas the genes homologous to MAH 104 (% of identity > 70%) are
highlighted in green.
*No similarity to member of MAC (other than MAP) was recorded.
^53% coverage / 74% identity to MAH 104

The probable function was determined for 14 proteins (including transcriptional
regulator, cytochrome P450, multiple enzymes and a cluster of 6 proteins involved in
virulence). No function has been assigned to the proteins encoded by MAP 2179, MAP
2180c, MAP 2182c and MAP 2195 genes.
Using "megablast" which compares only highly similar sequences, 17 genes were
found to be specific to MAP (no similarity other than MAP was observed).
When all the genes were compared to somewhat similar sequences using "blastn"
program, eight genes were homologous to Mycobacterium avium 104 sequences (with a
percentage of coverage and identity higher than 70%) (yellow) and six genes presented
nucleotide similarities with MAH 104 but the percentage of coverage was lower than
70% (Table 4.4). Interestingly, five regions (end of mbtA gene and 4 genes 2179,
2180c, 2187c and 2196) were found to be unique for MAP (green). None of these genes
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were identified in other members of the MAC complex. The decision was taken to focus
on these regions.
To check the specificity of these genes by PCR, several primers were designed by
PrimerSelect program (DNASTAR) for each individual gene. The sequences of a subset
of these primers, the size of the PCR products as well as the specific annealing
temperature and extension time used for the PCR are shown in Table 4.5.

Name

5' Sequence 3’

MmbtAF GTGCGGCCGGCGAAGACG
MmbtAR GAAGGTGCGGGAAAGTTGCTGACA
M79F

TCCACGTCGAGGGCAGATAC

M79R

AACCCGCGTCGAAGGAGGATTG

M80F

CACCGGGCCGCTGGACTGC

M80R

TGCCCGGCCGGAAAGAAATACAC

M87F

CGTCGAGCGGGCGCAAATACT

M87R

CCGCCAGCGTCGAGCCCGTGAA

M96F

CCGCCGAAGCCGACCATCAGA

M96R

TCACCGCCCACCGTCCATAGC

Gene

Product
size

Tm^

Ext
time®

End of
mbtA

163 bp

63 °C

7s

2179

288 bp

61 °C

12 s

2180c

177 bp

62 °C

8s

2187c

530 bp

64 °C

22 s

2196

136 bp

61 °C

6s

Table 4.5: Primers sequences targeting 5 genes oj the LSP^ 12 for the detection of MAP
^ Optimal Tm (recommended by PrimerSelect) usedfor the PCR.
^ extension time usedfor the real time PCR
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4.4.3 PCR
Specificity of the target
To evaluate the specificity of the primers, a PCR was performed on 26 non MAP
isolates and 30 MAP strains (cattle type and sheep type) (Table 4.6). The specificity of
the target was calculated by dividing the number of non-MAP with PCR negative
results by the total number of non-MAP isolates and multiplying by 100. The inclusivity
was calculated by dividing the number of MAP PCR positives by the number of MAP
isolates tested and multiplying by 100 [16].
The first region (end of mbtA) was found to be specific (100%) for MAP; all the
other MAC DNA samples were negative by PCR. However, the inclusivity of the target
was 80%; six DNA samples (Sheep type) were negative. The presence of primer-dimer
and non-specific products was observed on the melting curve profile and later
confirmed by gel electrophoresis analysis. This target was excluded because of the
partial inclusivity and the presence of primer-dimer and non-specific products.
The MAP2179 PCR produced a positive result for all MAP isolates (both cattle and
sheep types) and didn’t amplify any of the MAC isolates. The inclusivity and specificity
was excellent (100%) (Figure 4.8 and Figure 4.9).
The target MAP2180 was also specific for both types of MAP (100%), with a
maximal inclusivity (100%). However, the PCR amplified a nonspecific product for
MAA DNA sample and was excluded for this reason.
The MAP2187 PCR was completely specific to MAP (100%); all the MAC isolates
produced a negative result. However, this target was excluded because the inclusivity
was not maximal (93%), 2 MAP DNA samples (one cattle and one sheep type) were
PCR negative (Figure 4.10).
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The last target (MAP2196) was not 100% specific to MAP (92%), one DNA sample of
MAH and MAS produced a positive result by PCR. Also, two small peaks were
detected by melting curve analysis and were lightly visible upon conventional gel
analysis.
All samples which gave equivocal results were re-tested and confirmed.

Target

End of
mbtA

PCR
resuk

AL4P "C"

MAP "S"

MAH

MAA

MAS

M mtr

loclosh'in

Specificit>'

b=20

n=10

b=20

b=1

u-1

0=4

(%)

(•/i)

+

20

4

0

0

0

0
80

100

-

0

6

20

1

1

4

+

20

10

0

0

b

0
100

100

-

0

0

20

1

1

4

+

20

10

0

0

0

0
100

100

-

0

0

20

1

1

4

+

19

9

0

0

0

0
93

100

-

1

1

20

1

1

4

+

20

10

1

0

1

0
100

92

-

0

0

19

1

0

4

2179

2180

2187

2196

Table 4.6: Specificity and inclusivity of the 5 targets predicted to he unique in the LSP'’l2 of
MAP
A positive PCR test signifies that the gene tested for is present. Inclusivity was calculated as
follows: number of MAP isolates with positive PCR test / number of MAP isolates tested x 100.
Specificity was calculated as follows: number of non-MAP isolates which were negative by PCR
/ number of non-MAP isolates tested x 100.
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288 bp

-ve CTL

Figure 4.8: Melting curve profile of the PCR targeting 2179 and conventional gel analysis
MAP “C” and MAP “S" type are both PCR positive and represented by a peak. The 26 non
MAP isolates were negative.

288 bp

Figure 4.9: Melting curve profile oj the PCR targeting 2179 and conventional gel analysis
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AU the MAP samples were positive.

Figure 4.10: Conventional gel analysis of PCR products after amplification of the MAP2187
gene. Out of the 30 MAP isolates tested 2 isolates (one cattle type and one sheep type) were
negative*.

The PCR assay targeting MAP2179 was MAP speeific (100%) for the two main types
of MAP (cattle and sheep) and didn't produce any primer-dimer or unspecific products.
Having proven the potential of this target to detect MAP, the sensitivity of the target
was then evaluated by PCR.

Sensitivity of the PCR assay
PCR targeting MAP2179 was carried out in duplicate on the DNA samples (MAP
ATCC19698) with specific template copy number* (10^, 10^, lO'^, 10^, 10^, lO' and 1
copy) and the amplified products were analyzed using absolute quantification and gel
electrophoresis.
* As there is only one copy of the MAP2179 gene, the number of copies of a template
can be expressed as genome equivalents.
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Figure 4.11: Sensitivity of the MAPI 179 PCR
Graph showing the sensitivity of the real-time PCR assay with purified PCR product from the
MAP2179 target as the template (10^, !(/, 10^, 1&, l(f, lO' and 1 genome equivalents)
Corresponding gel showing the specific 288 bp PCR product

The experimental limit of detection was found to be one genome equivalent as detected
by 35 cycles of RT-PCR. MAP2179 PCR product for the DNA sample containing 10^
genome equivalents was detected after 16 cycles of PCR. MAP2179 PCR product for
the DNA sample containing 1 genome equivalent was detected after 29 cycles of PCR.

The highest concentrated DNA sample (containing 10^ genome equivalents) started to
amplify the product after 16 cycles of PCR and the lowest concentrated DNA sample
(containing 1 genome equivalent) started to amplify the product after 29 cycles of PCR.
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4.5 Discussion
Specific and sensitive diagnostic tools are required to develop control programs to
eradicate Johne’s disease.The completion of the MAP KIO genome has provided key
insights for the development of comparative genomic studies and molecular diagnostic
assays [7]. Several targets were previously identified in the MAP genome and are
widely used for diagnosis [8]. However, the specificity of some targets is uncertain and
the development of alternative markers is crucial to confirm the presence of MAP
[9,10]. Moreover, accurate molecular assays to detect MAP are limited by the very high
DNA similarity with other members of the MAC complex. Therefore the target selected
for am.plification in a PCR based diagnostic assay needs to be chosen with an
appropriate degree of specificity.
As MAH, the closest relative to MAP (>97% nucleotide similarity), can successfully
produce mycobactin, differences in the mycobactin cluster between the 2 organisms can
be exploited to develop specific PCR assays to detect MAP.
The direct comparison of the mbtA-J cluster between MAP and MAH revealed
amino acid differences in the 12 genes involved in the mycobactin biosynthesis (1) and
differences in the sequences separating mbtA, mtbJ and mtbl (2) and (3). The aim of
this study was to screen these 3 regions using Bioinformatic tools and PCR to evaluate
their diagnostic potential. The first objective was to test the entire mycobactin operon
(1), (2) and (3) for uniqueness (using BLAST analysis) to find a specific MAP gene or
sequence (sequence with no similarities with any other MAC members).
The 12 genes (mbtA-J), MAP2172 and MAP2176 were found to be homologous to
the mycobactin genes in MAH with a nucleotide similarity between 98 and 99%. The
main difference observed in this gene cluster was the size of the mbtA gene which is
1203 bp in MAP compared to 1656 bp in MAH. This high homology between the 2
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organisms was first shown at the amino acid level [7] and made this region impractical
for the design of a specific diagnostic PCR assay.
The second region analysed was the sequence separating mbtJ to mbtl. Among the 7
genes present in this region, 6 were predicted to be homologous with MAH genes with a
similarity ranging from 96 to 100 %. The presence of the IS900 element (encoded by
MAP2203) dividing the gene encoding for the fatty acid desaturase into 2 genes
(MAP2202 and MAP2204) was the main difference between MAP and MAH. Because
this insertion sequence has been widely used as a target for diagnostic PCR, this focused
the attention on the third region, the large sequence separating mbtA and mbtJ.
This large sequence is now identified as the large sequence polymorphism LSP^12.
LSPs were first revealed by microarray-based genomic comparison and are found to be
highly polymorphic among MAC isolates [15]. LSP^12 appeared to be unique to MAP
isolates and is present in both cattle and sheep strains [16]. This large sequence has been
already used to identify MAP. However most of the studies only amplified both ends of
the sequence to indicate its presence in the genome [17]. LSP^12 was never
characterized completely. In MAP KIO, LSP’"l2 is composed of 18 genes (NAP2179MAP2196). By using the "megablast" program, 17 genes were found to be specific to
MAP. Where the same genes were analyzed using the "blastn" program, only 5 genes
were found to be specific to MAP, and 8 genes were homologous to MAH genes with a
nucleotide similarity higher than 70%. Among these 8 genes, 5 belong to a cluster
encoding mce family protein, involved in virulence. Megablast and blastn programs
have different algorithms to compare the sequences. Megablast is optimized for aligning
highly similar sequences and producing closest matches to the query sequence. On the
other hand, blastn is optimized for comparing somewhat similar sequences and finding
sequence that can show a greater degree of variation. The different degree of similarity
173

identified by the 2 programs explains the different results found for the BLAST analysis
and highlights the importance of running several alignments with different parameters
to validate experimental findings. Homology analysis using bioinformatics only
compares genes for which the sequence information is currently available within public
database. A lot of mycobacterial species are not fully sequenced yet (such as MAA,
MAS and M intracellulare). Therefore it is important to confirm the specificity of a
target by PCR.
To evaluate the specificity of the 5 genes predicted to be unique for MAP, a PCR
was performed on each target after designing the primers. Of the five targets tested, four
were found to be completely specific to MAP (all the non-MAP isolates were negative)
and one target (MAP2196) gave a positive result for the MAS isolate and one MAH
isolate (92% specific). The inclusivity of the 5 targets varied from 80% (mbtA gene) to
100% (MAP2179, MAP2180 and MAP2196). The 3 targets (mbtA gene, MAP2187 and
MAP2196) were all excluded for further analysis because of the lack of specificity and
or inclusivity. MAP2120 was completely specific to MAP with a maximal sensitivity
(100%) but was excluded because of the presence of a non-specific product. The gene
having the best potential as a diagnostic target was the selected fragment of the
MAP2179 gene (100% specific and 100% inclusive). The sensitivity of the PCR assay
targeting MAP2179 was then evaluated by amplifying serial dilutions of MAP genomic
DNA (10^-1 o' genome equivalents) in real time PCR. The limit of detection was found
to be 1 genome equivalent detected after 35 cycles of PCR. However the limit of
detection was only performed on purified MAP DNA (MAP 19698) and should be
further tested from MAP cells in a variety of matrices.
In this study, we propose the MAP2179 gene as a specific and sensitive novel target
for MAP diagnosis. However, further evaluation of this assay should be carried out to
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validate and standardize the assay. The speeificity of the target should be evaluated
against a broader number of isolates, in the presence of an internal control. The
reproducibility of the assay should also be evaluated.
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Chapter 5

Rapid identification and differentiation of
Mycobacterium avium subsp. paratuberculosis
strains using a combination of real time PCR and
High Resolution Melting analysis
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5.1 Abstract
Mycobacterium avium subsp. paratuberculosis is a serious animal pathogen that can
infect a wide variety of hosts. Three types of MAP have been identified by different
typing methods: type I (“sheep”), type II (“cattle”) and type III (“intermediate”). Strain
differentiation through genotyping is a useful tool for epidemiological analysis and is
useful to track the spread of MAP. High resolution melting (HRM) analysis is a novel
molecular technique that can be used to differentiate sequence variation within PCR
amplicons. A DNA sequence variation has previously been observed between sheep and
cattle types of MAP. The objective of this study therefore was to evaluate the potential
of this target to differentiate MAP strains by using a combination of real time PCR and
HRM. For this purpose, 44 MAP isolates including strains from each of the 3 types
were examined. The specificity of the target was assessed by perfoming a HRM-PCR
on 80 isolates (44 MAP and 36 non MAP) and the sensitivity of the PCR assay was also
evaluated both as a diagnostic test and a typing method. The melting curve analysis
clearly differentiated the 44 MAP strains into 2 clusters; one which contain all MAP
isolates of type II and another which contains the isolates of type I and III. The 2 types
of “S” strains (I and III) were not discriminated significantly by this method.
Interestingly, the target was not completely specific to MAP as 6 Mycobacterium avium
subsp. hominissuis (MAH) isolates produced a positive PCR result. However, HRM
analysis distinguished these 6 isolates into 3 extra clusters. Overall, it appears that MAH
isolates are more similar to MAP "S" type than MAP "C" type. The sensitivity of this
target was evaluated by real-time PCR. The real-time PCR was able to detect one
genome equivalent of the target after 35 cycles of PCR. However, because the
concentration of DNA is a limiting factor for the HRM analysis, the limit of detection
for HRM-PCR as a typing method was considered to be 1000 genome equivalents.
179

In summary, this study describes the optimization and the application of a novel and
rapid HRM-PCR which clearly differentiates MAP strains into cattle and sheep types.

5.2 Introduction
Mycobacterium avium subspecies paratuberculosis (MAP) is the causative agent of
paratuberculosis, a chronic gastroenteritis of ruminants which is responsible for
significant economic losses worldwide. MAP is also considered a significant public
health threat due to its possible association with Crohn's disease in humans [ 1 ].
MAP is a serious animal pathogen which has a wide host range including ruminants,
farm animals, mammals and primates [2], and several studies have provided possible
evidence of interspecies transmission. The control of paratuberculosis requires a better
understanding of the genetic diversity of the pathogen. Strain differentiation by
genotyping is useful for studying epidemiology, pathogenesis, virulence, disease
transmission and may also provide additional insights into the mechanism of hostspecificity.
On the basis of restriction fragment length polymorphism of the IS900 element
(IS900 RFLP) MAP strains were first divided into two main groups; MAP cattle type
or "C" type (also called type II) and MAP sheep type or "S" type (also called type I) [3].
The improved discrimination of recent genotyping methods further divided MAP sheep
type into a new sub-group called "intermediary" or type III [4].
Most recent genotyping methods used to discriminate MAP strains are PCR-based
methods and target sequence variations such as single-nucleotide polymorphisms
(SNPs), insertions, deletions or variations in copy number of longer or shorter repeated
sequences [5,6,7]. High resolution melting (HRM) is a relatively new post PCR method
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that allows detection of sequence variations. Polymorphisms among DNA sequences are
distinguished by discrepancies in melting curve shape after PCR amplification using a
special nonspecific, highly saturating fluorescent dye (High Resolution Melting Dye)
(Roche). Each product can be characterized by its specific melting point, which depends
mainly on the GC content and length of the amplicon sequence.
HRM is a powerful technique for genotyping, mutation scanning and sequence
matching. This new technique has several advantages over other genotyping methods,
including the cost, the ease of use and rapidity [8].
HRM analysis have been previously described for the detection of Mycobacterium
tuberculosis [9], MAP [10] and members of the MAI complex [11]. The HRM analysis
of the type-specific nucleotide sequences in the MAP 1506 gene was able to differentiate
MAP type I, II and III [10],
A DNA sequence differing between sheep and cattle types was previously described
by Collins et al. (2002) [12]. This sequence is located between 2 hypothetical proteins
(MAP4270-MAP4269). MAP sheep type has a tandem repeat of 12 bp followed by a 4
bp linker part of which forms a 14 bp palindromic sequence. These 16 nucleotides are
not present in the cattle type and can be therefore used to distinguish between the two
types of MAP (Figure 5.1).
The aim of this study is to evaluate the potential of this target to detect and
differentiate MAP strains using High resolution melting PCR. The specificity and
sensitivity of the real-time PCR assay was also evaluated.
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ai4I*<
TCGGGACCCGGACACTCGAGACATCACCCCtagctgatatcagcttTAGCTGATATCATGCGGTAGTGCG

CattleSheep-

taaaaacccqQacactcaaaacatcacccc---------- --- Lagctgatatca cgcggtagtgcg
tqqqqacccgqacactcqaqacatxacccct’AGCTCATATCAbCTT Page tgata tea ^rcqqtaqtqcq

Figure 5.1: DNA sequence variation between cattle and sheep strains of MAP
The tandem repeat is shown in a red box and the palindromic sequence is underlined.

5.3 Materials and methods
5.3.1 Bacterial strains and culture

Forty four MAP isolates, 30 M. avium subsp. hominissius (MAH) isolates, 4 M.
intracellulare, 1 M. avium subsp. avium (MAA) isolate and 1 M. avium subsp.
silvaticum isolate (MAS) were used in this study (Table 5.1).
MAA (ATCC 25291), MAS (ATCC 49884) and MAP (ATCC19698) were obtained
from the DSMZ strain collection in Germany. Twenty nine MAP strains were isolated
in Ireland (Chapter III) from bovine faecal samples and were characterised as "Cattle
type" after amplification of the bovine specific LSP'^20 [13]. Ten MAP DNA samples
were obtained from the the Basque Institute for Agricultural Research and
Development, Neiker-Tecnalia (Spain) and were characterized as "Sheep type"
according to IS 1311 PCR-REA [14] or Type III according to pulse field gel
electrophoresis (PFGE) [4]. Four MAP DNA samples were provided as a gift by Dr.
Karen Stevenson. Those samples were extracted from sheep strains and were
characterized as Type I according to PFGE [4].
MAH and M intracellulare were isolated from clinical samples from St James
Hospital (Dublin) and were typed using 16S rRNA analysis and IS1245/IS1311 PCR
[15]
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No. of strains

Species

1
1
1^
29^
8®
2®
4^
30^
4^

MAA (ATCC 25291)
MAS (ATCC 49884)
MAP (ATCC 19698)
MAP
MAP
MAP
MAP
MAH
M intracellulare

Type

Source

Origin

"C"
"C"
"S"
"S"
"S"

Chicken
Wood Pigeon
Cattle
Cattle
Sheep
Goat
Sheep
Human
Human

Germany*
Germany*
Germany*
Ireland
Spain
Spain
Scotland
Ireland
Ireland

II
II
III
III
I

Table 5.1: Bacterial strains used
* DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH) strain collection
30 MAP strains were identified as cattle type ("C") or type II as previously described in
Chapter III
^ 10 MAP were identified as sheep type or "S" according to ISIS 11 PCR-REA [14] or type III
according to PFGE [4]
^ 4 MAP were identified as type I according to PFGE [4]
^ 30 MAH and 4 M. intracellulare were identified according to ISI245/IS1311 PCR [ 15]

5.3.2 Culture and preparation of Mycobacterial DNA
All isolates were propagated in 7H9 broth supplemented with OADC supplement,
0.2% glycerol and Mycobactin J (only for MAP isolates) as previously described in
Chapter III.
Mycobacterial DNA was prepared using the GITC lysis buffer and phenol chloroform
extraction as previously described in Chapter II. All the mycobacterial DNA samples
were standardized to 25 ng/pl prior to real-time PCR.

5.3.3 Primer design
Three primers HRMF2, HRMF3 and HRMRl were designed using PrimerSelect
(Lasergene® v7.0, DNASTAR) to amplify the region flanking the tandem repeat. These
primers were designed to produce amplicons smaller than 150 bp.
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To enable sequencing later, another set of primers (HRMFl and HRMR2) which
amplify a longer amplicon was also designed by PrimerSelect. These amplicons were
sequenced at Eurofms MWG Operon Company. Sequences were aligned using
MegAlign (Lasergene® v7.0, DNASTAR). All the primer sequences are listed in Table
5.2.

5.3.4 Optimization of the High Resolution Melting real time PCR (HRM-PCR)

All real-time PCR experiments were carried out with the LightCycler® 480 High
Resolution Melting Master Kit (Roche).
Two sets of primers (HRMF2-R1 and HRMF3-R1) were evaluated by HRM-PCR on
a subset of MAP strains (5 MAP cattle strains and 5 MAP sheep strains). The primers
giving the best results were then used for further optimization and overall testing.
Mg2+ concentrations between 1.0 to 3.5 mM and primer concentrations 0.1,0.2 and 0.3
pM were evaluated. DM SO concentrations 0 %, 5 % and 10 % were also tested.
After optimization, a typical reaction mixture (total volume, 20 pi) contained 2 mM
of MgCh (2mM), 0.2 pM of each primer, 10 pi of Master Mix, 2X cone, (containing
FastStart Taq DNA Polymerase, reaction buffer, dNTPmix, and High Resolution
Melting Dye), PCR grade water and 25 ng of DNA. A negative control consisted of
reaction mixture alone. Samples were amplified on the Lightcycler 480 (Roche) with
the following conditions: 95°C for 10 min to activate the FastStart Taq DNA
polymerase followed by 35 cycles of: 95°C for 10 sec, 62°C for 10 sec and 72°C for 4
sec.
Afterwards, amplicons were heated to 95°C for 1 min and cooled to 40 °C for 1 min.
Finally the melting curve was generated by measuring the fluorescence of the saturating
dye during a temperature increase from 70°C to 95°C. Results were analyzed using
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HRM software, which is an accessory module to the LightCycler® 480 System which
analyzes sequence variation in PCR amplicons.

5.3.5 Strain characterization of MAP
To evaluate the potential of this target to differentiate MAP strains, a real time PCR
using the optimized conditions above and the best primer set was performed on all 44
MAP DNA samples including 30 MAP II, 10 MAP III and 4 MAP I. The melting
curves were then analysed by the HRM software.

5.3.6 Specificity of the HRM-PCR
To evaluate the specificity of the HRM-PCR assay, a real time PCR was performed
on 36 non-MAP strains including, 30 MAH isolates, 4 M intracellulare, 1 MAA isolate
and 1 MAS isolate using the conditions as above. The presence or absence of a peak
was then analyzed by conventional melting curve analysis. The specificity of the HRMPCR assay was calculated by dividing the number of non-MAP which were PCR
negative by the total number of non-MAP isolates and multiplying by 100 [ 16].

5.3.7 Sensitivity of the HRM-PCR
The limit of detection of the HRM-PCR assay was determined with known amounts
of MAP DNA. The concentration of purified MAP DNA (ATCC strain 19698) was
determined using a Nanodrop® spectrophotometer (ND-1000) and the number of copies
was estimated using the "dsDNA copy number calculator" (URI Genomics &
Sequencing Center). The number of copies (or genome equivalents) evaluated to
determine the limit of detection of the HRM-PCR assay (10^, 10^, 10^, 10^, 10“^, 10^,
10 , 10 and 1 genome equivalents) was obtained by serial dilution. HRM-PCR was
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carried out in duplicate on all the DNA extracts using the conditions previously
described and amplified products were examined using quantification analysis.

5.4 Results
5.4.1 Assay optimization
Five primers were designed to amplify the region around the tandem repeat. The
sequences, the location of each primer in the MAP genome and the size of the
corresponding products are shown below (Table 5.2 and Figure 5.2).

Name

Location*

5’ Sequence 3'

HRMFl

4737907-4737930

GCGTCGCGACTTATGCAACTCCTT

HRMR2

4737729-4737748

TCCAGGCTTCGATGAGAGTC

HRMF2

4737793-4737816

GACCCGGACACTCGAGACATCACC

HRMRl

4737752-4737775

TCAACCTCCCATTTCCGCACTACC

HRMF3

4737877-4737896

GTCGCGCCGCCGTGTGAAAC

Product size
201 bp

64 bp
144bp

Table 5.2: Primers used in this stud)’ to differentiate MAP strains
*Location in the MAP genome K 10 (NC_002944.2)
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GTCAlbAAG
STTGGCTGCGTCAIISAAG—TCCCCTTGCTACTTAGCTGACCTATCTACAGGCT 55
GTCAljlGAG
CTTGACAACGTCAlIrGAGAATCCCCTTGCTACTTAGCTGACCTATCTACAGGCT
55

cattle
sheep

NL\P4270
FI
cattle
sheep

GGGTCAGCATAACCGCAGCGTCGGACAAGGCGTGGAGGAATC GCGTCGCGACTTATGCAJ^ 115
GGGTCAGCATAATCGCAGCGTCGGACAAGGCGTGGAGGAATC GCGTCGCGACTTATGCAA 115
F3

cattle
sheep

CTCCTT :AAAACCGGC 3TCGCGCCGCCGTGTGAAAC 3CAGGTCAATCCGCACCGGGATGG 175
CTCCTT :AAAACCGGC 3TCGCGCCGCCGTGTGAAAC 3CAGGTCAATCCGCACCGGGATGG 175
F2

cattle
sheep

TGATCGGTTCAAGTCGTCCGACCATGGGCGGTTGGCGACCCGGACACTCGAGACATCACC 235
TGATCGGTTCAAGTCGTCCGACCATGGGCGGTTGGGGACCCGGACACTCGAGACATCACC 235
R1

cattle
sheep

CC----------------^TAGCTGATATCAIGC 'jGIP GTGCGGAAATGGGAGGTTGA ZCI 279
CCTAGCTGATATCAECTTTAGCTGATATCAIGiGT^PTGCGGAAATGGGAGGTTGsfccT 295
* *

I

II

NLAP4269

R2
cattle
sheep

GACTCTCATCGAAGCCTGGATGGA TGCCCTC
GACTCTCATCGAAGCCTGGATGGA rGCCCTC

Figure 5.2: Alignment oj homologous DNA sequences between MAP4270-MAP4269from cattle
and sheep types of MAP. (Figure adaptedfrom Collins et al. [12])
The tandem repeat present in the sheep type is shown in a blue box and the palindromic region
is underlined. The primers usedfor the testing are shown in red boxes and the primers usedfor
the sequencing of nine isolates are shown in green boxes.

The HRM-PCR was carried out using two independent sets of primers (HRMF3-R1 and
HRMF2-R1) in order to evaluate the capacity of each set to classify a subset MAP
strains (5 cattle strains and 5 sheep strains). The melting curves obtained for each set of
primers after analysis are shown in Figure 5.3. It is clear that the set of primers
HRMF2-R1 (b) gives a cleaner signal, thus allowing a clear discrimination between the
two groups. This set of primers was therefore selected for further analysis.
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Figure 5.3: Comparison of two sets ofprimers to discriminate 10 MAP strains
(a) Melting curve analsyis of MAP strains after PCR ampijication using HRMF3-R1 primers
(b) Melting curve analsyis of MAP strains after PCR ampification using HRMF2-R1 primers

5.4.2 Strain characterization of MAP
A HRM-PCR was performed on all the 44 MAP isolates including DNA samples
from the 3 types of MAP (MAP type 11 ("C") and MAP type 1 and III ("S")). After PCR,
the melting curves were analyzed using the HRM software. The clustering of the
melting curves is based on 2 regions of the melting curve corresponding to the pre-melt
(initial fluorescence) and post-melt (final fluorescence). The first step in the analysis is
to set up the initial and final fluorescence values to uniform levels for all samples. To
obtain the best clustering, the pre-melt and post-melt regions were optimized to 78.5°C 79.5°C and 85.5°C - 86.5°C respectively (which is 4°C around the melting temperature
of the product, 82.5°C). The melting curves were then normalized to relatives values of
100% to 0% to eliminate the differences in background fluorescence. To distinguish the
different shape of the melting curves, HRM software shifted the temperature axis of the
normalized melting curve at the point where the entire double stranded DNA is
completely denatured. The default Temp Shift Threshold of 5% was used in this HRMPCR assay (Figure 5.4).
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ManiaNi*# *>4 SMfl*4 HaMtaf Carva*

Figure 5.4: Normalized and shifted melting curves of the amplified products of the tandem
repeat of the 3 different MAP types as obtained with the HRM software. The Type 11 is
represented in blue and the types 1 and 111 are represented in red.

To allow for comparison and melting curve differentiation between MAP strains, the
final step involves magnifying the melting curve differences. This is carried out by
substraeting each curve from the type II melting curve, whieh was chosen as the
reference curve or baseline thus generating a Difference Plot, which helps cluster the
samples automatically into groups that have similar melting curves (Figure 5.5).
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Figure 5.5: Normalized and temperature shifted difference plot of the melting curve of 3
different MAP types as obtained with the HRM software. Two groups were identified (blue and
red); the type II is represented in blue and the types I and III are represented in red.

The HRM-PCR assay clearly differentiated the 44 MAP isolates into 2 clusters (Figure
5.5) The first cluster (blue) contains all 30 MAP “C” type (type If) and the second, (red)
clustered 14 MAP "S" type. Even though HRM analysis didn't distinguish the 2 sheep
types I and III, it seems that the melting profile of the type I isolates (shown in a red
box) is different from the melting profile of type III isolates.
The PCR results and the differentiation of MAP strains into 2 groups were confirmed
by sequencing 9 MAP DNA samples including 3 samples of each type. The sequence of
the three MAP type II (cattle strains) lacked the tandem repeat present in MAP sheep
strains as expected. The sequence of the MAP isolates type I and type III (Sheep strains)
were identical thus explaining why they were clustered together in a different group
compared to type II (Figure 5.6). It was also observed that the sequence around the
tandem repeat appears to be conserved for all MAP isolates.
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^ ConsensTis

ACCCGCACACTCGAGACATCACCCCnGCTGiATATCAgctttagctgatatcaTGCGGTAGTGCGGAAATGGGAGGTTGACCTGACTCTCATCGj

Contig UP I 235
Contig UP I 189

ACCCGGACACTCGAGACATCAICCCC [AECTCA'TATC,
ACCCGGACACTCGAGACATC.ACCCC OGCTGA'iTAACCCGGACACTCGAGACATCAICCCCCAGCTGA’TATC,

Contig
Contig
Contig
Contig

UP
UP
UP
HAP

I 259
II 72
II 4
II ATCC

Contig HAP III
Contig HAP III
Contig UP III

ACCCGGACACTCGAGACATC.ACCCC nGCTGA'TATCA
ACCCGGACACTCGAGACATCACCCIdrAGCTGATATCA

AGCTGATATCAt CGGTAGTGCGGAAATGGGAGGTTGACCTGACTCTCATCG4
•AGCTGATATCAT CGGTAGTGCGGAAATGGGAGGTTGACCTGACTCTCATCGA
AGCTGATATCAT CGGTAGTGCGGAAATGggAGgttgaCCTGACTCTCATCGA
Tgcggtagtgcggaaatgggaggttgacctgactctcatcga

-TGCGGTAGTGCGGAAATGGGAGGTTGACCTGACTCTCATCGA
-TGCGGTAGTGCGGAAATGGGAGGTTGACCTGACTCTCATCGi
ACCCGGACACTCGAGACATCACCCI 'AGCTGATATC,A XIIT nGCTGATATCA 'GCGGTAGTGCGGAAATGGGAGGTTGACCTGACTCTCATCGA
ACCcGGACaCTCgAgACATCaCCCicfcAGCTGATaTC,lAfaCn CAgCTCATATcA 'GCGgTAGTGcGGAAATGGGAGGTTGACCTGACTCTCATCGP
ACCCGGACACTCGAGACATCACCCiCFAGCTGATATCA

ACCCGGACACTCGAGACATCACCCCfACCTGATATCACCTTrAfiniSATATCArGCGGTAGTGCGGAAATGGGAGGTTGACCTGACTCTCATCGJI

Figure 5.6: Representative alignment of the flanking region between MAP4269 and MAP4270
of 9 MAP isolates including 3 MAP type I, 3 MAP type II and 3 MAP type III. MAP isolates of
both types I and III have a tandem repeat (shown in a red box) of 12 bp followed by a 4 bp
linker which are missing in the 3 isolates of MAP type II.

5.4.3 Specificity of the target
All 44 MAP isolates including isolates Type I, II and III were positive by HRMPCR; the inclusivity was 100%. The same PCR assay was applied to 36 non MAP
strains to check the specificity of the target. MAA, MAS and M.intracellulare were all
PCR negative whereas six (of thirty) MAH isolates (MAH 3, 13, 18, 24, 30 and 35)
produced a PCR positive result (indicated by a peak in the conventional melting curve
analysis) (Figure 5.7). These 6 MAH isolates were all recovered from hospital patients
between 2005 and 2007 at St James' Hospital in Dublin. Overall, the specificity of the
target was therefore 83% based on the number of samples tested (Table 5.3).

MAP isobtes
PCR
results

Non-yLAP Isolates

MAPI
n=4

MAP II
n=20

MAPin
n=10

MAH
n=30

MAA
4=1

MAS
n=l

+

4

20

10

6

0

0

0

-

0

0

0

24

1

1

4

M. vUr
n=4

Inclasr\Tt>'

Specificity'

(%)

(%)

100°i

83%

Table 5.3: Specificity and inclusivity of the target
The specificity of the target was calculated by dividing the number of non-MAP PCR negative
results by the total number of non-MAP isolates and the inclusivity was calculated by dividing
the number of MAP with positive PCR result by the number of MAP isolates tested.
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Figure 5.7; Example of a conventional melting curve analysis of selected non-MAP strains and
2 MAP strains ("C" and "S" type) used as a positive control. Six MAH isolates produced a
positive PCR product indicated by a peak (~ 82.5°C).

The melting curves of the 6 MAH isolates that were positive by PCR were analyzed
using the HRM software with the same selected parameters as descibed for MAP. One
MAP isolate of each type was used as positive control.
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Figure 5.7 Normalized and temperature shifted difference plot of the melting curve of 6 MAH
and 2 MAP isolates. The HRM software categorized the 6 MAH isolates into 3 clusters; MAH35
was classified as a single isolate, MAH 3, 24 and 30 were grouped together, as were 13 and 18.
As expected the positive controls MAP "C" and MAP "S" were clearly distinct from these
clusters.

The high resolution melt analysis distinguished the 6 MAH isolates into 3 melting
groups represented by different eolors (pink, grey and green). The first group (pink) was
unique with only one isolate (MAH35) whereas the other two groups (grey and green)
contain 3 and 2 MAH isolates respectively. None of the MAH isolates were clustered in
the same groups as MAP strains (blue for cattle type and red sheep type) (Figure 5.7).

According to the relative signal difference, overall MAH isolates are more similar to
MAP "S" type than MAP "C" type which is identified as a distinct cluster. Interestingly,
MAH 35 seems to have an intermediate profile between MAP “C” and MAP “S”
(Figure 5.7).
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5.4.4 Sensitivity of the HRM-PCR assay
A real time PCR using the optimized conditions previously described was carried out
in duplicate on the DNA samples with specific genome equivalents (10^, 10^, 10^ 10^,
10“^, 10^, 10^, lO' and 1 genome equivalents) and amplified products were analyzed
using the absolute quantification analysis (Figure 5.8).
tetMNMt** Cw«««

Figure 5.8: Sensitivity oj the HRM-PCR
Graph showing the sensitivity of the real-time PCR assay (HRMF2-R1 primers) from the
"tandem repeat target" with MAP DNA concentration of 10^, 10^, 10^, l(f, l(f, l(f, l(f, lO' and
1 genome equivalent.

The real time PCR was able to detect one genome equivalent of the gene after 35 cycles
of PCR. The highest concentrated DNA sample (containing 10^ genome equivalents)
started to amplify the product after 12 cycles of PCR whereas the last 3 DNA samples
containing 100, 10 and 1 genome equivalents started to amplify the product after 30
cycles. Products that generate amplification after 30 cycles (due to low amount of
template DNA) typically produce un-readable High Resolution Melting results due to
amplification artefacts (data not shown). For this reason, the limit of detection of the
HRM-PCR assay was considered to be 10^ genome equivalents.
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5.5 Discussion
Most of the methods used to differentiate MAP clearly distinguish strains into at least
two main groups, the cattle type (“C”) or type II and the sheep type (“S”) or type I [3].
Recent labour intensive genotyping techniques can now divide the sheep type into a
new sub-group called intermediary type or type III. Collectively then type “S” isolates
are designated as type I/III [4],
Traditional identification and genotyping of MAP is time consuming and often
requires large quantity of high quality DNA. Molecular strain typing using PCR based
methods have considerably increased the speed of typing methods, and provide a good
discrimination for studying broad genetic diversity within MAP [10,12].
High-resolution melting (HRM) is a recent enhancement to traditional real time PCR
melting analysis and can be used to differentiate sequence variations within PCR
amplicons. The observed melting profile after PCR amplification is characteristic of a
particular DNA sample. Variations in DNA sequence are detectable because of the
change of the shape of the melting curve. As HRM provides a very simple and cost
effective alternative for genotyping, mutation scanning and sequence matching, its
popularity is growing [8].
As mentioned, HRM analysis has been previously described for the detection and
differentiation of MAP [10]. In this study, the HRM approach was based on 4 single
nucleotide polymorphism (SNP) of the MAP 1506 locus which had been sequenced
previously [17]. In total, 47 MAP strains which were recovered from 10 different
countries and different hosts and 3 non-MAP strains (MAH, MAA and MAS) were
analyzed by HRM. All the MAP isolates were discriminated into 3 clusters (type I, II
and III). However, the main limitation of this assay was the specificity of the targets
used. The melting profile of MAH isolate was clustered with MAP II isolates and MAA
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and MAS gave the same melting profile as MAP type 1. Unlike their study, our HRMPCR assay can differentiate between MAH and MAP strains.
A particular DNA sequence variation (tandem repeat of 12 bp plus 4bp linker)
between cattle and sheep type of MAP was identified by Collins et al. (2002) [12]. Our
study describes the potential of this target to differentiate MAP strains using a
combination of real time and HRM analysis. The specificity and the sensitivity of the
HRM-PCR were also evaluated.
Two separate sets of primers were designed to amplify the region flanking the
tandem region and were evaluated by HRM-PCR on a subset of MAP strains. The
HRMF2-R1 primers which amplify the smaller amplicon (64 bp ("C") and 80 bp ("S"))
gave the best melting profile allowing a clear separation of MAP strains (Figure 5.3). A
single base variation affects the melting behaviour of a 100 bp amplicon more than a
500 bp (LightCyclcr® 480 Gene Scanning Software handbook). Therefore a shorter
amplicon is more likely to show the effects of small sequence changes as evidenced
here.
In total, 44 MAP strains including (4 MAP type 1, 20 MAP type 11 and 10 MAP type
111) were used to evaluate the typing potential of the HRM-PCR assay. The analysis of
the melting curves by the HRM software clearly differentiates the 44 MAP strains into 2
groups; the first group contains all the MAP isolates cattle strains (type II) and the
second group contains all the MAP isolates sheep type (Type I / III). The sequencing of
the tandem region in 9 MAP isolates also confirms the discrimination of MAP strains
into two clusters.
The specificity of the target was assessed by running a HRM-PCR on 36 non-MAP
isolates (including 30 MAH strains, 4 M intracellulare, 1 MAA and 1 MAS). The
target was not specific to MAP as six MAH samples were also positive. Attempts were
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made to sequence the MAH amplicons but were inconclusive (data not shown). The
analysis of these 6 melting curves by HRM discriminates the 6 MAH isolates into 3
clusters, which were different to the 2 clusters identified for MAP. This illustrates the
discriminatory power of HRM and highlights the potential of this assay over other
genotyping methods (Figure 5.7).
The sensitivity of the HRM-PCR assay was then evaluated by running DNA samples
with specific amounts of template. Although the PCR assay was able to detect 1 genome
equivalent, DNA samples containing 100, 10 and 1 genome equivalents were detected
after 30 cycles. Low amounts of DNA produce variable HRM results due to
amplification artefacts. The differences observed in the melting profiles were
considered useful only for amplification reactions which occurred prior to 30 cycles of
PCR. Therefore the limit of detection of the HRM-PCR was considered to be -1000
genome equivalents (Figure 5.8). In general, the concentration and the purity of the
DNA required for HRM-PCR is an added consideration. Salt concentration in the DNA
template as well as optimized primer concentration should be as uniform as possible for
all the samples. The next phase of testing should involve the application of this assay in
conjunction with an optimized extraction strategy using spiked environmental samples.
To conclude, we have developed and described an optimized High Resolution
Melting technique based on a known sequence difference between cattle and sheep
types of MAP, capable of clearly differentiating MAP "C" type from MAP "S" type.
This genotyping technique is simple, inexpensive and provides results in less than 20
min after amplification. The finding that some MAH isolates cross-reacted with the
primer set is not unusual based on previous studies showing the high genetic similarity
between MAP and its elosest relative [18]. However their amplification did not impact

197

on the ability of this assay to classify them into a separate cluster thereby validating the
initial design and potential application of this assay.
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General Discussion
Despite uncertain estimates of the burden of paratuberculosis in livestock in different
European countries, the prevalence is thought to be significant and may be increasing
[1].

In Ireland, the exposure and transmission of MAP increased through the importation
of infected animals after the opening of the European market in 1992. Although the
current prevalence of Johne's disease among Irish herds in Ireland is lower than that
reported in many countries in Europe, it is likely that the prevalence in Ireland will
continue to rise to match rates seen elsewhere, unless appropriate preventive measures
are taken.
Model-based estimates project that if no control measures are taken the prevalence of
JD will further increase, seriously affecting the quality of domestic livestock in Europe
and elsewhere [2]. The effect of paratuberculosis at the animal level and the significant
financial losses, have been well documented [3]. However due to the fact that disease in
domesticated livestock is largely sub-clinical and non-notifiable, JD is likely to be
significantly under-reported [4]. Therefore the financial losses can be expected to be
significantly higher than reported in the literature, further supporting the need for
effective control programmes.
The most important reasons to control and eradicate paratuberculosis are the
economic losses experienced by the farming industry, as well as the zoonotic potential
of MAP. Any conceivable control programme for paratuberculosis will be based on
reducing the risk of transmission of MAP within the herd. Therefore control measures
should focus on a combination of management changes reducing the risk of
transmission between animals that shed MAP and other non-infected animals, and the

201

removal of infected animals by early detection (test and cull) or vaccination strategies
[5].
In general, vaccination is used for small ruminants, where it contributes to control
but not eradication of JD. Although experimental use of cattle vaccination has been
effective in controlling paratuberculosis [6] as well as profitable [7], interference with
the tuberculin intradermal test for bovine tuberculosis restricts its use in cattle. Because
effective vaccines are still not available in most countries in Europe, the control strategy
currently focuses on the identification and elimination of MAP infected animals and on
good management.
Control schemes for JD based on a test and cull approach depend on the availability
of suitable diagnostic assays to detect infected animals as early as possible, preferably
before transmission of MAP to other non-infected animals. However due to the slow
pathogenesis of MAP, a measurable response to many existing tests is most reliable
during the later stage of the infection. As a consequence, multiple rounds of testing over
longer periods are required to acquire reliable information of the herd status.
There are two principal themes for diagnosis of Johne's disease: the rapid detection
of the pathogen and detection of host responses directed against the pathogen. Despite
much progress in the last 10 years, globally there is a poor standardization of culture
methods; unfortunately it is against these that all other detection methods need to be
compared. Solid medium culture predominates in many countries despite the proven
advantages of liquid culture systems. Furthermore, rapid detection methods based on
PCR have proliferated in the literature but remain research tools in most instances [8].
In earlier reviews of PCR based assays for detection of MAP, it was concluded that
PCR alone for direct detection had not performed well enough to make it a practical
alternative to other diagnostic tools. Since that time, there have been considerable
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advances in PCR techniques, such that PCR holds more promise now for the diagnosis
of paratuberculosis. Significant improvements in PCR-based detection of MAP included
improvements spanning sample processing, amplification and detection methods. The
use of nested PCR, real time PCR and specific probes increased both specificity and
sensitivity which makes PCR detection an attractive diagnostic method for the detection
of MAP. However, the specificity of the target used for amplification is crucial and
PCR assays need to be validated and standardized before being commercialized. In this
context, a ready-to-use PCR kit available in veterinary diagnosis laboratories should
have a useful role to play in combination with other diagnostic tools for the control of
Johne’s disease.
VetAlert™ Johne’s Real-Time PCR is the only USDA licensed PCR Kit available in
the United States. This PCR assay utilizes a probe that targets the hspX gene, which
contains MAP specific DNA sequences that allow for molecular discrimination of MAP
from other closely related Mycobacterium species. This Real-Time PCR kit is
performing well for direct faecal analysis and culture confirmation of MAP organisms
from bovine samples [9].
In this study, we have developed a new real time PCR assay for the rapid detection of
MAP (Chapter 4). We have demonstrated the potential of a specific and sensitive novel
target for MAP diagnosis. However, further evaluation of this assay should be carried
out to validate and standardize the assay. The specificity of the target should be
evaluated against a much broader number of isolates and the sensitivity and
reproducibility of the assay should be also investigated from MAP cells in a variety of
matrices. This test could be then used to detect DNA extracted directly from bovine
faecal samples or from culture media used to amplify the agent in bovine faecal
samples. Because only one PCR kit for the detection of MAP is available, this is a great
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opportunity for Ireland to commercialize a new test to help in the diagnosis of Johne's
disease in cattle.
Meanwhile, immune recognition changes following host and pathogen contact have
been described, giving hope for early detection of infection. Through the genome
sequence of MAP, unique antigens have been identified and these provide new
opportunities for immunological tests to diagnose MAP [10].
Animal husbandry in Europe is characterized by diversity of farming systems, both
between and within countries. As a consequence, the options for introduction of control
programme depends on the difference in farming systems, but are also dictated by
financial criteria. The possible options can differ significantly between regions as well
as between animal species and the overall disease status of the herd will also be an
important determinant of what measures are applicable, if any. Because of these
different situations and the variable amount of resources available to address this
problem, a wide array of different approaches and control schemes in Europe have been
developed.
In France two national programmes have been launched in 2004: the control of JD in
infected herds and a monitoring programme of negative herds. In addition to
management changes aimed at reducing the transmission of MAP within the herd,
different testing including serology, faecal culture or PCR have been developed for the
control of MAP [11]. Austria has a compulsory control programme for paratuberculosis
since 2006. The programme is based on a surveillance of slaughtered animals and dead
animals and on regular clinical inspections of the herds by state veterinarians. Samples
of suspected animals are tested by serology and PCR by the national reference
laboratory for confirmation, and clinically ill, MAP positive animals have to be culled
within 3 days. In addition, the use of milk from elinical cases is prohibited [12]. Other
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countries such as Netherlands and Denmark developed new control programmes (2006)
which focus on milk quality and aims to reduce the amount of MAP present in milk
entering factories. In Iceland, the development of the improved heat-killed vaccine by
Sigurdsson (1952) and the subsequent introduction of a vaccination programme were
successful in controlling Johne's disease. Since 1996, vaccination has been compulsory
in endemic areas and losses have been reduced considerably [13]. In Spain, vaccination
has been the chosen strategy for the control of JD in sheep since the first cases in the
early 1970s and vaccination is now widely used. A common factor in all approaches is
acknowledgement of the need to introduce management changes to reduce transmission
and the need to warn participating herd owners that controlling paratuberculosis will
take time and efforts.
Because of the late introduction of MAP in Ireland, no effective control measures are
in place at the national level. Most control schemes are on a voluntary basis and the
initiatives and funding depend on the local situation. Most of the studies conducted in
Ireland over the last 20 years were aimed mainly at improving the general awareness of
MAP and promoting better management practices to reduce MAP transmission by
identifying infected animals using serological and culture methods. To create an
adequate control programme, it is important to focus at both farm and national level.
Improvements in diagnostic strategy as well as a better understanding of the molecular
epidemiology of the pathogen are essential to control MAP in Ireland.
Based on our experience, two different schemes should be applied to control MAP in
Ireland: the control of MAP in infected herds and the routine monitoring of negative
herds. The diagnostic strategy for both approaches should be based on PCR and faecal
culture testing. Because PCR tests produce rapid results, suspected herds or animals
should be first tested by PCR (at an interval between 6-12 months for infected herds
205

and 12-24 months for negative herds) and PCR positive animals should be confirmed
by faecal culture. The identification of infected animals should be followed by the
culling of the animal and the use of milk from those animals should be banned. Every
new imported animal should be tested after purchase to avoid the introduction of
subclinical animals. Farmers should make every effort to maintain a closed-herd policy
and continue to improve biosecurity measures in their herds to prevent the introduction
of Johne's disease.
Because MAP infects a broad range of hosts and has been associated with Crohn's
disease in humans, a better knowledge of the genetic diversity is critical to control the
disease nationally and internationally. In this regard, molecular epidemiology is
invaluable. Because of the late introduction of MAP in Ireland and also because of the
fastidious nature of the organism, Ireland lacks such information. This is the first report
of genotyping data for MAP on the island of Ireland and will be very useful for
analysing and tracking the dissemination of MAP. This study also describes the
development of an alternative typing method that can easily produce fast results. We
have developed and described an optimized High Resolution Melting technique capable
of clearly differentiating the two main types of MAP in less than 20 min after
amplification.

In summary, this project advanced our knowledge of the importance of MAP in Ireland,
through the evaluation and implementation of molecular diagnostic techniques and the
optimisation of diagnostic typing assays which produced novel epidemiological data.
Future work to control MAP in Ireland would be the validation and standardization of a
PCR method in combination with faecal culture for an effective diagnostic strategy. It is
also important to develop a national database providing epidemiological information of
206

Irish MAP strains. This database would allow spatial and temporal tracking to monitor
the diversity of MAP strains in Ireland.
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